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Group II Intron Thermophilic Reverse 
Transcriptases 
 
 
ABSTRACT 
 
 
A reverse transcription reaction allows the production of complementary DNA 
(cDNA) using an RNA template and relies on polymerases displaying reverse 
transcriptase (RT) activity.  This process, with major applications in both 
research and in medical diagnostics, is often limited by the nature of the RTs 
available.  RNA secondary structure can prove problematic where mesophilic 
retroviral RTs are used while the alternative approach, using thermophilic DNA 
polymerases with RT activity, often results in error-prone cDNA production.   
This project recognised the need to study other possible sources of thermophilic 
RTs and outlines the study of four previously uncharacterised Group II Intron-
encoded proteins (IEP), with RT domains, from thermophilic bacteria.  While 
cloning of the IEP genes and their expression on a small scale proved 
successful, difficulties were encountered when attempting purification.  Despite 
a lack of overall purity, samples containing IEPs from Thermosinus 
carboxydivorans and Petrotoga mobilis were shown to have RT activity but 
characterisation of these IEPs was not carried out.  However, an IEP from 
Bacillus caldovelox proved to be an excellent candidate for characterisation as 
successful purification was achieved.  Enzyme engineering was also performed, 
fusing a Sac7d domain onto the C-terminus of this protein.  These enzymes 
were shown to have optimum RT activity at 54ºC with activity still being 
displayed at 76ºC.  Other studies on these enzymes showed that, unlike the 
retroviral RTs, the IEPs displayed no DNA-dependent DNA polymerase activity.  
The Sac7d fusion protein was also studied in terms of possible enhancements 
to the RT activity of an IEP.  However, preliminary studies showed that, 
although this domain did not prove to be detrimental to the enzyme, it had little 
effect on improving the processivity of the RTs.   
Although this class of RT looks promising in terms of use as an alternative 
thermophilic RT, the IEPs studied in this report did incur major limitations during 
cDNA synthesis, which included lower than expected optimum reaction 
temperatures, very low fidelity and an inability to synthesise cDNA using 
complex RNA templates.    
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Chapter 1 - Introduction 
1.1 - INTRODUCTION 
 
Discovery of Reverse Transcriptases 
The Central Dogma theory was originally stated by Crick in 1958 and was 
covered again in a later article in 1970 and discussed the transfer of information 
between the three main polymers (Figure 1.1): DNA, RNA and protein.  Three 
classes of transfers were considered.   
• Class I – Transfers for which some form of evidence existed for their 
occurrence and included: 
o DNA-DNA – now termed replication and involves DNA-dependent 
DNA polymerases.  
o DNA-RNA – now termed transcription and requires a DNA-
dependent RNA polymerase. 
o RNA-Protein – now termed translation and carried out by 
ribosomes. 
o RNA-RNA – This was presumed to occur due to the existence of 
RNA viruses and is now known to be carried out using RNA-
dependent RNA polymerases. 
• Class II – In 1958 no evidence and, at the time, no theoretical 
requirement could be seen for these transfers and therefore were 
considered rare or absent; this class contained: 
o DNA-Protein 
o RNA-DNA 
• Class III – involved transfer from proteins.  Due to the complexity of 
proteins, this class was removed from the central dogma diagram as they 
were considered impossible and included: 
o Protein-protein 
o Protein-DNA 
o Protein-RNA.   
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Figure 1.1: 
(a) Represents all possible simple information transfers between the 
polymers.  
(b) Represents the view of information transfers as stated in 1958.   
In (b) the solid arrows represent all probably transfers while the dashed arrows 
represented possible transfers.  The absence of arrows in (b) that are seen in 
(a) represents transfers thought to be impossible (Crick, 1970). 
 
Work by two independent groups, Baltimore (1970) on Rauscher mouse 
Leukaemia Virus and Temin (1970) on Rous Sarcoma Virus, led to the 
discovery of the, once considered unlikely, transfer of information from RNA to 
DNA.  The genomes of these viruses were known to be RNA and Temin and 
Baltimore independently showed that a DNA step was essential to their life-
cycle by inhibiting infectivity with the use of DNA synthesis inhibitors.  They 
concluded that, in order to carry out this process, a unique enzyme would be 
required displaying RNA-dependent DNA polymerase activity.  This provided 
evidence for the Class II transfer of information of RNA-DNA and, due to the fact 
that the enzyme was functioning in reverse to regular transcription, the reaction 
was termed reverse transcription and the enzyme referred to as a Reverse 
Transcriptase (RT). 
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Sources of Reverse Transcriptases  
Originally termed as unlikely or rare, the transfer of RNA-DNA is actually highly 
prevalent with a major involvement in shaping eukaryotic genomes, causing 
disease and also an essential requirement for the survival of many organisms.  
The main source of RT activity can be found in the form of retroelements.  
Retroelements are a class of mobile elements that, with the use of an RT and a 
DNA intermediate, move by a “copy and paste” mechanism allowing 
complementary DNA (cDNA) insertion into a host genome (Reviewed by 
Gogvadze and Buzdin, 2009).  They replicate independently of the host genome 
using both cellular resources and element-encoded proteins, and are often 
considered ‘selfish DNA’ or nuclear parasites (Sabot and Schulman, 2006). 
 
The only feature in common across all retroelements is their reverse 
transcriptase domain (Xiong and Eickbush, 1990), all of which contain seven 
amino acid motifs, totalling 178 residues, with important structural functions 
(Figure 1.2a).  The deciphered structure of HIV-1 RT shows that, like other 
polymerases, RTs have a typical right-hand appearance including a palm, 
thumb and fingers.  The location of the seven conserved motifs within all RTs 
can be seen within this diagram showing their location and structural importance 
(Figure 1.2b).  
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Figure 1.2: 
(a) Represents the seven amino acid motifs conserved in all RTs from 
retroelements. 
(b) The crystal structure of the p66 subunit of HIV-1 RT.  A view from the 
back of the ‘right-hand’. 
The location of the motifs seen in colour in (a) can be seen on the HIV-1 RT 
structure (b) (modified from Nakamura et al. 1997). 
 
Most structure and activity studies of RTs have been carried out on HIV-1 RT, 
but the basic mechanism of extending DNA by all polymerases is essentially the 
same.  In the case of HIV-1 RT the polymerase binds to the template-primer 
substrate and the dNTP creating a ternary complex.  A conformational change 
occurs, where the polymerase forms a ‘closed’ structure with the finger and 
thumb regions touching, which then orients the dNTP for catalysis.  The palm of 
the polymerase is the active site containing aspartate residues and, with the use 
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of two metal ions, catalyses the incorporation of a new nucleotide on the 3’-OH 
of the primer.  Another conformational change occurs as the polymerase forms 
an ‘open’ structure with the thumbs separating from the finger releasing the 
pyrophosphate that was liberated during the reaction (Castro et al. 2007, and 
reviewed by Herschorn and Hizi, 2010). 
 
Origin of Reverse Transcriptases 
RNA viruses, not including retroviruses, contain RNA as their genetic material.  
However, they do not use a DNA intermediate as part of their life cycle and 
therefore have no requirement for RT activity.  With the fact that RNA viruses 
have a greater genomic diversity, both in organisation and sequences, and are 
present in a more diverse range of prokaryotes and eukaryotes than any 
retroelement, it is generally considered that they are in fact older than all the 
retroelements (Xiong and Eickbush, 1990).  This, along with the fact that the 
seven amino acid motifs that define an RT can also be found in the RNA-
dependent RNA polymerase of RNA viruses, can allow a phylogenetic tree to be 
constructed (Figure 1.3).  This tree uses RNA virus RNA-dependent RNA 
polymerase as the root and draws relationships between the different types of 
retroelements.  Rooting the tree in this manner is not making the assumption 
that RTs evolved from RNA-dependent RNA polymerase, but that they both 
shared a common ancestor. 
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Figure 1.3:  A possible phylogenetic tree of the relatedness of retroelements 
rooted with RNA dependent RNA polymerases from RNA viruses (red).  The 
tree was constructed by Nakamura et al. (1997) using the neighbour joining 
method and the conserved domains of the RTs of the retroelements.  Two main 
groups arise from this tree with the blue group representing the non-LTR 
retroelements and the yellow group representing the LTR retroelements.  The 
RTs from telomerases are also included in the tree (green).  The length of each 
box corresponds to the most divergent element within that box. 
 
This phylogenetic tree puts the different retroelements into two main groups. 
• The group highlighted in yellow are those that contain long terminal 
repeats (LTR) at both ends of their genomes and includes: 
o LTR retrotransposons 
o Hepadnaviruses 
o Caulimoviruses 
o Retroviruses 
• The group highlighted in blue do not contain LTRs and includes: 
o Retrons 
o Fungal mitochondrial plasmids  
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o Non-LTR retrotransposons  
o Group II Introns.   
 
Role of Reverse Transcriptases in Nature 
LTR Retroelements  
LTR retroelements are characterised by the LTRs flanking their genomes 
formed during the tRNA primed RT step generating DNA from the RNA template 
(reviewed by Haig and Kazazian, 2004).  Integration into the host genome does 
not occur in all LTR retroelements and where it does it is independent of the RT 
step. 
• LTR retrotransposons – these elements constitute a large portion of 
eukaryotic genomes and have their ssRNA converted into DNA by their 
encoding RT.  This DNA can then be integrated into a host genome by 
element-encoded integrase in a mechanism of transposition similar to 
that of retroviruses.  Although very similar to retroviruses in that they 
contain a gag and a pol gene, the lack of an env gene, coding for an 
envelope glycoprotein means that their replication cycle is contained 
within a single cell and they are not infectious (as reviewed by Wilhelm 
and Wilhelm, 2001).  There are two families of LTR retrotransposons 
which group according to the order of their domains in the pol gene: 
o Ty1-copia family are ordered protease-RT-integrase  
o Ty3-gypsy family are ordered protease-integrase-RT.  
• Pararetroviruses – these are the Hepadnaviruses and Caulimoviruses 
that infect vertebrates and plants respectively.  These elements have a 
partially single-stranded circular DNA genome that is ‘filled in’ by their RT 
upon infection to create closed-circular dsDNA.  This completed genome 
can then be transcribed into RNA and translated into virus encoded 
proteins.  Unlike retroviruses, these viruses do not integrate into the host 
genome (reviewed by Flavell, 1995) 
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• Retroviruses – these are viruses that require RT activity to allow their 
ssRNA genome to be converted into dsDNA allowing its insertion into a 
host genome.  Unlike LTR retrotransposons, the presence of an env 
gene within their genome allows the expression of an envelope 
glycoprotein enabling the retrovirus to enter a new host cell.  The RT of 
retroviruses will be discussed in greater detail further on in this chapter. 
 
Non-LTR retroelements 
These elements lack flanking LTRs and instead typically contain a 3’ poly(A) tail 
and the 5’ end often has various truncations.  The RT step occurs at the 
genomic target site in a process termed target-primed reverse transcription, 
allowing integration of the element into the host genome (reviewed by Haig and 
Kazazian, 2004). 
• Retrons – as yet have no known function but are responsible for the 
production of multi-copy small ssDNA (msDNA) in bacteria.  As reviewed 
by Travisano and Inouye (1995), the retron consists of an RT gene (ret) 
and at least the two other genes msr and msd.  Once an RNA transcript 
is produced, the RT is translated and is responsible for the production of 
cDNA from msd RNA.  The final msDNA element contains a chimera of 
ssDNA linked to ssRNA. 
• Fungal mitochondrial plasmids – found in species of Neurospora by 
Collins et al. (1981) these retroelements, of which Mauriceville and 
Varkud are the best characterised, are small double-stranded plasmid 
DNA found in mitochondria.  As reviewed by Griffiths (1995), these 
plasmids have been shown to insert into DNA via an RNA intermediate.  
They replicate via a transcription-reverse transcription method and utilise 
a mitochondrial RNase to remove the RNA template. 
• Non-LTR retrotransposons – these are one of the most abundant 
transposable elements of which there are two types: 
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o Long interspersed nuclear elements (LINEs) – The LINE’s ‘copy 
and paste’ replication mechanism means they occupy 
approximately 20% of most mammalian genomes.  The full-length 
mRNA transcript contains two ORFs with ORF1 coding for nucleic 
acid chaperones that form trimers creating an RNP with the LINE 
mRNA.  ORF2 encodes an endonuclease and an RT required for 
retrotransposition (reviewed by Belancio et al. 2008).   
o Short interspersed nuclear elements (SINEs) – SINES are 
considered non-autonomous retroelements since they rely on 
ORF2 of LINEs for their retrotransposition. 
• Group II Introns – found in the organelles of lower eukaryotes, in bacteria 
and in the Methanosarcina genus of Archaea (Toro, 2003).  These 
mobile elements are able to interrupt genes with no deleterious effect to 
the organism due to their ability to auto-splice from the mRNA transcript.  
Once spliced out of the transcript, the reverse transcriptase is 
responsible for generating a DNA copy of the intron allowing its insertion 
into the genome.  It has been theorised that Group II Introns are in fact 
progenitors of nuclear spliceosomal introns due to the similar nature of 
their splicing.  Group II Introns will be discussed in more detail towards to 
the end of this chapter. 
 
Telomerases 
Since DNA polymerases cannot complete the synthesis of both strands of blunt 
ended DNA during replication, the role of a telomerase is to protect the ends of 
linear chromosomes.  Forming a ribonucleoprotein (RNP), the RNA acts as a 
template for the synthesis of the telomeres with the use of the telomerase 
reverse transcriptase (TERT) (as reviewed by Nakamura and Cech, 1998).  The 
seven previously mentioned RT motifs have been found in TERT, showing that 
it is both functionally and structurally related to retroelement RTs.   The inclusion 
of TERT within a phylogenetic tree proved difficult as, unlike other RTs, 
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telomerases are not transposable elements and are therefore not replicated by 
the low fidelity RTs.  However, by rooting the tree with RNA-dependent RNA 
polymerases as the common ancestor, the telomerases were found to be most 
closely related to the group containing the non-LTR retrotransposons (Eickbush, 
1997; Nakamura et al. 1997). 
 
Applications of RTs 
The discovery of RT activity has proved essential in the cloning and expression 
of eukaryotic genes using bacterial systems.  As reviewed by Sharp (1994) 
eukaryotic genes are often interrupted by large regions of non-coding 
sequences called introns.  During eukaryotic protein expression, these introns 
are removed from the RNA transcript in the nucleus, in a process called splicing, 
before the messenger RNA (mRNA) is directed to the cytoplasm where 
translation occurs.  Bacteria lack this machinery to splice introns from an RNA 
transcript.  Therefore, cloning a gene into bacteria directly from eukaryotic 
genomic DNA would not produce the correct protein.  Creating cDNA directly 
from an mRNA transcript offers a huge advantage as it eliminates the need of 
intron splicing.  Utilising RT activity has therefore made it possible to express 
eukaryotic proteins in bacterial systems. 
 
Identification of individual mRNA transcripts also indicates the proteins that are 
being expressed at that particular time within a cell or tissue sample (Richert et 
al. 1996, Gravelat et al. 2008).  Studying mRNA allows gene expression to be 
monitored and, coupled with qPCR, allows the mRNA levels within the sample 
to be quantified.  Gene expression studies provide a useful tool for a variety of 
different applications including drug trial analysis, identification of developmental 
pathways and assessing the affect of environmental conditions on a particular 
tissue type or organism.  Care has to be taken with this technique as it has been 
documented that mRNA levels within a cell do not necessarily correlate to 
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protein levels within the cell (Gygi et al. 1999).  However, this technique still 
forms a necessary tool for the study of gene expression. 
RTs have also proved to be important in disease diagnosis.  RT-PCR and RT-
qPCR are essential as a quick and sensitive method for diagnosis of infectious 
human diseases (Towner et al. 2004), live stock diseases (Moniwa et al. 2007) 
and also in monitoring certain types of cancer (Takano et al. 2000).  The speed 
and sensitivity of this method are often required in highly contagious diseases, 
where early diagnosis can help to quarantine individual cases and contain the 
disease. 
 
Commercially Available Reverse Transcriptases 
The main source of RTs available commercially is retroviruses.  As reviewed by 
Herschorn and Hizi (2010), RTs are essential to the life cycle of a retrovirus.  
These viruses have a genome consisting of two copies of ssRNA and require an 
enzyme to convert their RNA genome into dsDNA that can be inserted into the 
host genome.  The RT enzyme they possess therefore has three activities: 
• RT activity to create a cDNA strand 
• RNase H activity to degrade the RNA in the DNA:RNA hybrid 
• DNA-dependent DNA polymerase activity to create the dsDNA. 
The RNA- and DNA-dependent DNA polymerase activities are carried out in the 
same active site.  However, the RNase H activity requires an additional active 
site and is joined by a connecting region to the typical right-hand polymerase 
conformation.  The main two retroviral RTs that are used for cDNA synthesis are 
the monomeric retroviral RT isolated from Moloney Murine Leukaemia Virus 
(MMLV-RT) (Verma, 1975) and the heterodimeric RT isolated from Avian 
Myeloblastosis Virus (AMV-RT) (Houts et al. 1979).  The heterodimer of AMV-
RT is made up of two polypeptide subunits, α and β, with molecular weights of 
65kD and 105kD respectively.  The smaller α subunit is structurally related to 
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the β subunit and results from proteolytic cleavage of the β subunit (Rho et al. 
1975).  A typical RT reaction with the use of these mesophilic RTs can be seen 
in Figure 1.4. 
 
 
Figure 1.4:  A typical RT reaction.  RNA is initially heated, allowing denaturation 
of any secondary structure.  The reaction is then cooled, allowing primers to 
anneal and the RT to be added.  cDNA synthesis occurs when the reaction is 
incubated, typically for 60min at 37-42°C.  The cDNA produced can then be 
used for further applications. 
 
As an alternative to the retroviral RTs, thermophilic DNA-dependent DNA 
polymerases, typically used for PCR, can also show reverse transcriptase 
activity with the use of manganese as the divalent cation instead of magnesium 
(Myers and Gelfand, 1991).  The thermophilic nature of the enzyme prevents 
the need to cool the reaction before the addition of the RT and prevents RNA 
secondary structure becoming detrimental to the cDNA yield as will be 
discussed below.  Subsequent cDNA amplification can also be carried out with 
the same enzyme, therefore eliminating the need for additional enzymes or 
reactions steps. 
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Limitations of the Current RTs 
Although a well established technique, cDNA synthesis does incur several 
disadvantages, both as a fault of the enzymes used and the difficulty of the RNA 
template that is essential for the reaction. 
 
Low Fidelity 
Many DNA-dependent DNA polymerases possess a 5’-3’ exonuclease activity.  
However, this is lacking in retroviral RTs, possibly as a method to allow the virus 
to continue evolving and evading immune responses.  HIV-1 RT has been 
reported to mis-incorporate 1 nucleotide in every 6,900 nucleotides polymerised, 
while MMLV-RT has higher fidelity with a mis-incorporation rate of 1 in 28,000 
(Ji and Loeb. 1992).  The lack of this proof-reading ability can lead to mutations 
being incorporated into the cDNA, which becomes problematic when the cDNA 
is required for downstream applications such as cloning and sequencing, where 
an accurate representation of the RNA is required (Malboeuf et al. 2001). 
 
Low fidelity can also be found when using thermophilic DNA polymerases 
possessing RT activity.  The presence of manganese has been documented to 
lower the fidelity of polymerases (Goodman et al. 1983).  The manganese can 
lower the specificity of the 3’-5’ exonuclease, which normally removes unpaired 
and mismatched nucleotides at the primer terminus prior to elongation, and also 
reduces the accuracy of base-pair selection (El-Diery et al. 1984).  Therefore, 
cDNA synthesis with these enzymes is often error prone and any manganese 
that contaminates subsequent PCRs may also prove to be mutagenic. 
 
Low Yields 
A common problem with the wild-type mesophilic RTs is the low yield of full-
length cDNAs produced and a background level of truncated products.  Different 
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types of mRNA templates can be reverse transcribed with different efficiencies 
(Buell 1978) which can be attributed to two main factors: the mesophilic nature 
of the enzymes and the RNase H activity associated with the RT. 
 
Mesophilic RTs 
The typical RT reaction temperature used in vitro for cDNA synthesis is between 
37-42ºC for wild-type mesophilic retroviral RTs.  RNA is single-stranded and 
therefore often forms complex secondary structures, such as loops and hairpins.  
Although this secondary structure can be denatured prior to enzyme addition, 
the low reaction temperatures can allow this to reform.  Studies have shown that 
HIV-1 RT makes contact with the RNA spanning a region of approximately 30 
bases at any one time.  Small hairpins can stall the RT when they reach the 
active site of the enzyme, while a larger hairpin can pause the RT when the 
finger domain of the enzyme, spanning approximately 7 nucleotides, makes 
contact with the hairpin before it can reach the catalytic core of the RT (Figure 
1.5) (Harrison et al. 1998). The RT is then in contact with the template for a 
further 23 bases after its catalytic core, during which secondary structure within 
this region can still act to pause the polymerase (Harrison et al.  1998). When 
an RT does pause, it can dissociate from the template and so cease the 
synthesis of full-length cDNA.  Therefore, sites of secondary structure within 
RNA templates, both 5’ and 3’ of the catalytic core, can interfere with efficient 
cDNA synthesis, allowing the accumulation of truncated products and low yields 
of the full-length cDNA.  
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Figure 1.5:  Effects of secondary structure of RNA on an RT.  HIV-1 RT spans a 
region of approximately 30 nucleotides.  RNA secondary structure present 
within this region can pause the RT, with large hairpins pausing the RT 6 
nucleotides before it reaches the catalytic core as it interacts with the finger 
domain of the enzyme (a) and smaller hairpins stalling the RT as they reach the 
catalytic core (b).  (figure from Klasens et al. 1999). 
 
RNase H activity 
Retroviral RTs require RNase H activity to degrade the RNA strand of an 
RNA:DNA hybrid prior to the creation of dsDNA.  However, in vitro this activity 
can limit the yield of full-length cDNA synthesis.  The RNase H activity is an 
endonuclease that cleaves the RNA at the 3’-OH end of the growing DNA chain.  
This allows un-copied RNA to dissociate, preventing further cDNA extension, 
and removes a portion of the mRNA for further cDNA synthesis (Kotewitcz 
1988).  This problem is further increased by the pausing of the RT at regions of 
secondary structure, as mentioned above, as this increases the likelihood of a 
cleavage event (Gerard 1997). 
 
Low Primer Specificity 
A high background signal of non-specific products can be produced when using 
mesophilic RTs with specific primers.  The 42ºC reaction temperature is 
normally below that of the melting temperature of the primers, and therefore 
false annealing can occur (Freeman et al. 1996). 
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Current Solutions to Reverse Transcriptase Limitations 
One of the main solutions to the problems mentioned above has been to 
manipulate the wild-type RTs in the hope of enhancing the enzymes.  Two of 
the main manipulations have been to increase the thermostability of the enzyme 
and to remove the RNase H activity. 
 
Thermostable Reverse Transcriptases 
A thermostable enzyme will allow cDNA synthesis to occur at greater efficiency.  
The higher temperature will allow secondary structures within the RNA template 
to be denatured and will also increase the specificity of the synthesis when 
using gene-specific primers (Fuchs et al. 1999).  Freeman et al. (1996) discuss 
unpublished work by Xu and Sonntag where they noticed a decrease in 
background signal of RT-PCR when increasing the reaction from 42 to 45ºC, 
showing that just a small increase of 3ºC can greatly improve the efficiency of 
the reaction.  Utilising thermophilic DNA-dependent DNA polymerases where 
mRNA secondary structure becomes problematic is one solution to increasing 
cDNA yields.  However, the presence of manganese causes additional 
problems as mentioned previously.  Manufacturers have mutated mesophilic 
retroviral RTs to increase their thermostability compared to the wild-type 
enzyme.  ThermoScript™, from Invitrogen, is an AMV-RT with point mutations in 
the RNase H domain that reduce RNase H activity and also enhance its 
thermostability.  The optimum reaction temperature of ThermoScript is 65ºC, 
compared to the wild-type AMV-RT that has a recommended reaction 
temperature of 37ºC.  ThermoScript™ will synthesise cDNA at temperatures as 
high as 70ºC (Schwabe et al. 1998).  SuperScript™III, a mutated MMLV-RT also 
manufactured by Invitrogen, is reported to be fully active at 50ºC.  Both 
enzymes are marketed as having high performance with difficult RNA templates 
with the ability to achieve longer cDNA lengths and higher yields. 
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RNase H Minus Mutants 
Due to the fact that the DNA polymerase and RNase H activities of retroviral 
RTs are structurally separated and their activities are not coupled (DeStafano et 
al. 1991), RNase H minus mutants can be generated.  Kotewicz et al. (1988) 
found that the amino acids 503-611 of MMLV-RT are required for RNase H 
activity.  However, deletion of one fourth of the MMLV-RT, to remove this 
activity, prevented the enzyme from synthesising cDNA efficiently.  
Manufacturers now offer modified retroviral RTs that contain point mutations to 
reduce RNase H activity.  These mutations are found both in AMV-RT, 
Invitrogen’s ThermoScript™ (Schwabe et al. 1998), and MMLV-RT, 
SuperScript™ also from Invitrogen.  These mutant enzymes are marketed by 
their manufacturers as able to synthesise more full-length cDNA due to the 
reduction in RNase H activity helping to eliminated RNA degradation during the 
course of the reaction. 
 
As an alternative to manipulating the RT enzymes themselves, other attempts to 
improve RT reactions often involve additions or alterations to the typical reverse 
transcription protocol. 
 
Nucleocapsid proteins 
Nucleocapsid (NC) proteins have been used to try to reduce the limitations of 
RNA secondary structure without the need for increasing temperatures of the 
RT reaction.  NC proteins are small basic proteins that have a structural role in 
the retroviral lifecycle, promoting efficient DNA synthesis during replication (as 
reviewed by Darlix, 1995).  The NC protein is thought to aid in reverse 
transcription by destabilising regions of secondary structure within the RNA.  
This ability was utilised by Wu et al. (1996), who showed that the presence of 
HIV-1 NC protein could reduce pausing of the MMLV-RT 8-10 fold during cDNA 
synthesis.  However, Das et al. (2001) found that improvements in the quality of 
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first-strand synthesis reactions with the addition of HIV-1 NC protein were only 
seen on the RNase H minus variants with no improvement on wild-type MMLV-
RT.  Since RNase H minus mutants tend to have improved thermostability this 
could negate the requirement for the addition of NC to the reaction. 
 
An Alternative Solution – A Naturally Occurring Thermophilic RT 
Thermophiles belong to a larger group of organisms known as extremophiles.  
This group includes organisms from all domains of life that live in environments 
that are regarded as extreme.  These conditions can include extremes such as 
temperature, radiation, pressure, desiccation, salinity and pH (Rothschild and 
Mancinelli 2001) (Table 1.1). 
 
Proteins from thermophilic organisms need to have structures adapted to allow 
their correct folding and efficient functioning at the high growth temperatures of 
their native organism.  These proteins could overcome these extremes in 
temperature by either lowering their rate of unfolding at the high temperatures 
and/or increase their rate of (re)folding at these conditions.  All studies so far 
link the higher thermodynamic stability of thermophilic proteins to a decrease in 
their rate of unfolding at the higher temperatures (Das and Gerstein. 2001). 
 
Das and Gerstein (2001) reviewed the different methods that thermophilic 
proteins adopted in order to maintain their thermostability and ordered them into 
two main categories: 
1. Stabilising features considered to be of minor importance, fond in only a 
certain number of families and included: 
I) An increased number of hydrogen bonds 
II) Higher packing density with smaller more condensed proteins 
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III) Shorter polypeptide chains 
IV) Improved hydrophobic interactions 
V) Optimised surface area 
2. Major stabilising features that have been found in most thermophilic 
protein studies 
I) Increase in electrostatic interactions by formation of salt bridge 
networks. 
II) Stabilisation of α-helices 
III) Increase in the fraction of Pro and β-branched amino acids 
decreasing the entropy of the unfolded state 
IV) Decrease in uncharged polar residues which helps avoid chemical 
degradation at the high temperatures 
 
A combination of several of these methods will render a thermophilic protein 
more thermostable than its mesophilic homologue despite the fact that, on initial 
analysis, the two proteins would seem to have a very similar structure. 
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Environmental 
Parameter 
Extremophile Definition Examples 
Temperature Hyperthermophile 
 
 
Thermophile 
 
Pyschrophile 
 
Growth >80ºC 
 
 
Growth 60-80ºC 
 
Growth <15ºC 
Pyrococcus 
furiosus 
 
Thermus aquaticus 
 
Psychrobacter, 
some insects 
Radiation   Deinococcus 
radiodurans 
Desiccation Xerophiles Anhydrobiotic Arternia salina; 
nematodes, fungi, 
lichens 
Salinity Halophile 2-5M NaCl Halobacteriaceae, 
Dunaliella salina 
pH Alkaliphile 
 
 
Acidophile 
pH>9 
 
 
pH<4 
Natronobacterium, 
Bacillus firmus 
OF4,  
 
Cyanidium 
caldarium, 
Ferroplasma 
species 
 
Oxygen Tension Anaerobe Cannot tolerate 
oxygen 
Methanococcus 
jannaschii 
 
Table 1.1:  Classification and examples of extremophiles (adapted from 
Rothschild and Mancinelli, 2001). 
 
Industrial processes can be expensive and non-specific, which can result in the 
production of unwanted biproducts that will need to be removed and safely 
disposed of.  The use of mesophilic enzymes has been limited, due to their 
restrictions at extreme environments limiting their use in an industrial setting 
(Demirjian et al. 2001).   The discovery of extremophilic organisms has allowed 
their exploitation in situations where their mesophilic counterparts would not 
survive.  These extremophiles often display novel metabolic pathways, and the 
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organisms and their enzymes can be utilised in situations that can combine 
biochemistry with industrial processes (Hough and Danson, 1999).  
 
An example of thermophilic enzymes revolutionising an already established 
scientific research technique can be seen in their use in DNA amplification.   
When PCR was first invented, its major drawback was the use of the Klenow 
fragment of E. coli DNA polymerase I (Saiki et al. 1985).  The template 
denaturation step during the PCR also caused the thermolabile enzyme to be 
destroyed, and therefore fresh enzyme had to be added at every extension step 
in the cycle.  As a consequence, PCR was labour intensive, expensive and not 
achievable on a large-scale.  The replacement of the Klenow fragment with the 
Thermus aquaticus (Taq) DNA polymerase revolutionised this technique.  This 
polymerase is heat resistant, and therefore not denatured in the high 
temperature template denaturation step.  Using thermophilic enzymes simplified 
this technique and also improved the actual performance, with enhancements 
seen in yield, sensitivity and the length of targets that could be amplified (Saiki 
et al. 1988) 
 
Group II Introns 
A novel potential source of thermophilic RTs was recognised by Vellore et al. 
(2004) and Ng et al. (2007).  Their work involved studying intron-encoded 
proteins (IEPs), which posses an RT domain, from a Group II Intron in 
thermophilic bacteria.  They showed that these proteins did indeed possess RT 
activity at high reaction temperatures compared to that of the wild-type retroviral 
RTs.  The work by these two groups will be discussed in greater detail 
throughout this report. 
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As mentioned previously, Group II Introns are found in all three domains of life 
both in non-coding and coding regions of the genome.  These elements are 
found in mitochondria and chloroplasts of eukaryotes but have not yet been 
discovered in the nuclear genomes of these organisms.  In bacteria the introns 
tend to be found in non-coding regions or on other mobile elements such as 
plasmids in copies of one to a few per cell (Bechocine et al. 2007).  They do not 
seem to confer any advantage to their host organism however; providing they 
retain the ability to self-splice they can interrupt genes with no deleterious 
effects. 
 
Intron Structure 
The actual DNA sequences of Group II Introns tend to be very diverse.  
However, they are defined by a conserved RNA secondary structure that 
consists of six double-helical domains radiating from a central wheel (Figure 
1.6).  This structure forms a catalytically-active ribozyme capable of splicing 
itself from an RNA transcript.  Fedorova and Xingler (2007) reviewed the 
different domains in the intron structure, which include: 
• Domain I – the largest of the functional domains and essential for 
splicing.  This domain contains two 5’ exonic substrate recognition 
sequences (EBS1 and EBS2) that interact with the corresponding 
sequence on the 3’ end of the 5’ exon (IBS1 and IBS2).  These 
interactions help identify the 5’ splice site and also aid in the recognition 
of specific sites for homing to occur.  Domain I also contains the EBS3, 
which is essential for recognition of the 3’ splice site (IBS3) required in 
the second step of the splicing reaction.  Domain I is also responsible for 
forming a scaffold allowing the assembly of the other domains into the 
catalytic structure. 
• Domain II – contains sites for interactions with Domain I and Domain VI 
forming long-range tertiary contacts aiding in the structure of the 
ribozyme. 
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• Domain III – referred to as a catalytic effector.  It is expected that this 
domain forms tertiary interactions with the intron and its presence 
enhances reaction rates of Group II Introns.  However, it is not strictly 
required for catalysis 
• Domain IV – resides outside of the catalytic core of the ribozyme and is 
highly variable in length.  It can contain an ORF that codes for an IEP 
that will be discussed in further detail below. 
• Domain V – along with domain I this domain is also considered 
absolutely essential for splicing and is the most phylogenetically 
conserved of the whole intron.  It has a structural role with its binding to 
domain I as well as a role in catalysis 
• Domain VI – contains the bulged (non base paired) adenosine that is 
essential for the splicing reaction, which is discussed in detail below. 
 
 
Figure 1.6:  Generic RNA secondary structure of a Group II Intron forming a 
ribozyme.  Domain IV contains an ORF with possible RT activity and resides 
outside the catalytic core of the ribozyme (Toro et al. 2007). 
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Intron-Encoded Protein 
An ORF is often found in domain IV which resides outside the catalytic core of 
the ribozyme (Figure 1.6).  This single ORF codes for an intron-encoded protein 
that possess up to four different enzymatic activities.  These activities aid in the 
mobility and the splicing of the intron.  In bacterial Group II Introns this IEP 
consistently contains an RT domain, although in some cases this is presumed 
inactive due to the loss of some of the conserved motifs (Mohr et al. 1993).  This 
RT domain is then followed by domain X.  Domain X has been designated as a 
maturase as it is thought to stabilise the catalytically-active RNA structure 
(Blocker et al. 2004).  The predicted secondary structure of the LtrA IEP from L. 
lactis has been compared with the crystal structure of HIV-1 RT (Figure 1.7).  
This comparison shows that the RT domain of the IEP contains the same seven 
conserved motifs that are found in HIV-1 RT and all other RTs.  The comparison 
also showed that the domain X appears to have retroviral RT structural features 
that relate to the ‘thumb’ and connection domains of the polymerase (Blocker et 
al. 2007).  Since these domains in retroviral RTs bind the template RNA and 
primer, it has been speculated that the maturase domain functions in specific 
binding of the intron RNA for splicing and reverse transcription (Mohr et al. 
1993).   Even in situations where the RT motifs of the IEP are mutated, and 
presumably have lost their function, the maturase domain tends to remain intact 
suggesting it has an essential role in the splicing of the intron (Mohr et al. 1993).  
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Figure 1.7:  LtrA (IEP) from Lactococcus compared with HIV-1 RT.  Domain 0 is 
characteristic of RTs from non-LTR-retroelements.  Domains 1-7 are conserved 
sequences found in all RTs in the finger and palm domains; the actual 
conserved motifs are shown below.  RNA-binding domain (X), containing 3 
alpha helices, correspond to those found in the HIV-1 RT thumb domain.  
(Figure from Blocker et al. 2007). 
 
While some IEPs from bacteria only contain the RT and maturase domains, 
others have been associated with C-terminal DNA-binding and/or DNA 
endonuclease domains (Figure 1.8).  The endonuclease domain can aid re-
insertion of the intron by cleavage of the antisense strand of the target DNA 
(Filippo and Lambowitz.  2002).  One theory suggests that the earliest bacterial 
introns contained just the RT and the maturase domains, and therefore evolved 
mobility in the absence of this endonuclease.  It is thought that the 
endonuclease was therefore acquired separately from a bacterial family of DNA 
nucleases (Zimmerley et al. 2001).  However, another theory suggests that 
these domains have in fact been lost from the IEPs that now only contain the RT 
and the maturase domains (Mohr et al. 1993). 
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Figure 1.8:  A model showing the various domains that can be found within 
bacterial IEPs.  Shaded, numbered areas in the RT domain correspond to 
conserved domains found across RTs (Blocker et al. 2004).  IEP LI.LtrB found in 
Lactococcus lactis contains all 4 domains, RmInt1 from Sinorhizobium meliloti is 
lacking both the DNA-binding (D) and the DNA endonuclease (En) domains and 
GBSi1 from group B Streptococcus species is lacking the endonuclease domain 
but the DNA-binding domain is present.  Diagram taken from Toro et al.  (2007). 
 
 
Splicing Mechanism 
In order to prevent permanent interruption of an RNA transcript, and therefore 
incorrect protein expression, it is necessary for the Group II Intron to splice from 
the RNA.  This relies on the conserved secondary structure of the RNA and the 
maturase that is coded for by domain IV (Wank et al. 1999).  Where the IEP is 
lacking from the intron it is assumed that host proteins must be relied on for 
splicing to occur.  The recognition of the 5’ splice site occurs with the interaction 
of EBS1 and EBS2 of the intron with the IBS1 and IBS2 of the exon, and the 3’ 
splice site is recognised by interaction of EBS3 with IBS3 (Figure 1.6).  The 
bulged adenosine found in domain VI contains an exposed 2’-hydroxyl group 
that acts as nucleophile attacking the phosphate at the 5’-end of the intron.  An 
intermediate product forms where Exon 1 is released and the intron lariat is still 
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connected to Exon 2.  Base pairing interactions of Exon 1 to the intronic RNA 
still occur, which position the 3’-OH site of Exon 1 to allow a second nucleophilic 
attack at the 3’ splice site.  During this step the two Exons are joined together 
and the lariat RNA is released (Saldanha et al. 1993; Fedorova and Zingler et 
al. 2007) (Figure 1.9). 
 
 
Figure 1.9:  Splicing of the intron from an RNA transcript via a lariat 
intermediate.  The 2’-OH of the bulged adenosine attacks the phosphate at the 
5’ splice site releasing Exon 1.  The 3’-OH group of Exon 1 acts as a second 
nucleophile attacking the 3’ splice site.  The final product consists of the two 
exons ligated together and a released intron lariat.  Diagram from Toro (2003). 
 
 
Mobility 
Group II Introns are mobile elements that have two types of mobility: 
 
Retrohoming 
Retrohoming occurs when the Group II Intron copies itself into an identical but 
intron-less DNA site, a trait that requires some form of recognition sequence.  It 
is thought that in LI.LtrB integration EBS1 of the intron base pairs to the IBS1 
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site 5’ to the intron insertion site (Cousineau et al. 2000).  The RNP consisting of 
the intron RNA and the IEP promotes reverse splicing of the intron into the 
dsDNA and endonucleolytic cleavage.  As the RNA splices itself into the sense 
strand the second strand is cleaved by the endonuclease which allows this 
strand to act as the primer for the cDNA synthesis of the intron (Cousineau et al. 
2000; Martínez-Abarca et al. 2000; Moher et al. 1993; Fedorova and Zingler et 
al. 2007).  This cleavage event is unlikely to be essential as homing has been 
reported in introns lacking the endonuclease domain (Martínez-Abarca et al. 
2000), although the mechanism for retrohoming in the absence of this activity is 
unclear it is known to be Rec-A independent, unlike retrotransposition,  and 
likely to occur at a replication fork or a site of an actively transcribe gene.   The 
RT activity generates cDNA, which is then followed by second-strand synthesis 
followed by repair (Figure 1.10a). 
 
Retrotransposition 
Retrotransposition is when the intron inserts into an entirely new site and occurs 
less frequently than retrohoming.  This event is thought to be independent of the 
endonuclease activity and instead involves host-encoded RecA.  Instead of 
reverse splicing into a specific dsDNA site, the intron reverse splices into an 
exon RNA.  cDNA synthesis occurs generating a DNA strand containing the 
exon and the Group II Intron, and this is followed by second-strand synthesis.  
In order to integrate into the genome, a homologous recombination event has to 
occur, which is dependent on the host encoded RecA, and then resolution 
leaves a once intron-less chromosomal allele becoming an intron-containing 
allele (Cousineau et al. 2000) (Figure 1.10b). 
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Figure 1.10:  A diagram showing a) the retrohoming and b) the 
retrotransposition of the LI.LtrB Group II Intron.  The RNP is depicted on a grey 
background with the intron lariat (red) and the trifunctional protein, LtrA with 
reverse transcriptase (RT), endonuclease (E) and maturase (M) activities.  
Functions required exclusively for one pathway are shown in green. 
a) Retrohoming occurs when the intron reverse splices into dsDNA and 
endonuclease cleavage occurs (1a) then cDNA synthesis of the intron 
and the DNA occurs (2a and 3a) followed by second-strand synthesis 
(4a) and finally repair (5a). 
b) Retrotransposition occurs when the intron reverse splices into RNA (1b) 
followed by cDNA synthesis (2b) and then second-strand synthesis (3b).  
A recombination event then has to occur to integrate the dsDNA 
containing the intron into the genome (4b), followed by resolution creating 
an intron-containing allele (5b). 
(Cousineau et al. 2000) 
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Aims of Project 
The aim of this Ph.D project was initially to isolate bacteria, from environmental 
soil samples, that grew at temperatures above 60ºC.  A screening process 
would then be used to identify any bacteria that contained an IEP RT domain 
from a Group II Intron.  In parallel to this screening process, a bioinformatics 
approach would also be adopted to identify any sequenced but uncharacterised 
IEP from thermophilic bacteria.   
 
Identification and cloning of these IEP genes would follow the screening 
process, along with the expression and purification of the protein.  Additional 
manipulations could be made during the cloning stage of the IEP gene to 
generate the fusion of protein domains that could potentially enhance the 
properties of the enzyme. 
 
Once the proteins had been successfully expressed and purified, research 
would begin on defining the characteristic of these enzymes.  These enzymes 
would be studied in ways that would gauge how successful they would be as an 
RT in a research or diagnostic environment.  These assays would include: 
• Researching the enzymes’ requirements in terms of reaction buffers, 
divalent cation usage and optimum reaction temperature 
• Assessing the thermostability of the enzyme 
• Comparing the ability of the IEP-RTs with the retroviral RTs to see how 
they perform at reaction temperatures exceeding their optimum 
• Measuring the fidelity of the enzyme 
• Assaying for additional enzymatic activities such as DNA-dependent 
DNA polymerase activity 
• Measuring the polymerases processivity 
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• Challenging the polymerases with difficult targets and areas of known 
secondary structure 
• Analysing whether the manipulations made to the enzyme affect any of 
the above factors in either a negative or positive way. 
 
In addition to these commercially valuable factors it would also be necessary to 
further the research on the actual proteins.  To date no crystallisation of the IEP 
has been carried out, although their theoretical structure has been compared to 
that of HIV-1 RT.  This research could provide knowledge on the structural basis 
of these proteins, how they interact with their substrate and how the additional 
domains beyond the RT have a role in the structure of these proteins. 
 
It was hoped that the IEP would show RT activity at a higher optimum 
temperature than the wild-type mesophilic RTs due to the thermophilic nature of 
the organism they would have been isolated from.  This could allow the use of a 
naturally thermophilic enzyme to synthesise cDNA at high temperatures and 
therefore increase efficiency of reverse transcription. 
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Chapter 2 – Identification of Thermophilic 
Bacteria Containing an Intron-Encoded Protein 
 
2.1 - INTRODUCTION 
 
The main RTs available commercially are those from retroviral origin and 
include MMLV-RT and AMV-RT.  These retroviruses infect mesophilic hosts and 
as a result the enzymes optimum reaction temperature tends to be adapted to 
the mesophilic temperatures of the hosts at around 37-42ºC.  As mentioned 
previously, these reaction temperatures can cause problems when these RTs 
are used for cDNA synthesis and complex secondary structures, such as 
hairpins and stem loops, are found within an RNA template.  These RNA 
structures can cause pausing and dissociation of the enzyme (Harrison et al., 
1998; Klasens et al., 1999) leading to a low yield of full-length cDNA and a high 
yield of truncated products.  It has been recognised that there is a need for an 
RT enzyme that can function at higher temperatures, allowing complex 
secondary structures to be denatured and higher quality cDNA produced.   
 
Vellore et al. (2004) recognised that a potential solution to the problem of 
mesophilic RTs could be to discover a functioning RT within thermophilic 
bacteria.  The approach they adopted to search for such an RT was to 
assemble a consensus amino acid sequence from RTs found in a broad range 
of bacteria which included retrons and Group II Intron ORFs. This consensus 
sequence was used as the query sequence in a BLAST search, which revealed 
several previously un-described ORFs with similarities to this sequence.  This 
search identified the trt gene, an ORF within a Group II Intron, from the partial 
genome sequence of Bacillus stearothermophilus.  The trt gene contained the 
typical RT and maturase domains, as seen in all IEPs, but did not contain the 
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DNA endonuclease or DNA-binding domains that can be found in other IEPs.  
Although Vellore et al. (2004) successfully cloned the trt gene, they found that 
when they expressed the protein the majority was insoluble and they were only 
able to partially purify the enzyme.  Using a highly-sensitive Product-enhanced 
RT assay (PERT), Vellore et al. (2004) were able to prove that this Trt did 
indeed have RT activity.  This activity was quantified using a second assay that 
incorporated radiolabelled nucleotides.  Using this assay, the enzyme showed 
maximal RT activity at 65ºC.  The activity was however significantly reduced at 
75ºC, despite the Trt protein showing detectable RT activity, using the PERT 
assay, at temperatures as high as 85ºC. 
 
Ng et al. (2007) also realised the potential of finding thermostable RTs within 
thermophilic bacteria and decided to focus on IEPs within Group II Introns.  
Using the method described below, they identified an IEP within Bacillus 
caldolyticus EA1.  Similarly to Vellore et al. (2004), this group had difficulties 
with obtaining soluble protein and achieved a low yield with  approximately 10% 
solubility of this IEP when expressing using a Baculovirus system.  Despite this 
low solubility, they too showed this IEP to have RT activity by the incorporation 
of radiolabelled nucleotides into poly(rA)●p(dT)12-18 but were unable to detect 
cDNA synthesis activity, possibly due to the low concentration of enzyme 
available for the reaction. 
 
The results from these two groups outlined the true potential of finding a 
thermostable RT within thermophilic bacteria.  However, due to the significant 
level of insoluble protein, both groups concluded that it might be necessary to 
clone the entire intron element to increase solubility, as other IEPs are known to 
be more stable when in a complex with their intron RNA. (Zimmerly et al., 1999) 
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In order to identify novel IEPs within thermophilic bacteria for this report, it was 
decided that the best approach would be to adopt the method used by Ng et al. 
(2007) as this would allow the possibility of finding previously un-sequenced 
IEPs.   
 
Ng et al. (2007) began by making an alignment of mesophilic prokaryotic and 
eukaryotic IEPs and assessing them for conserved regions across the group.  
These conserved regions offered potential primer sites for the design of 
CODEHOP style primers (Rose et al., 1998).  This style of primer contains a 3’ 
degenerate core that is relatively short with only 3-4 conserved residues 
required.  This allows for codon usage within an organism and, by keeping the 
degeneracy low, prevents a low yield of individual primers that would otherwise 
be used up early in the reaction cycles.  At the 5’ end of these primers is a non-
degenerate clamp that allows higher annealing temperatures in later cycles but 
does not add to the degeneracy of the primer.   
 
Ng et al. (2007) designed three CODEHOP style primers, RTF1, RTF2 and 
RTR1 (Figure 2.1a), based on the alignment of sequences.  Two conserved 
regions were selected for the design of these primers (Figure 2.1b) with the 
forward primer based on the G(TV)PQG conserved motif and the reverse primer 
based on the YADD conserved region.  Just downstream of the conserved 
sequence within the forward primer was a second, less conserved motif 
SPLLANI where the SP was highly conserved.  Alignment of the IEP sequences 
showed these designed primers flanked a region that was highly variable in 
length, between 130-300bp.  A Touch-Down PCR method was used where the 
high initial annealing temperature was decreased by 1.5ºC per cycle.  This 
cycling protocol increases the specificity of the PCR as only exact matches will 
anneal to the primers at the higher temperatures.  Gradually decreasing this 
temperature ensures that this specific annealing will take place.  When the lower 
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temperatures are reached, a pool of specific PCR products provide further 
templates for the subsequent rounds of PCR.  Touch-Down PCR products 
between the correct target sizes were sequenced and analysed for the presence 
of the conserved SPLLANI motif just downstream of the 5’ primer confirming the 
presence of an RT domain within the bacteria. 
 
 
Figure 2.1: 
(a) CODEHOP style primers designed by Ng et al. (2007) to identify IEP 
from Group II Introns. 
(b) Full-length IEP with all four possible enzymatic domains.  The diagram 
shows the relative position of the primers within the RT.  Downstream of 
RTF1/2 is a second conserved site, SPLLANI, where the SP is very 
highly conserved and provides confirmation of a reverse transcriptase 
domain within a Group II Intron-encoded protein. 
 
This diagnostic technique would only identify a small region, 130-300bp, of the 
IEP gene sequence.  It would therefore be necessary to devise a method to 
discover the remainder of the sequence.  The method selected for the purpose 
of this project was to use an inverse PCR as a Gene-Walking technique (Figure 
2.2).  PCR normally relies on knowing the 5’ and 3’ termini of the region to be 
amplified.  However, in this instance, the internal sequence was known with the 
flanking sequence yet to be identified.  This problem was rectified by creating a 
library of self-ligated gDNA fragments. gDNA was initially fragmented using 
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restriction endonucleases (RE)  and then the digested template circularised in a 
dilute ligation reaction designed to reduce the formation of multimer, as detailed 
in the methods for this chapter.  Primers were designed using the identified 
internal fragment facing out toward the unknown sequence.  The circularised 
gDNA therefore provided a template where the primers can direct the DNA 
polymerase away from the internal fragment toward the unknown flanking 
sequence.  A second-round PCR uses the product from the inverse PCR with a 
second, nested, set of primers to increase the specificity of the reaction. 
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Figure 2.2:  A diagrammatic representation of an inverse PCR adopted for a 
Gene-Walking technique adapted from Triglia et al. (1988). 
1. The initial 130-300bp of the IEP has to be identified using Touch-Down 
PCR followed by sequencing. 
2. Forward and reverse primers are designed on this identified sequenced 
facing toward the unknown flanking sequenced. 
3. Genomic DNA is digested using restriction enzymes to produce a 
fragmented library. 
4. A dilute ligation reaction is carried out on the digested library to promote 
circularisation of the template. 
5. An inverse PCR is performed using the self-ligated template followed by 
a second-round PCR using nested primers to increase the specificity of 
the products. 
 
The product generated from the Gene-Walking PCR could then be TA cloned, 
as in the methods to this chapter, to allow for sequencing, and then a BLAST 
search could be used to confirm if the Gene-Walking was successful and 
additional IEP gene sequence had been obtained.  If necessary, Gene-Walking 
could be repeated with additional primers designed at the ends of the larger 
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identified fragment.  Steps can be made to try to force the direction of the Gene-
Walking by designing primers close to the end that is required and by choosing 
restriction enzymes that cut just before these primer sites so that circularisation 
would include the majority of the unidentified sequence. 
 
This chapter reports the use of the Touch-Down PCR as a way of identifying 
IEP genes in thermophilic bacteria, isolated from various soil samples.  The 
inverse PCR Gene-Walking technique would then provide additional sequence 
information to allow cloning primers to be designed to amplify the IEP gene.  
Additionally, this chapter also reports on a search for IEP genes within 
sequenced thermophilic bacteria that would also be studied in this project. 
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2.2 – MATERIALS AND METHODS 
 
Growth Media 
Luria Broth (LB): 10g/litre tryptone, 5g/litre yeast extract, 5g/litre NaCl.  With 
1.5%(w/v) agar added for LB agar petri dishes.  All components were from 
Melford, Ipswitch, UK. 
Tryptone soya broth (TSB): 30g/litre tryptone soya broth (Sigma, Gillingham, 
UK).  1.5%(w/v) agar was added for TSB agar plates 
SOC:  2g/litre Bacto Tryptone, 0.5g/litre Bacto yeast extract (both from BD, 
Oxford, UK), 10mM NaCl, 2.5mM KCl (Fisher Scientific, Leicestershire, UK).  
Once autoclaved 10mM MgCl2, 10mM MgSO4 (filter sterilised), and 20mM sterile 
glucose was added (all Sigma, Gillingham, UK) 
YENB:  7.5g/litre Bacto yeast extract, 8g/litre Bacto nutrient broth (BD, Oxford, 
UK).  Medium was made up to correct volume using Milli-Q water. 
 
Buffers 
Cell lysis buffer A:  30mM Tris pH8.0 (Fisher Scientific, Leicestershire, UK), 
20%(w/v) sucrose (Fisher Scientific, Leicestershire, UK), 1mM EDTA (Fisher 
Scientific, Leicestershire, UK), 1mg/ml lysozyme (Sigma, Gillingham, UK). 
Cell lysis buffer B:  100mM Tris pH8.0, 1%(w/v) Tween20 (Sigma, Gillingham, 
UK) 
Cell lysis buffer C: 1x TE (10mM Tris pH8.0, 1mM EDTA), 7.5%(w/v) Chelex-
100 (BioRad, Hemel Hempstead, UK), 0.05M EDTA pH8.0, 0.1%(w/v) SDS 
(Melford, Ipswitch, UK)]. 
Sequencing buffer: 400mM Tris-base, 10mM MgCl2 
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Isolation of Environmental Strains 
Soil samples used for the isolation of thermophilic bacterial strains were either 
collected from hot compost heaps belonging to the Department of Estates, 
University of Bath, or were previously collected from different international 
locations at hot temperature sites.  1g of soil was re-suspended in 3ml sterile 
Milli-Q water, mixed and the contents left to settle for 20min.  100µl of the 
supernatant was spread onto LB agar plates or TSB agar plates.  The agar 
plates were incubated overnight at various temperatures exceeding 65ºC.  
Colonies were then re-streaked onto fresh plates and incubated overnight at the 
original growth temperature.  This process was repeated until individual colonies 
could be obtained. 
 
Environmental Sample Genomic DNA Extraction 
In order to release genomic DNA (gDNA) from the bacteria, cell lysis was 
carried out using a method adapted from Sambrook et al. (1989).  Individually 
isolated colonies were re-suspended in 100µl cell lysis buffer A and incubated at 
25ºC for 10min.  Samples were then microfuged at 13,000xg for 10min and the 
supernatant discarded.  The pellet was re-suspended in 100µl cell lysis buffer B.  
Samples were heated at 95ºC for 20min and then cooled to -70ºC after briefly 
mixing.  This temperature fluctuation was repeated three times and the samples 
were then microfuged at 13,000xg for 10min.  The supernatant was retained as 
the source of gDNA.  To ensure sufficient cell lysis had occurred, the 
supernatant was used as a template in a 16S ribosomal RNA (rRNA) gene 
PCR. 
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16S Ribosomal RNA Gene Amplification 
This PCR used primers based on the 16S rRNA gene, which is highly 
conserved between different species of bacteria.  A positive amplification 
product was used to indicate that sufficient genomic material had been isolated.  
The final reaction contained 1x Taq mastermix (GeneSys Ltd, Camberley, UK), 
25pmol 27F primer and 25pmol 1429R primer (Invitrogen Ltd, Paisley, UK) 
(Appendix I), 1µl gDNA and sterile Milli-Q water added to a final volume of 50µl.  
The reaction was cycled under the following conditions: 
94ºC  3min 
 
94ºC  10s 
52ºC  10s  40 cycles 
72ºC  2min 
 
72ºC  7min 
5µl of the reaction was visualized on a 1%(w/v) agarose gel (Lonza Biologics 
plc, Slough, UK), with the presence of a 1402bp PCR product indicating 
sufficient gDNA material was present at the start of the reaction. 
 
Genomic DNA Extraction for Lyophilised Samples 
This method, taken from Götz et al. (2002), was used to extract gDNA from 
lyophilized bacterial samples obtained from The German Collection of 
Microorganisms and Cell Cultures (DSMZ).  Lyophilised pellets were re-
suspended in 567µl of cell lysis buffer C.  100µg proteinase K (Sigma, 
Gillingham, UK) was added to each sample and then incubated, with occasional 
mixing, for 60min at 50ºC.  Chelex-100 was separated from the supernatant 
using a microfuge at 1,000xg for 5min and the supernatant transferred to a 
sterile 1.5ml screw capped microfuge tube.  100µl 5M NaCl and 80µl 
cetrimonium bromide (CTAB; Sigma, Gillingham, UK) [10%(w/v) in 0.7M NaCl] 
was added and the sample inverted gently.  The samples were incubated for 
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30min at 65ºC.  DNA was then extracted using a phenol/chloroform extraction 
protocol.  An equal volume of buffer-saturated phenol (SureChem Products Ltd, 
Suffolk, UK) was added to the sample and the mixture vortexed for 1min and 
then microfuged at 13,000xg for 5min.  The upper aqueous phase, containing 
the DNA, was removed to a fresh microfuge tube and a 1:1 volume of buffer-
saturated phenol and chloroform (Surechem Products Ltd, Suffolk, UK) was 
added.  The sample was mixed and microfuged as before.  The upper aqueous 
phase was removed to a fresh microfuge tube and an equal volume of 
chloroform was added.  The samples were mixed and microfuged as before and 
the chloroform step repeated.  The upper aqueous phase was then removed to 
a fresh tube and an equal volume of isopropanol (Surechem Products Ltd, 
Suffolk, UK) added, the sample was mixed and immediately microfuged at 
13,000xg for 20min.  The DNA pellet was washed twice with 70%(v/v) ethanol 
(Fisher Scientific, Leicestershire, UK), allowed to air dry, and then re-suspended 
in 20µl TE.  An aliquot was electrophoresed on a 1%(w/v) agarose gel to 
estimate DNA concentration.   
 
If the gDNA yield was low, further gDNA was produced using a GenomiPhi™V2 
DNA amplification kit (GE Healthcare, Chalfont St. Giles, UK) as per 
manufacturing protocol. 
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Identification of RTs within Un-Sequenced Strains 
Extracted gDNA from un-sequenced samples (environmental isolates) was used 
as a template in a Touch-Down PCR with the following cycling conditions: 
94ºC    1min 
 
94ºC    30s 
70ºC (-1.5 ºC/cycle)  30s  20 cycles 
72ºC    30s 
 
94ºC    30s 
55ºC    30s  30 cycles 
72ºC    30s 
 
This cycling was followed by a final extension step at 72ºC for 20min to ensure 
sufficient A-tailing by the polymerase.  The final reaction contained 1x Taq:Pfu 
(20:1) mastermix (GeneSys Ltd, Camberley, UK), 25pmol RTF1 or RTF2, 
25pmol RTR1, 50ng gDNA and water to a final volume of 50µl.  Primers, 
RTF1/2 and RTR1 (Invitrogen Ltd, Paisley, UK), were CODEHOP style primers 
designed by Ng et al. (2007) (Appendix I). 
 
PCR products were analysed on a 2.5%(w/v) agarose gel and any amplicons 
between 130-300bp were used directly for TA cloning. 
 
TA cloning  
3µl PCR product using a Taq:Pfu mix of 20:1 was ligated into 0.5µl pCR®2.1 
using the TA Cloning® kit (Invitrogen Ltd, Paisley, UK) as per manufacturer’s 
instructions.  Ligations were carried out overnight at 16ºC and then heated to 
70ºC for 20min to denature the T4 DNA ligase.  TA clones could then be 
ethanol-precipitated before further use. 
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Ethanol Precipitation of DNA 
0.1 volume of 2.5M sodium acetate pH5.2 (Sigma, Gillingham, UK) was added 
to the sample followed by 2 volumes of 100% ethanol.  Samples were incubated 
at -20ºC for 20-30min and then microfuged at 13,000xg for 10min to pellet the 
DNA.  The DNA pellet was washed with 70%(v/v) ethanol and then microfuged 
as before.  The supernatant was discarded and the DNA pellet left to air dry 
before re-suspending in nuclease-free water.   
 
Electroporation 
Electroporation allowed the transformation of plasmids into various E. coli 
strains.   
• pCR®2.1 plasmids were transformed into E. coli TOP10F’ (New England 
Biolabs, Hitchin, UK) (Appendix II). 
• pET vectors (Novagen® through Merk, Nottingham, UK) were 
transformed into E. coli KRX (Promega, Hampshire, UK) (Appendix II) 
containing the chloramphenicol-resistant plasmid pRARE2 extracted from 
Rosetta™2 (Novagen®) (Appendix II).  The pRARE2 plasmid supplies 
rare tRNAs for the codons AUA, AGG, AGA, CUA, CCC, GGA and CGG 
to reduce protein expression limitations by the codon usage of E. coli. 
• pUCSacB vector was transformed into TOP10 (NEB Hitchin, UK) 
(Appendix II).  
 
40µl of electrocompetent E. coli cells in 10%(v/v) glycerol (Sigma, Gillingham, 
UK) were thawed slowly on ice.  DNA from ligation reactions was re-suspended 
in 5µl nuclease-free water before being used in an electroporation 0.5-1µl of 
ligated, ethanol-precipitated DNA was added to the cells, incubated on ice for 
2min and then added to a 0.1mm electroporation cuvette (BioRad, Hemel 
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Hampstead, UK).  Samples were pulsed using the Micropulser™ (BioRad, 
Hemel Hampstead, UK) at 1.80kV, 3.5-5ms.  The cells were then immediately 
re-suspended in 1ml SOC medium and were incubated at 37ºC with aeration for 
1h.  Typically, 50-100µl of the 1ml sample was spread onto an LB agar petri 
dish containing the appropriate antibiotic for the vector used and incubated 
overnight at 37ºC.  
 
Where TA vector pCR®2.1 was used, samples were spread onto LB agar plates 
containing 50µg/ml kanamycin, 1mM IPTG, 40µg/ml X-gal (Melford, Ipswitch, 
UK). 
 
Colonies could then be selected using a sterile toothpick and screened using 
the colony-screening PCR method, as detailed below, to analyse the cloned 
DNA fragment.  Where pCR®2.1 was used in TA cloning, positive colonies were 
initially selected using blue/white screening.  However, white colonies presumed 
to be positive were still further screened using the colony-screening PCR. 
 
Preparation of Electrocompetent E. coli Cells 
10ml LB was inoculated with the appropriate E. coli strain and incubated 
overnight at 37ºC with aeration at 225rpm.  2x 250ml YENB in baffled 500ml 
shaker flasks were each inoculated with 2.5ml of an overnight E. coli culture and 
incubated at 37°C at 225rpm.  Once an OD600 of 1 had been reached, the 
cultures were cooled to 4ºC and the cells pelleted in a pre-chilled centrifuge at 
5,000xg for 10min.  The supernatant was removed and the cell pellet 
resuspended in 50ml ice cold sterile Milli-Q water.  The cells were centrifuged 
as before and washed with 50ml ice cold water.  The supernatant was discarded 
and the cell pellet resuspended in 5ml ice cold 10%(v/v) glycerol and 
centrifuged as before.  The supernatant was discarded and the cells 
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resuspended in 1.5ml ice cold 10%(v/v) glycerol and dispensed into 0.5ml 
microfuge tubes pre-chilled to -80ºC.  The electrocompetent cells were then 
stored at -80ºC until needed.  In order to test the efficiency of the cells, a known 
concentration of plasmid was electroporated into the cells and a colony count 
taken of various dilutions of the electroporation sample. 
 
Colony-Screening PCR 
Individual colonies were selected with a toothpick and gridded on an appropriate 
antibiotic LB agar plate, to be retained as a reference plate, and the remaining 
cells on the toothpick re-suspended in 20µl sterile water.  The cells were lysed 
by heating to 100ºC for 5min and the supernatant used as a template in a 
screening PCR.  Screening primers were dependent on the vector used with 
M13 forward and reverse primers (Invitrogen LTD, Paisley, UK) (Appendix I) 
used for pCR®2.1 and T7 promoter and terminator primers (Invitrogen, Paisley, 
UK) (Appendix I) for pET vectors. 
 
The reactions were set up as follows (final concentrations): 1x Taq:Pfu (20:1) 
mastermix, 25pmol forward and reverse primers, 1µl lysed template and 
nuclease-free water to a final volume of 50µl.  The reactions were cycled as 
follows 
94ºC  3min 
 
94ºC  10s 
55ºC  10s     30 cycles 
72°C  1min/kb 
 
72ºC  7min 
 
The PCR product was analysed on an agarose gel to ensure the correct size 
product was present. 
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ABI 3100 Sequencing 
5-10µl of PCR product to be sequenced was first treated with 1µl ExoSap [5U/µl 
Exonuclease I (NEB, Hitchin, UK), 0.75U/µl shrimp alkaline phosphatase 
(Roche, Welwyn Garden City, UK)] and incubated at 37ºC for 15min followed by 
80ºC for 15min.  The DNA could then be used in a sequencing reaction.  
Plasmids isolated using a mini-prep kit, in this instance The Wizard® Plus SV 
mini-prep kit (Promega, Hampshire, UK), could be used directly in the 
sequencing reaction without the need for an ExoSAP step. 
 
Sequencing reactions were set up as follows: 1µl BigDye® Terminator V3.1 
(Applied BioSystems™, Warrington, UK), 7µl sequencing buffer, 3.2pmol 
sequencing primer (Invitrogen, Paisley, UK), 150-300ng DNA template and 
nuclease-free water to a final volume of 20µl.  Cycle sequencing was carried out 
with the following conditions: 
 
96ºC  1min 
 
96ºC  10s 
50ºC  5s  30 cycles 
60ºC  4min 
 
70ºC  20min 
 
Sequencing reactions were then processed with the addition of 5µl 125mM 
EDTA and 62µl 100%(v/v) ethanol.  Samples were incubated on ice for 30min 
and then microfuged at 16,000xg for 20min.  The supernatant was removed and 
the DNA pellet washed with 100µl 70%(v/v) ethanol and microfuged as before.  
The supernatant was removed and the samples air dried.  Sequencing reactions 
were then re-suspended in 10µl Hi-Di™ formamide (Applied BioSystems™, 
Warrington, UK) and then loaded onto an ABI PRISM® 31000 Genetic Analyzer.  
Sequencing runs were analysed using Applied BioSystems™ sequence scanner 
v1.0. 
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Gene-Walking 
Gene-Walking used an inverse PCR method to identify unknown DNA sequence 
found beyond the boundaries of a known DNA fragment. 
 
Primer Design 
Gene-Walking primers were based on known sequence either identified from 
the initial Touch-Down PCR or from previous rounds of Gene-Walking.  Two 
sets of primers were designed to face out toward the unknown sequence to 
allow inverse PCR to be carried out (Figure 2.2). 
 
Digest Library 
Genomic DNA was digested with selected restriction endonucleases (RE) from 
New England Biolabs (NEB, Hitchin, UK).  RE reactions contained: 1x NEB 
recommended buffer, 1x BSA where required, 100ng gDNA, 10U RE and made 
to a final volume of 25µl with nuclease-free water.  Reactions were incubated at 
the optimum enzyme temperature for 3h. 
 
Self Ligation 
Digested fragments were ligated in a reaction designed to promote 
circularisation of fragments instead of multimers.  50ng of the gDNA from each 
digest was ligated in a reaction containing 1x T4 DNA ligase buffer, 12.5U T4 
DNA ligase (NEB, Hitchin, UK) and made up to 100µl with nuclease-free water.  
Ligations were incubated overnight at 16ºC. 
 
Initial Gene-Walking PCR – Inverse PCR 
The self-ligated template was used in a PCR with the inner pair of Gene-
Walking primers.  The final reaction contained 1x Taq:Pfu (20:1) mastermix, 
25pmol of forward and reverse primers, 2µl (1ng) of self-ligated gDNA and the 
final volume made to 50µl with nuclease-free water.   
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The reactions were cycled using the following conditions: 
94ºC  4min 
 
94ºC  10s 
55ºC  10s  35 cycles 
72ºC  5min 
 
72ºC  7min 
 
Nested Gene-Walking PCR 
2µl PCR product from the initial Gene-Walking PCR was used as a template in a 
nested PCR to increase specificity of the products.  The reaction was set up as 
before but with 30 cycles and a final 72ºC hold for 20min. 
 
TA Cloning 
PCR products from the nested PCR were visualised on a 1%(w/v) agarose gel. 
Any products over 300bp were TA cloned as described previously.  Screening 
and sequencing were carried out as before to identify more of the unknown IEP 
gene sequence. 
 
Gene-Walking was repeated as necessary to obtain the entire IEP gene 
sequence 
 
 
BLAST Searches 
Using the NCBI Basic Local Alignment Search Tool (BLAST), sequenced Gene-
Walked DNA was used as the query sequence in a search against a database 
of sequenced bacteria to identify whether it matched IEP gene sequences.  The 
same tool was used to compare known or identified IEPs with others that have 
been sequenced.  The tool was also used to identify sequenced thermophilic 
bacteria containing an IEP. 
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2.3 – RESULTS 
 
Non-Sequenced DSMZ Strains 
Identification of an IEP 
Various, non-sequenced thermophilic bacteria, with growth temperatures 
ranging from 60-80ºC, were ordered from the DSMZ microorganism collection 
(Table 2.1). 
 
DSMZ 
Number 
Strain Growth 
temperature (ºC) 
2178 Thermodesulfobacterium commune 70 
2913 Hydrogenobacter hydrogenophilus 72-76 
7242 Thermolithobacter carboxydivorans 65 
11255 Carboxydothermus ferrireducens 65 
11347 Thermodesulfovibrio yellowstonii 60 
11420 Hydrogenophilus hirschii 60 
11699 Desulfurobacterium thermolithotrophum 70 
12046 Hydrogenothermus marinus 65 
12570 Thermodesulfovibrio islandicus 65 
12571 Thermodesulfobacterium hveragerdense 65 
14290 Thermodesulfovacterium hydrogeniphilum 70 
14350 Persephonella marina 70 
14351 Persephonella guaymasensis 70 
14484 Thermocrinus albus 80 
14884 Marinithermus hydrothermalis 70 
15103 Persephonella hydorgeniphila 70 
15120 Sulfurihydrogenibium subterraneum 62 
15241 Sulfurihydrogenibium azorense 68 
15242 Caldanaerobacter subterraneus sub-
species tengcongensis 
75 
15286 Thermodesulfatator indicus 70 
15698 Thermovibrio ammonificans 75 
16304 Balnearium lithotrophicum 70 
16510 Hydrogenivitga caldilitoris 75 
16646 Thermosediminibacter oceani 68 
 
Table 2.1:  DSMZ bacterial strains and growth temperatures. 
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The DSMZ bacterial samples arrived lyophilised and the gDNA was extracted 
using the method taken from Götz et al. (2002).  Where gDNA concentration 
was low, the yield was enhanced using the GenomiPhi™V2 DNA amplification 
kit to ensure enough DNA was present for use in a Touch-Down PCR.  The 
CODEHOP style primers, designed by Ng et al. (2007), were used in two 
individual Touch-Down PCRs.  The first reaction contained the primer pair RTF1 
with RTR1, and the second contained RTF2 with RTR1 (Appendix I).  The 
products from the Touch-Down PCRs were analysed using a 2.5%(w/v) agarose 
gel. 
 
0.5µg of 2-log ladder marker (NEB, Hitchin, UK) was used to identify any 
products between 130-300bp in length which could potentially indicate an RT 
domain, from a Group II Intron, within the bacteria.  Strains 2913, 7242, 11420, 
12046, 14484, 14884, 15241, 16510 produced the required product using the 
primer pair RTF1/RTR2 and strains 15286, 16304 and 16646 produced 
products within this range using the primer pair RTF2/RTR1.  The PCR product 
from these strains was used directly in a ligation to TA clone the fragments into 
pCR®2.1.  Once ligated, 1µl of the ethanol-precipitated DNA from this reaction 
was transformed into electrocompetent E. coli strain TOP10F’.  100µl of the 
transformation was plated onto LB agar plates containing 1mM IPTG and 
40µg/ml X-Gal allowing for blue-white screening.  10 white colonies from each 
transformation were selected, gridded and screened using colony-screening 
PCR with M13 Forward and Reverse primers (Appendix I).   The size of the 
PCR product was analysed on an agarose gel.  The PCR products from any 
successfully screened TA clones were treated with ExoSAP and sequenced 
following the ABI 3100 sequencing protocol.  Despite the fact that several 
strains were positive for the correct sized product, sequencing of these 
fragments failed to identify any that contained the conserved motif, SPLLANI, 
indicative of an RT domain from an Intron-Encoded Protein.  Instead, 
sequencing revealed these products to contain either fragments of genes from 
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within the organisms, reflecting a lack of specificity during the PCR, or were a 
result of a multimer formation of the primers. 
 
Non-Sequenced Donated Genomic DNA 
Identification of an IEP 
GeneSys Ltd (Camberley, UK) donated gDNA from their collection of isolated 
environmental and DSMZ samples.  These samples consisted of unidentified 
bacteria, presumed to be various Bacillus species from Australia and Hong 
Kong and the known Bacillus species, B. stearothermophilus, B. caldotenax and 
B. caldovelox.  1ng of these gDNAs was used in the two Touch-Down PCRs as 
before, and a marker on an agarose gel used to select those strains with 
potential RT domains (Figure 2.3). 
 
 
Figure 2.1:  A 2.5%(w/v) agarose gel of the Touch-Down PCR products from a 
thermophilic bacterial screen.  The RTF1/RTR1 CODEHOP primer pair 
positively amplified DNA fragments between 130-300bp in two Bacillus species 
B. caldotenax (B. ctnx) and B. caldovelox (B. cv). 
 
The agarose gel (Figure 2.1) showed a background amplification of products of 
a consistent size within all the reactions that proved negative for the required 
130-300bp diagnostic length.  The very small, brighter band is consistent with a 
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primer dimer formation.  However; the larger band seen just below the 100bp 
marker is likely to be due to a multimer formation of the primers as they 
continually primer against each other and fragments of the template due to their 
degenerate nature. 
 
B. caldotenax had two products between 130-300bp in length and B. caldovelox 
contained one.  In order to see if these were indeed due to amplification of a 
conserved domain within an IEP, the PCR products were ligated into pCR®2.1.  
These constructs were transformed into electrocompetent E. coli TOP10F’ and 
white colonies from the blue/white screening procedure were selected for further 
analysis.  Once a fragment of the correct size had been confirmed using colony-
screening PCR with M13 forward and reverse primers, the PCR product was 
treated with ExoSAP and used in an ABI3100 sequencing reaction. 
 
B. caldovelox 
The sequencing of the Touch-Down PCR identified the following sequence of 
DNA: 
cacaaaactgaggaagggacgccacagggagggccgctcagtccactcctgtccaacat
tctcctggatgagctggacaaagaattggaaaaacgagggcacaagtttgtacggtatg
cagacgatttcgtaatcaccgtc 
 
Translation of this DNA sequence into a protein sequence (Figure 2.4) revealed 
similarities to the conserved SPLLANI motif indicating that this strain contained 
an RT domain from an IEP. 
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HKTEEGTPQGGPLSPLLSNILLDELDKELEKRGHKFVRYADDFVITV 
 
Figure 2.4:  Translated protein sequence from a potential IEP found in B. 
caldovelox.  The green highlighted regions indicate the conserved domains from 
the primer sequence.  The yellow highlighted region shows the conserved motif 
found in RT domains of Group II Introns. 
 
A BLAST search using this acquired protein sequence also verified that the 
protein matched that of an RT domain within an IEP with the closest match 
being identical to the Geobacillus kaustophilus recombinase of Bh.Int-like 
element locus tag GK1355-IEP. 
 
This identified internal IEP sequence allowed primers to be designed facing out 
toward the unknown DNA sequence (Figure 2.5) to allow Gene-Walking to be 
carried out. 
 
 
Figure 2.5:  A schematic representation of the location of the Gene-Walking 
primers designed for B. caldovelox.  Nter and Cter represent the DNA encoding 
the N-terminus and C-terminus of the protein respectively and U and L relate to 
upper and lower strand dictating the direction of the primers.  Full details of the 
primers can be found in Appendix I.  The red primers are used as a pair in the 
initial inverse PCR while the blue primers are used as a pair in the second, 
nested PCR. 
 
B. caldotenax 
The Touch-Down PCR fragments from this B. caldotenax were TA cloned into 
pCR®2.1 and sequenced using the ABI 3100 sequencing protocol.  Despite 
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showing two products from the Touch-Down PCR, only one of the products was 
successfully cloned and identified through sequencing: 
cacaaaactgaggaaggtacgccacaaggtggcatactctcaccgctgctggccaacat
cgctctgacggtgttggacgcacatttccgtgtgaaatgggatgcccatcggacatctc
agcggcgagatgcccatcgcaaacgtggcggggccacctatcggatcgtccgctacgca
gacgatttcgtaatcaccgtc 
 
Translation of this DNA sequence into a protein sequence (Figure 2.6) revealed 
the conserved motif, SPLLANI, indicative of an RT domain. 
 
HKTEEGTPQGGILSPLLANIALTVLDAHFRVKWDAHRTSQRRDAHRKRGGATYRIVRYA
DDFVITV 
 
Figure 2.6:  Translated protein sequence of a potential IEP found in B. 
caldotenax.  The green highlighted regions indicate the conserved domains from 
the primer sequence.  The yellow highlighted region shows the conserved motif 
found in RT domains of Group II Introns. 
 
This 191bp of identified sequence provided enough sequence information to 
allow the design of Gene-Walking primers facing out toward the unknown DNA 
upstream and downstream of this internal fragment (Figure 2.7). 
 
 
Figure 2.7:  A schematic representation of the location of the Gene-Walking 
primers (Appendix I) designed using the known IEP sequence.  Nter and Cter 
refer to the C-terminus and N-terminus of the protein sequence and the U and L 
refer to the upper and lower primer sequence, dictating the direction that the 
primers face.  The red primers are used as a pair in the initial inverse PCR while 
the blue primers are used as a pair in the second, nested PCR. 
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Gene-Walking 
The gDNA from both Bacillus species had to be digested with restriction 
enzymes to produce a fragmented DNA library.  12 REs were initially selected 
from NEB (Hitchin, UK); these enzymes were chosen because they were 6 
cutters and so would not cut the gDNA too frequently, thereby allowing larger 
fragments to be self-ligated.  The enzymes chosen left both sticky and blunt 
ended fragments.  The REs selected for the library were Kpn I, Hind III, Xba I, 
EcoR I, Nco I, BamH I, Sal I, Pst I, EcoR V, Sac II, Aat II and Nde I.  Individual 
digests were carried out on 100ng of the gDNA and the template was digested 
for 3h to ensure complete digestion.  A dilute ligation, designed to promote self-
ligation and reduce the likelihood of multimers forming, was set up with 50ng of 
the digested gDNA.  This ligation could then be used as a template in the initial 
Gene-Walking PCR. 
 
Gene-Walking was carried out using the Gene-Walking primers, designed to 
face upstream and downstream of the known sequence, and the self-ligated 
gDNA library.  Two rounds of PCRs were required, the first using the inner 
primer set in an inverse PCR and the second using template from the first PCR 
with the nested primer pair.  This second PCR allowed an enhancement of the 
specificity of the Gene-Walking, reducing the yield of non-specific fragments.  
Any fragments greater than 300bp from the second Gene-Walking PCR were 
cloned into the TA vector, pCR®2.1, transformed into TOP10F’ and screened 
using colony-screening PCR.  Any fragments of suitable size were then 
sequenced using the ABI 3100 sequencing protocol to identify possible IEP 
gene sequences. 
 
Gene-Walking of B. caldotenax gave several bands greater than 300bp in length 
from the digest libraries of BamH I, EcoR I and Hind III.  However, sequencing 
of these fragments and using them as the query sequence in a BLAST search 
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showed that, although the fragments matched other Bacillus genes, none of 
them matched any known IEP within the search database.  Increasing the 
annealing temperature of the primers in the Gene-Walking PCR to increase 
specificity resulted in no products greater than 300bp. 
 
Gene-Walking of the B. caldovelox strain gave several bands greater than 
300bp from digest libraries Aat II, Kpn I, Nde I and Xba I.  These bands were TA 
cloned into the pCR®2.1 vector, transformed into TOP10F’ and sequenced to 
identify the fragments.  All fragments from these digests corresponded to an 
IEP.  Piecing together the different fragments revealed a total of 642bp of IEP 
gene sequence (Appendix III).  When using the NCBI BLAST tool, this 642bp of 
acquired sequence matched identically to an IEP within Geobacillus 
kaustophilus HTA426, the recombinase of Bh.Int-like element (Appendix III), 
locus tag GK1355.  From here on this G. kaustophilus IEP will be referred to as 
the GK1355-IEP. 
 
Non-Sequenced Environmental Strains 
For this investigation into novel IEPs, it was necessary to isolate different 
thermophilic bacteria in the hope they would contain a Group II Intron with an 
IEP.  Initially, samples from hot compost were collected from the University of 
Bath with permission from the Department of Estates.  The samples from this 
collection ranged from the oldest, at approximately 3 years old, to the youngest 
of approximately 6 months old.  The hottest samples were retrieved from 
regions estimated to be 1 year old.  1g of material from these samples was 
resuspended in water and the supernatant spread on both LB and TSB agar 
petri dishes.  These petri dishes were incubated overnight at temperatures of 
65, 70 and 75ºC.  No thermophilic bacteria were isolated at the 70 and 75ºC 
temperature ranges.  Therefore, all thermophilic bacteria isolated and studied 
were incubated at 65ºC.  The initial plating of the supernatant from the 65ºC 
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incubation produced a lawn of mixed bacterial types.  These were re-plated onto 
fresh agar until individual colonies could be isolated.  Individual colonies, with 
differing morphologies, were then lysed to extract the gDNA, and the 
supernatant tested using a 16S rRNA PCR, to ensure that enough gDNA was 
present for amplification.  In total, 20 different bacterial strains, four from each 
age of compost,  were successfully lysed and their gDNA used as template in 
two Touch-Down PCRs, one with RTF1/RTR1 primers and the other with 
RTF2/RTR1 primers.  The samples were analysed on an agarose gel and 
comparison with markers revealed none of the samples to contain a fragment 
between 130-300bp in length, suggesting none of the isolated strains from this 
compost contained an IEP with an RT domain. 
 
In order to expand the search for thermophilic bacteria containing an IEP, 
additional soil samples had to be screened.  The additional samples were from 
the collection belonging to the Centre for Extremophile Research, University of 
Bath and were stored at 4ºC.  The soil samples that were used were from 
Lanzarote, Melbourne Yarrow River, Kuala Lumpur, New Zealand and Bali.  A 
total of 16 individual strains were isolated from these samples, all growing on 
either LB or TSB plates at 65ºC.  The gDNA from these strains was used in two 
Touch-Down PCRs with the two different primer sets to identify any strains with 
an RT domain (Figure 2.8). 
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Figure 2.8:  An agarose gel of the products from a Touch-Down PCR and 
RTF2/RTR1 primer pair.  Isolate numbers 1 and 2 from Melbourne, and 8,9,10 
and 11 from New Zealand have a product between 130-300bp in length. 
 
The Touch-Down PCR products from isolates 1 and 2 (from Melbourne) and 8, 
9, 10 and 11 (from New Zealand), all at the critical size between 130-300bp, 
were cloned into the TA vector pCR®2.1, transformed into TOP10F’ and then 
sequenced.  Out of the strains sequenced, New Zealand strain 11 which grew 
on TSB was shown to contain a potential IEP with an RT domain. 
 
New Zealand Strain 11 
The cloned fragment from the Touch-Down PCR was sequenced and revealed 
the following DNA sequence: 
cctcaaggcggtcccctcagccccctgctggcgaacatccttctcgacgatttagacaa
ggagttggagaagcgtggattgaaattctgccgctacgctgacgat 
 
Translation of this DNA sequence into a protein sequence (Figure 2.9) revealed 
the conserved SPLLANI motif indicative of an RT domain. 
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PQGGPLSPLLANILLDDLDKELEKRGLKFCRYADD 
 
Figure 2.9:  Translated protein sequence of a potential IEP found in a 
thermophilic bacterial strain isolated from New Zealand. The green highlighted 
regions indicate the conserved domains from the primer sequence.  The yellow 
highlighted region shows the conserved motif found in RT domains of Group II 
Introns. 
 
16S rRNA sequencing of this isolate from New Zealand showed it to be a strain 
of B. stearothermophilus.  The identification of this species was reflected in the 
fact that a BLAST search of this obtained IEP protein sequence matched 
identically with that from the sequenced B. stearothermophilus Ttr gene that is 
an Intron-Encoded Protein with an RT domain.  However, on a DNA sequence 
level, there were differences between the two strains.  Using the sequence 
obtained from the Touch-Down PCR, primers were designed to face out toward 
the unknown IEP gene sequence (Figure 2.10). 
 
 
Figure 2.10:  A schematic of the location of the Gene-Walking primers 
(Appendix I) designed using the known IEP sequence.  Nter and Cter refer to 
the C-terminus and N-terminus of the protein sequence and the U and L refer to 
upper and lower primer sequence, dictating the direction that the primers face.  
The red primers are used as a pair in the initial PCR while the blue primers are 
used as a pair in the second, nested PCR. 
 
In order to create a library of digested gDNA, it was necessary to obtain a purer 
and higher yield of DNA than that provided by the cell lysis step.  Initially, 10ml 
of TSB were inoculated with a single colony of strain 11 and incubated overnight 
with aeration at 65ºC.  This strain failed to grow under these conditions; 
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however, incubation of the culture at 65ºC overnight with no aeration allowed 
the strain to grow in the TSB medium.  Once the cells had been pelleted by 
centrifugation, the DNA was extracted using the DNeasy Tissue Kit (Qiagen, 
Crawley, UK) following the protocol for the isolation of genomic DNA from 
Gram-positive bacteria.  12 REs were selected from NEB to digest the gDNA 
and create a fragmented gDNA library.  REs that mainly used 6 bases as a 
recognition sequence were selected, as before, to prevent the gDNA becoming 
too fragmented and thereby to allow fragments greater than 300bp to be cloned.  
The enzymes used for the digest library were Aat II, BamH I, EcoR I, HinD III,  
Kpn I, Msp I (4 base recognition sequence),  Nco I, Nde I, Nhe I, Nsi I, Sal I and 
Pst I.  100ng of the gDNA was digested with each enzyme in 12 individual 
digests.  The restriction enzymes were then heat-killed according to NEB 
guidelines and 50ng of the digested gDNA used in a dilute ligation reaction 
designed to promote circularisation of the fragments.  The Gene-Walking 
primers designed using the known IEP gene sequence were then used in two 
Gene-Walking PCRs.  The second PCR used the product from the first PCR 
and the nested primers allowed an increase in specificity.  The product from the 
second-round Gene-Walking was analysed on an agarose gel (Figure 2.11).  
Products from the digest library from Aat II, EcoR I, Nco I and Sal I were above 
300bp in length and were cloned into TA vector pCR®2.1, transformed into 
TOP10F’ and screened using blue-white screening and colony PCR. 
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Figure 2.11:  A 2.5%(w/v) agarose gel of the second-round Gene-Walking PCR.  
Fragments from digests Aat II, EcoR I, Nco I and Sal I were used in ligation 
reaction as their products were greater than 400bp in length. 
 
The agarose gel from the second round gene walking sometimes included 
multiple fragments for each digested library.  This is likely to be due to two 
separate aspects of the process.  Firstly incomplete digestion of the genomic 
template could result in more than one different sized fragments being produced 
with the same primer set.  Alternatively, the ligation reaction itself could result in 
some multimer formation, as well as circularisation of the fragments, therefore 
producing additional size products with the same primer sites.  The smears can 
be seen in some of the reactions were no specific product is produced could be 
down to the presence of undigested gDNA. 
 
The sequencing results of all these fragments gave sections of the IEP within 
this New Zealand strain.  Piecing together these fragments gave 936bp of the 
IEP gene sequence from this Bacillus.  When using the ClustalX multiple 
sequence alignment programme, this sequence was aligned against the B. 
stearothermophilus Trt gene and was shown to contain the ATG start site.  
However, the sequence obtained so far did not reach the 3’ end and therefore 
the stop codon for this gene.  Using the NCBI nucleotide BLAST program, the 
gene sequence from the New Zealand strain was shown to have 97 % identity 
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to the Trt gene.  New Gene-Walking primers, 7.6_GW2, were designed based 
on the new sequencing information from the 3’ end of the gene to try to identify 
the 3’ end, downstream from that already identified, and to reach the stop codon 
(Figure 2.12). 
 
 
Figure 2.12:  A schematic representation showing the location of the second set 
of Gene-Walking primers for the New Zealand strain of B. stearothermophilus.  
The primers were designed at the 3’ end of the known gene sequence to allow 
Gene-Walking into the remainder of the IEP gene sequence.  Cter refers to the 
C-terminus of the protein and U and L denotes the upper and lower DNA strand 
respectively and therefore the direction of the primers. 
 
The digested, self-ligated libraries of gDNA were again used as template in a 
Gene-Walking PCR with the new set of primers.  However, Gene-Walking 
proved to be unsuccessful with the new primers being non-specific to the IEP 
gene sequence.  New Gene-Walking primers, 7.6_GW3 (Appendix I) were 
designed to try to increase the specificity of the Gene-Walking reactions; 
however, despite the fact that some of the REs were known to cut just upstream 
of the primer locations, these new primer sets failed to obtain any new IEP gene 
sequence. 
 
Sequenced DSMZ strains 
Investigations into sequenced thermophilic bacteria containing IEPs were also 
carried out.  Using the NCBI protein BLAST tool, the G. kaustophilus HTA426 
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GK1355-IEP element was compared to other known IEPs within the database.  
The majority of the matches were from mesophilic organisms with growth 
temperatures ranging from 28-37ºC.  However, the BLAST search did reveal 
two thermophilic bacteria with potentially thermostable IEPs: 
• Thermosinus carboxydivorans Nor1 had an optimum growth temperature 
of 60ºC and contained one IEP gene sequence with 63% protein identity 
to the G. kaustophilus HTA426 GK1355-IEP. 
• Petrotoga mobilis had an optimum growth temperature of 55ºC and 
contained 3 IEPs within its genome, two with a 54% identity and one with 
a 53% identity to the G. kaustophilus HTA426 GK1355-IEP. 
 
It was hoped that these IEP gene sequences would code for an IEP capable of 
showing RT activity at high temperatures. 
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2.4 – DISCUSSION 
 
In this chapter, a number of methods were described to identify thermophilic 
bacteria containing an IEP with an RT domain.  Initially, un-sequenced bacteria 
were screened for a conserved motif found within the RT domain.  This 
screening method was based on the same method used by Ng et al. (2007) 
where CODEHOP primers, based on alignments of bacterial RTs, were 
designed to allow the amplification of a conserved region within the RT.  When 
Ng et al. (2007) used this technique the group identified 6 thermophilic bacteria, 
out of the 34 studied, that contained this RT motif.  The thermophilic bacteria 
containing IEPs identified by this group included Bacillus caldolyticus EA1; 
Bacillus caldolyticus YP-T; Caldibacillus cellulovorans (CompA2); 
Thermoanaerobium species TOK 6B.1; Clostridium thermohydrosulfurium 
species RT66B.1; and Thermus thermophilus HB8.  When this method was 
adopted for this project, the occurrence of these IEPs was found to be lower 
than that suggested by Ng et al. (2007). 
 
An initial screening of 24 thermophilic bacteria from the DSMZ revealed that 
none of them contained this conserved domain.  The search for an IEP within 
thermophilic bacteria was then expanded to include additional gDNA from 
thermophiles isolated by GeneSys Ltd.  This search revealed two Bacillus 
species to contain a possible IEP.  B. caldotenax contained two possible RTs, of 
which the conserved region from one of these IEP was identified from 
sequencing, and B. caldovelox contained one possible IEP.   
 
In order to expand the search further, unidentified thermophilic bacteria were 
isolated from a hot compost heap belonging to the Department of Estates, 
University of Bath as well as from soil samples belonging to the Centre for 
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Extremophile Research, University of Bath.  The samples from the collection 
from the Centre for Extremophile Research were from Lanzarote, Melbourne 
Yarrow River, Kuala Lumpur, New Zealand and Bali.  In all cases it proved 
difficult to isolate any bacteria growing at temperatures above 65ºC.  It is 
possible that any bacteria that grow at temperatures exceeding the 65ºC would 
require different media with additional supplements, such as trace elements or 
minerals, which were not provided in the media used in this study.  Altering the 
media could allow the broadening of the search for thermophilic bacteria with an 
IEP.  In total 36 different thermophilic bacteria, with growth temperatures of 
65ºC, were isolated and screened using Touch-Down PCR as a method of 
identifying any bacteria containing an IEP.  Of the 36 isolates, one strain from 
New Zealand, a B. stearothermophilus strain, was revealed to contain the 
conserved region indicative of an RT domain from an IEP. 
 
Once the conserved regions were identified, Gene-Walking primers were 
designed to allow an inverse PCR to be carried out to discover the remaining 
IEP gene sequence.  These Gene-Walking primers were designed against one 
of the RT fragments from B. caldotenax, the fragment discovered in B. 
caldovelox and the fragment identified in the New Zealand strain 11, B. 
stearothermophilus.  Once the gDNA of these strains had been fragmented by 
RE digest and circularised in a ligation reaction, inverse PCR was carried out 
followed by a nested PCR to increase specificity in the identification of additional 
IEP gene sequence. 
 
B. caldotenax 
Large fragments of DNA were isolated from the two rounds of Gene-Walking 
PCR.  However, cloning revealed that, although they matched Bacillus genes, 
they were not specific to the IEP.  Attempts were made to improve the specificity 
of the Gene-Walking including increasing the annealing temperature of the 
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primers.  However, no new IEP gene sequence, beyond the boundaries of the 
conserved fragment, could be identified.  Due to the limitations of size of this 
conserved fragment, it was not possible to re-design new Gene-Walking primers 
and as a result, this IEP was left unidentified. 
 
B. caldovelox 
The Gene-Walking PCRs from the conserved IEP gene fragment gave several 
large PCR products to be sequenced.  Several of these products revealed new 
IEP gene sequence and when pieced together, this technique allowed an 
identification of 642 bases of IEP gene sequence.  Using the BLAST tool 
revealed them not only to match an IEP, but also to be identical to an IEP within 
G. kaustophilus HTA426.  This gene, a recombinase of Bh.Int-like element 
referred to as GK1355-IEP, included the RT domain and maturase domain 
typical of that seen in IEP and which had not been previously studied.  Using the 
knowledge that the IEP gene sequence obtained so far from B. caldovelox was 
identical to this fully-sequenced gene, no further Gene-Walking was necessary. 
 
Bacillus stearothermophilus, New Zealand strain 11 
The first round of Gene-Walking of this strain proved to be very successful with 
several large DNA fragments obtained.  Sequencing and piecing together these 
fragments revealed 936bp of IEP gene sequence which, when translated into a 
protein sequence, had a 97% identity to the known Trt protein from B. 
stearothermophilus.  These 936bp identified included the start codon of the 
gene; however, the stop codon had not yet been reached.  Attempts were made 
to Gene-Walk to the 3’ end of the gene.  This included designing primers 
specifically at this end of the gene, ensuring that the gDNA digest library 
included enzymes that cut just upstream of these primer sites and two different 
primer sets being designed for Gene-Walking.  However, despite these efforts, 
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the 3’ of this gene was not fully identified.  Any cloning primers would therefore 
have to be based on the known sequence of the trt gene. 
 
The work presented in this chapter revealed a number of thermophilic bacteria 
that contain an IEP.  Screening of un-sequenced isolates found three potential 
IEP with RT activity.  B. caldotenax contained an IEP that was not successfully 
Gene-Walked.  However, B. caldovelox and a New Zealand strain of B. 
stearothermophilus were Gene-Walked successfully and the identification of 
these genes would allow their cloning and subsequent expression of the IEP.  
Using a BLAST search also revealed two additional sequenced thermophilic 
bacteria that contain IEPs.  P. mobilis contained three IEPs and T. 
carboxydivorans contained one.  The sequence of these would allow the design 
of primers to allow the cloning of these genes and the expression of the 
proteins.  It was hoped that with a variety of different IEPs identified they would 
show RT activity at the temperatures at which the bacteria grow and therefore 
have a potential use as a thermophilic reverse transcriptase.  
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Chapter 3 – Cloning of Intron-Encoded Protein 
Genes, Manipulation and Protein Expression 
 
3.1 – INTRODUCTION 
 
Intron-Encoded Proteins in Thermophilic Organisms 
The screening of unidentified or un-sequenced bacteria carried out in chapter 2 
revealed IEPs from different Bacillus and Geobacillus species.  These genera 
are extensive, containing rod-shaped bacteria with a diverse range of growth 
conditions and capable of forming endospores.  These can include aerobic to 
faculatively anaerobic organisms and growth conditions can range through the 
extremes of temperature, pH and salt concentration (Nazina et al. 2001).  Two 
Bacillus species, B. caldovelox and B. caldotenax, discovered in superheated 
pool water in the USA by W. Heinen (DSMZ online), were identified as 
containing IEPs.  The partial IEP gene sequence identified within B. caldovelox 
was identical to the GK1355-IEP from G. kaustophilus HTA426.  This was 
surprising due to their geographical separation as the G. kaustophilus strain 
HTA426 strain was isolated from deep sea mud of the Mariana Trench (Takami 
et al. 2004).  The GK1355-IEP contains the typical RT and maturase domains; 
however, it lacks the DNA-binding and endonuclease domains at the C-
terminus.   
 
Other Bacillus/Geobacillus species known to contain IEPs include the B. 
caldolyticus EA1 IEP (mentioned in chapter 2), which is almost identical to 
another, G. kaustophilus IEP, GK1296-IEP.  These IEPs differ by two 
nucleotides, causing one amino acid alteration, and an apparent frame-shift at 
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amino acid 38 in GK1296-IEP.  At present, it is unclear whether this frame-shift 
is genuine or due to a sequencing error (Ng et al. 2004).  The GK.Int 1 intron, 
containing the GK1296-IEP, was found to interrupt a recA gene (Chee and 
Takami. 2005) (Figure 3.1) and EA1 IEP also interrupts a gene with high 
homology to recA.  RecA is considered ubiquitous and multifunctional with 
involvement in homologous recombination, DNA repair and the SOS response.  
GK.Int 1 intron was found to self-splice from the recA transcript, restoring its 
activity (Chee and Takami.  2005).  Both the EA1 and the GK1296-IEP contain 
the RT and maturase domains, lack a DNA-binding domain but contain an 
endonuclease domain at the C-terminus of the protein. 
 
 
Figure 3.1:  A schematic diagram of the recA gene of G. kaustophilus 
interrupted by a 2782bp self-splicing Group II Intron (Gk.Int 1).  The arrow 
marked GK1296 corresponds to the IEP within the Group II Intron.  (Chee and 
Takami.  2005). 
 
The BLAST search detailed in chapter 2 identified an IEP within the thermophile 
T. carboxydivorans.  This thermophile has an optimum growth temperature of 
60ºC and was isolated from a small mud and water pool in the Norris Basin of 
Yellowstone National Park (Sololova et al. 2004).  This bacterium is a curved 
motile rod with a cell wall like that of Gram-negative bacteria; however, its 16S 
rRNA sequence revealed it to comprise a new genus, within the Bacillus-
Clostridium phylum of the Gram-positive bacteria (Sokolova et al. 2004).  The 
IEP within this bacterial strain contained the typical RT and maturase domains 
seen in all bacterial group II IEPs.  However, the DNA-binding and 
endonuclease domains were absent. 
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The BLAST search also revealed the presence of three IEPs within the 
thermophile Petotoga mobilis.  This thermophile, with an optimum growth 
temperature between 58-60ºC, was isolated from hot oil-field water of a North 
Sea oil reservoir (Lien et al. 1998).  This bacterium is a rod-shaped cell with a 
characteristic sheath-like outer cell membrane (‘toga’), typical of the 
Thermotoga species.  However, unlike other members of the order 
Thermotogales, P. mobilis is able to tolerate higher salt concentrations and 16S 
rRNA sequencing revealed it to be a distinct lineage within this order (Lien et al. 
1998).  The three IEPs within this bacterium show high similarity to each other 
and although they contain the typical RT and maturase domains, they do not 
contain the DNA-binding or endonuclease domains. 
 
It was hoped that, with the variety of different IEPs discovered, some would 
show potential as an active soluble protein with an optimum RT activity 
reflecting the growth temperatures of the organism from which they originate. 
 
Protein Engineering 
Protein engineering has been performed on DNA polymerases as a way of 
improving their commercial value and broadening their usage.  These 
approaches can include increasing the resistance of a polymerase to inhibitors 
that could appear in an impure DNA sample to coupling characteristics such as 
high-fidelity with high processivity, two desirable features that do not often 
naturally occur together.  The latter enhancement would aim to use an enzyme 
with known high-fidelity, such as Pfu DNA polymerase, and increase its 
processivity to prevent limitations with the size of fragment that can be 
amplified.  Enhancing the processivity of a polymerase will mean that more 
nucleotides are incorporated during a single enzymatic event before the 
dissociation of the enzyme (Davidson et al. 2003) and has the potential of 
enhancing the length of amplification product that can be achieved as well as an 
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additional affect of increasing the speed of the reaction.  Possible solutions have 
included:  
• Addition of a hairpin-helix-hairpin (H-h-H) motif – this sequence is found 
in a variety of DNA-binding proteins.  As the motif contacts the sugar-
phosphate backbone of the DNA rather than individual bases (Pavlov et 
al. 2002), these proteins are able to bind DNA in a non-specific manner.  
However, the addition of H-h-H domains within DNA polymerases has 
produced mixed results and although processivity in Pfu was enhanced, 
no improvement was seen with Taq DNA polymerase. 
• Insertion of a thioredoxin binding domain – with no natural affinity to 
either ss or dsDNA (Huber et al. 1986), thioredoxin is thought to act as a 
processivity factor, clamping the polymerase onto the DNA (Bedford et al. 
1997).  T7 DNA polymerase binding in vitro to added E. coli thioredoxin 
will have enhanced processivity from usually no more than 12 to over 
thousands of nucleotides (Tabor et al. 1987).  However, introduction of a 
thioredoxin binding domain into an analogous position within Taq DNA 
polymerase greatly lessened the activity of the enzyme (Davidson et al 
2003) and therefore its use in PCR is yet to be proven 
• Insertion of a dsDNA-binding domain – Sso7d is a small dsDNA-binding 
protein found in Sulfolobus solfataricus.  Its role in Nature is believed to 
mimic that of eukaryotic histones (McAfee et al. 1995), stabilising the 
DNA of the thermophilic organism at their high growth temperature.  
Sso7d fused onto the C-terminus of Taq or the N-terminus of Pfu DNA 
polymerase has been shown to greatly increase the processivity of these 
polymerases (Wang et al. 2004). 
 
Mesophilic RTs have also been targeted for modifications to improve their 
performance in synthesising cDNA.  Mutations within RTs tend to be made to 
improve the efficiency of cDNA production.  Common manipulations were 
discussed in detail in chapter 1 and include: 
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• RNase H minus mutants – RTs from retroviruses contain an additional 
RNase H domain that functions to degrade the RNA strand of an 
RNA:DNA hybrid.  This activity, when present in first-strand synthesis 
reactions, prevents high yields of full-length cDNA and can eliminate the 
potential of repeated copying of the RNA template (Berger et al. 1983).  
This RNase H activity can both increase the level of RNA required as a 
template and can lead to this template becoming fragmented. 
• Thermostability mutations – running reactions at a higher temperature 
allows the melting of RNA secondary structure that can act to stall the 
enzyme leading to its dissociation from the template.  A variety of 
mutations are found in commercially-available RTs, such as that in 
SuperScript III (Invitrogen) where the enzyme’s optimum reaction 
temperature has been increased to 50ºC.  
 
It was hypothesised that the IEPs discovered in this report would be more 
thermostable and thermoactive than the mesophilic retroviral RTs and that the 
absence of an RNase H domain could further reduce the problem of truncated 
cDNA synthesis.  However, a method to increase processivity by reducing the 
occurrence of dissociation of the RT from the template, therefore increasing the 
amount of nucleotides incorporated during one enzymatic event, was deemed 
as being desirable.   
 
A single-stranded binding protein (SSB) from Thermus thermophilus, TthSSB, 
was shown to have an unexpected influence on the efficiency of cDNA 
synthesis by the T. thermophilus DNA polymerases.  In the absence of TthSSB, 
T. thermophilus DNA polymerase produced cDNA fragments of at least 264bp.  
However, this polymerase failed to produce cDNA where a larger 1085bp target 
was used.  With the addition of TthSSB to the cDNA synthesis reaction DNA 
products up to 3285bp could be detected by PCR (Perales et al. 2003).  Perales 
 
82 
et al. (2003) hypothesised that this would be due to the TthSSB having an 
unfolding effect on the RNA template.  It was therefore agreed that a DNA-
binding protein could serve to enhance the processivity of an RT enzyme.  
dsDNA-binding proteins from Sulfolobus species were selected as ideal 
candidates due to their high thermostability and their proven use with DNA 
polymerases in PCR (Wang et al. 2004).  Although Wang et al. (2004) used the 
dsDNA-binding protein Sso7d to improve the processivity of polymerases, 
Sac7d from S. solfataricus was selected for this project as, unlike Sso7d, it has 
not been associated with ribonuclease activity (Fusi et al. 1993). 
 
A PCR approach would have to be adopted to allow the artificial fusion of two 
different genes into one ORF.  The technique that was used for this report was 
an overlap extension PCR (reviewed by Ling and Robinson, 1997) (Figure 3.2). 
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Figure 3.2:  A diagram showing an overlap extension PCR method 
(a) The sequences of the two genes, one at the 5’ end and one at the 3’ end 
of the final fused product, have to be known 
(b) Four primers are designed, two for each gene.  
Primer 1:  Contains  the start codon and downstream sequence of the 
                 5’ gene. 
Primer 2: Overlaps the two genes with the primer including the end of  
the 5’ gene (stop codon removed) extending beyond the 
start of the 3’ gene. 
Primer 3:  An antisense version of primer 2. 
Primer 4:  Contains  gene specific sequence of the 3’ gene followed 
                 by the stop codon. 
Two PCRs are performed.  The first uses the 5’ gene template with 
primer pair 1 and 2 and the second uses the 3’ gene template with 
primer pair 3 and 4. 
(c) Two PCR amplicons produced:  
1. 5’ gene with a removed stop codon and 20-25 bases of the start of 
the 3’ gene. 
2. 3’ gene with an upstream region containing 20-25 bases of the 
end of the 5’ gene. 
(d) The products from the first two PCRs are mixed together and used as the 
template in the final PCR, to fuse the two genes together, using primers 1 
and 4 for amplification. 
(e) The final product fuses two domains together in one ORF allowing the 
production of a single protein. 
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This technique involves the amplification of individual genes in separate PCRs 
with primers adding extended bases matching the region to be fused.  The 
annealing step in the final PCR allows the overlapping regions to hybridise and 
the extension step allows the DNA polymerase to extend along the remainder of 
the gene.  The resulting product is two fused genes in one ORF that will be 
translated as a single protein. 
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3.2 – MATERIALS AND METHODS 
 
Buffers  
Cell lysis buffer D:  50mM Tris-HCl, pH8.0, 100mM NaCl, 1mM EDTA 
Protein loading buffer:  0.1M Tris pH6.8, 20%(w/v) sucrose 4%(w/v), SDS, 
0.2%(w/v) bromophenol blue (Sigma, Gillingham, UK)] 
SDS PAGE gel running buffer:  52mM Tris-base, 0.1%(w/v) SDS, 0.4%(w/v) 
glycine 
SDS PAGE gel stain: 0.025%(w/v) Coomasie brilliant blue (R250) (Sigma, 
Gillingham, UK), 45%(v/v) methanol, 10%(v/v) glacial acetic acid (Fisher 
Scientific, Leicestershire, UK). 
SDS PAGE gel de-stain: 20%(v/v) methanol, 10%(v/v) glacial acetic acid 
 
Cloning Primer Design 
Cloning primers were designed based on a known gene sequence to allow 
amplification of the gene and subsequent ligation into an appropriate vector. 
 
Forward Cloning Primers 
These contained six random nucleotides (N) followed by an Nde I site making 
use of the natural ATG start site in the gene, and then 18-25 bases of gene 
specific sequence directly downstream of the ATG start site. 
5’- (N6) CAT ATG (gene specific nucleotides18-25) - 3’ 
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Non His-tagged Reverse Primer  
These contained 18-25 bases of gene specific sequence ending in the gene’s 
natural stop codon (altered to TAA if necessary), followed by an Xho I site and 
six additional random nucleotides (N) to allow cleavage with the Xho I RE. 
3’ - (gene specific nucleotides18-25) TAA CTC GAG (N6) - 3’ 
 
Reverse Primer to Allow C-Terminal His-Tagging  
These contained 18-25 bases of gene specific sequence, and the gene’s natural 
stop codon was deleted and replaced with an Xho I site.  This would utilise the 
6his-tag found in pET24a(+) when using the Xho I site at the 3’ end of the gene. 
3’ - (gene specific nucleotides18-25) [TAA replaced with CTC] GAG (N6) - 3’ 
 
Gene Amplification 
Phusion® DNA polymerase (NEB, Hitchin, UK) was the enzyme of choice for 
gene amplification due to its high-fidelity, with an error rate 50-fold lower than 
that of Taq.  Components of the PCR included 1x Phusion® High-Fidelity (HF) 
buffer, 0.2mM dNTPs (GeneSys Ltd, Camberley, Surrey), 50pmol upper and 
lower primers, 50ng gDNA, and 2U Phusion® DNA polymerase.  The final 
volume was made up to 100µl with nuclease-free water.  The reactions were 
cycled as follows 
98ºC   30s 
 
98ºC   10s 
Primer Tm+3ºC 10s              20 cycles 
72ºC   30s/kb 
 
72ºC   7min  
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PCR products were visualised on a 1%(w/v) agarose gel and purified using 
Wizard® SV Gel and PCR Clean-up system (Promega, Hampshire, UK) and 
DNA was eluted in 50µl nuclease-free water. 
 
Restriction Endonuclease Digest 
The appropriate vector, either pET24a(+) or pET24a(+)NdeI6his, and the 
purified PCR product, were usually digested with Nde I and Xho I (NEB, Hitchin, 
UK) following the recommended protocol.  Digested vectors were 
electrophoresed on an agarose gel alongside uncut vector to assess whether 
complete digestion had taken place.  Once fully digested, the vectors were 
treated with Antarctic Phosphatase (NEB, Hitchin, UK) to remove the 5’ 
phosphate group, so preventing self-ligation of the plasmid.  Antarctic 
phosphatase reactions were carried out according to NEB instructions.  Digest 
products were purified using Wizard® SV Gel and PCR clean-up system, and 
run on an agarose gel with 0.5µg of 2-log ladder to allow estimation of DNA 
concentration. 
 
Ligations 
Ligation reactions typically contained 1x T4 DNA ligase reaction buffer, 12.5U 
T4 DNA Ligase (NEB, Hitchin, UK), 1:4 molar ratio of vector to insert and were 
made up to 10µl with nuclease-free water.  Reactions were incubated overnight 
at 16ºC and then heated to 70ºC for 20min to denature the ligase enzyme.  The 
DNA was then precipitated using ethanol as detailed in chapter 2 and re-
suspended in 5µl of nuclease Milli-Q water to allow electroporation. 
 
Electroporation 
E. coli strain KRX (Promega, Southampton, UK), containing the pRARE2 
plasmid (Rosetta2, Novagen) that encodes seven rare codons, was made 
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competent for the uptake of plasmid DNA following the method as detailed in 
chapter 2.  0.5µl of the ligation product was incubated on ice with 40µl KRX 
(pRARE2) in 20%(v/v) glycerol for 2min and electroporation carried out as 
detailed in chapter 2.  After the 1h incubation step at 37ºC, 100µl of the cells 
were spread onto LB agar plates containing kanamycin (50µg/ml) 
chloramphenicol (34µg/ml) and incubated overnight at 37ºC. 
 
Colonies from the overnight incubated plates were gridded and screened using 
PCR as detailed in chapter 2 methods.  Screening primers used for pET vectors 
were T7 promoter and T7 terminator sequences (Appendix I).   
 
Mini Plasmid Prep 
5ml of LB containing kanamycin and chloramphenicol were inoculated with 
positive colonies identified from the PCR screen and incubated overnight at 
37ºC with aeration at 225rpm.  Cultures were then centrifuged at 5,000xg for 
10min and the supernatant discarded.  Plasmid DNA was extracted from the cell 
pellet using Wizard® plus SV mini-prep kit (Promega, Hampshire, UK).  DNA 
was eluted in 50µl nuclease-free water and a 1µl aliquot loaded on a 1%(w/v) 
agarose gel to allow an estimation of the concentration of the purified plasmid.  
The purified plasmid could be used for sequencing as detailed in chapter 2 
methods. 
 
Small Scale Protein Expression 
KRX (Promega, Hampshire, UK) 
Clones containing a pET24a(+) vector construct with the gene of interest were 
used to inoculate 3ml LB containing 50µg/ml kanamycin and 34µg/ml 
chloramphenicol and incubated overnight at 37ºC with aeration at 225rpm.  
100µl of the overnight culture was used to inoculate 10ml LB containing 
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antibiotic as before.  Cultures were incubated at 37ºC with aeration until an 
OD600 of 0.4-0.5 was reached.  The temperature was then lowered to 15-25ºC 
before protein expression was induced with 0.1%(w/v) rhamnose (Promega, 
Hampshire, UK) and 1mM IPTG (Melford, Ipswitch, UK) once the OD600 had 
reached 0.5-0.6.  Cultures were then incubated overnight at 15ºC with 225rpm 
aeration.  After overnight incubation, the OD600 was measured and the cells 
harvested by centrifugation at 5,000xg for 10min. 
 
ArcticExpress™ (DE3) RIL (Stratagene, Agilent Technologies UK Ltd, Cheshire, 
UK) 
Colonies positive for the gene of interest within a pET24a(+) vector were grown 
overnight with 20µg/ml gentamycin (Sigma, Gillingham, UK), 75µg/ml 
streptomycin (Sigma, Gillingham, UK) and 50µg/ml kanamycin.  250ml LB with 
appropriate antibiotic was inoculated with 2.5ml of the overnight culture and 
incubated at 30ºC for 3h at 225rpm.  The temperature was then decreased to 
12ºC for 10min and then IPTG added to 1mM final concentration.  Induced 
cultures were incubated for a further 24h at 12ºC with aeration at 225rpm.  The 
cells were then harvested at 5,000xg for 5min and the supernatant discarded. 
 
12.5% SDS PAGE 
12.5% gels were cast with a running gel containing 3ml running gel buffer [1.5M 
Tris-base, 0.4%(w/v) SDS], 5ml 30%(v/v) acrylamide (BioRad, Hemel 
Hampstead, UK) and 4ml Milli-Q water.  The gel was set with the addition of 
12.5µl TEMED (Sigma, Gillingham, UK) and 50µl 10%(w/v) APS (Melford, 
Ipswitch, UK).  The running gel was topped with a stacking gel containing 2.4ml 
stacking gel buffer [0.478M Tris-Base, 0.4%(w/v) SDS], 0.9ml 30%(v/v) 
acrylamide, 3.6ml Milli-Q water and set with the addition of 10µl TEMED and 
50µl 10%(w/v) APS. 
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Protein Sample Preparation 
The cell pellets from a 10ml culture were re-suspended in cell lysis buffer D and 
sonicated for 30s at 50W.  The cell debris and insoluble protein material were 
separated from the soluble proteins by centrifuging at 14,000xg for 5min.  The 
supernatant could be used directly as the soluble protein fraction.  The cell 
pellet was washed with cell lysis buffer D, pelleted as before and then re-
suspended in the same volume of cell lysis buffer D.  This fraction contained the 
insoluble proteins.  
 
Protein samples were mixed with an equal volume of protein loading buffer and 
denatured by heating to 100ºC for 3min.  Samples were loaded onto a cast 
12.5% SDS PAGE gel and were electrophoresed at 70V in the protein running 
buffer until past the stacking gel.  Once through the stacking gel, the voltage 
was increased to 240V until the tracker dye reached the base of the gel. 
 
At the end of the run, SDS PAGE gels were rinsed in water and then placed in 
stain for 30min to allow staining of the protein; destain was then used to remove 
background dye from the gel. 
 
Site-Directed Mutagenesis (SDM) 
This procedure was used to alter individual nucleotides in a gene sequence.  
SDM primers were designed to contain the desired mutation on both strands 
situated in the middle of the primers and were between 25-45 bases in length.  
The GC content of the primers had to be a minimum of 40% and ideally 
terminated in one or more G or C bases. 
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SDM primers were used with Phusion® DNA polymerase with the template of 
circular vector containing the desired gene to be altered.  The final reaction 
components consisted of 1x HF buffer, 0.2mM dNTPs, 10pmol of forward and 
reverse primers, 25ng plasmid DNA, 1U Phusion® DNA polymerase and made 
to a final volume of 50µl with nuclease-free water.  The reactions were cycled as 
follows: 
98ºC  30s 
 
98ºC  30s 
55ºC  1min  18 cycles 
68ºC  6min 
 
68ºC  7min 
 
1µl of the reaction was electrophoresed on a 1%(w/v) agarose gel to ensure a 
successful amplification before the addition of 10U Dpn I (NEB, Hitchin, UK) and 
incubation at 37ºC for 1h to remove the original, non mutated template. 
 
The amplified vector was heat-treated at 80ºC for 20min to denature the Dpn I 
and then purified using Wizard® SV Gel and PCR Clean-up system.  The DNA 
was eluted in 30µl nuclease-free water and 1µl transformed into 
electrocompetent E. coli TOP10F’.  100µl of the transformation was spread onto 
LB agar containing 50µg/ml kanamycin and incubated overnight at 37ºC. 
 
Positives colonies were isolated using the screening PCR protocol as detailed in 
chapter 2.  Where an RE site had been added or removed using SDM, this PCR 
could be used in an RE digest with the appropriate enzyme to ensure 
mutagenesis had taken place.  Successful mutagenesis was confirmed by using 
sequence analysis, which also ensured that no additional mutations had 
occurred. 
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Overlap Extension PCR 
This technique results in the fusion of two genes into one open reading frame, 
as detailed in the introduction to this chapter, and allows the translation of a 
single protein containing both gene products.  Four primers had to be designed 
as follows: 
Primer 1: Contained the natural start codon of the 5’ gene, followed by another 
18-25bp of downstream gene-specific bases.  In addition, this primer also 
contained RE sites upstream of the start codon to allow directional cloning of the 
final product. 
Primer 2:  An antisense version of primer 3 
Primer 3:  Contained 20-25 bases of the end of the 5’ gene.  The stop codon of 
the 5’ gene was replaced with the start codon of the 3’ gene, followed by 
additional 20-25 downstream gene-specific bases of the 3’ gene 
Primer 4:  Contained 18-25 gene-specific bases ending with the stop codon, 
altered to TAA where necessary, followed by an RE site allowing directional 
cloning of the gene. 
 
Two initial PCRs were carried out.  The first contained 20ng of template for the 
5’ Gene, 1x HF buffer, 0.2mM dNTPs, 25pmol primer 1 and primer 2, 1U 
Phusion®  DNA polymerase and the final volume made up to 50µl with 
nuclease-free water.  The second PCR was set up in the same way but using 
template for the 3’ Gene and primers 3 and 4.   
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The PCRs were cycled as follows: 
98°C  30s  
 
98°C  10s 
55°C  10s      20 cycles 
72°C  30s/kb 
 
72°C  7min 
 
Samples from the reactions were electrophoresed on an agarose gel to ensure 
that the correct size product has been produced, and then 10U Dpn I (NEB, 
Hitchin, UK) was added followed by incubation at 37°C for 2h, ensuring removal 
of parental DNA template. The reactions were then purified using the Wizard® 
SV Gel and PCR Clean-up system; the DNA was eluted in 50µl nuclease-free 
water and could be used as a template in a PCR to fuse the two genes together. 
 
The gene fusion PCR used 1x HF buffer, 50pmol primers 1 and 4, 100ng of 
each purified product from the first two PCRs, 0.2mM dNTPs, 2U Phusion®  
DNA polymerase and the volume made up to 100µl with nuclease-free water.  
The reactions were cycled as before and the product visualized on an agarose 
gel to ensure fusion had taken place.  Gel purification was performed as per 
manufacturing instructions to remove any contamination from the initial parental 
template.  DNA was eluted in 50µl nuclease-free water. 
 
The purified fused PCR product could then be digested and ligated into an 
appropriate vector as detailed in the methods in Chapter 2. 
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3.3 – RESULTS 
 
B. caldovelox IEP Gene Cloning and IEP Expression 
Gene-Walking of the IEP gene within B. caldovelox revealed 642bp of DNA 
sequence identical to the recombinase of Bh.Int-like element from G. 
kaustophilus, locus tag GK1355.  Rather than continuing to Gene-Walk this 
strain, it was decided to design cloning primers based on the sequence in the 
database for this gene.  Selected cloning vectors for the expression of the IEP 
were pET24a(+) and a modified version of this vector, pET24a(+)NdeI6his.  This 
modified vector introduced 6 histidine residues onto the N-terminus of the 
protein when cloning using the Nde I RE recognition site at the start of the gene.  
However, a restriction map of GK1355-IEP gene revealed an internal Nde I site 
toward the 3’ end of the gene (Figure 3.3).  In order to use the chosen vectors, it 
was therefore necessary to clone the IEP in two fragments (Figure 3.3), an 
upper fragment of 495bp and a lower fragment of 816bp, and primer pairs 
(Appendix I) were designed accordingly: 
Upper Fragment:   
• Forward primer:  B.cv_IEP_F1_start_NdeI primer designed with an initial 
6 random nucleotides followed by an Nde I site incorporated into the start 
codon followed by an additional 24 bases of gene-specific sequence. 
• Reverse primer:  B.cv_IEP_R1_EcoRI primer designed to flank and 
incorporate a naturally-occurring EcoR I site found upstream of the Nde I 
site. 
Lower Fragment  
• Forward primer:  B.cv_IEP_F2_EcoRI primer was an antisense version of 
the reverse primer B.cv_IEP_R1_EcoRI, designed to flank and 
incorporate a naturally-occurring EcoR I site 
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• Reverse primer:  B.cv_IEP_R2_Stop_SalI contained 23 bases of gene-
specific sequence ending with the stop codon, altered to TAA, followed 
by a Sal I site and then additional random nucleotides to ensure RE 
digestion. 
 
 
Figure 3.3:   A diagram showing the positions of the primers to clone the IEP 
from B. caldovelox into two fragments. The upper fragment can be amplified 
using the F1 and R1 primer set, and the lower fragment can be amplified with 
the F2 and R2 primer pair. 
 
Initially the primers were first tested to ensure that they would amplify the 
expected size fragments and were used with both B. caldovelox and B. 
caldotenax gDNA.  Interestingly, despite the fact that this IEP gene was only 
Gene-Walked from B. caldovelox, amplification of the correct size product 
occurred using both strains as template (Figure 3.4).  This could be explained 
by the results of the Touch-Down diagnostic PCR (Figure 3.5). 
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Figure 3.4:  A 1%(w/v) agarose gel showing the two IEP fragments amplified 
from B. caldotenax gDNA.  The correct sizes of 816bp for the lower fragment 
and 495bp for the upper fragment were observed. 
 
 
Figure 3.5:  Touch-Down PCR results on various strains.  B. caldotenax 
contained two possible IEP genes (labelled as a and c).  Amplicon (a) from B. 
caldotenax was identified as being from an IEP but subsequent Gene-Walking 
was unsuccessful.  B. caldovelox contains one fragment (b) that has been 
identified as identical to the GK1355-IEP and this amplicon runs at 
approximately the same size as the unidentified fragment (c) from B. 
caldotenax. 
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When the initial Touch-Down PCRs were carried out on B. caldotenax (Chapter 
2) there were in fact two bands between the critical size of 130-300bp.  The 
larger fragment was identified as an RT domain with a different sequence from 
the now almost fully identified IEP from B. caldovelox.  However, Gene-Walking 
failed to obtain the remainder of this gene.  The second, smaller fragment with 
B. caldotenax remained unidentified.  However, the fact that this smaller 
fragment runs at approximately the same size as the fragment from the B. 
caldovelox IEP, in addition to the amplification product of correct size being 
seen with the B. caldovelox primers and using B. caldotenax gDNA as template 
(Figure 3.4), suggested that this fragment could correspond to a similar IEP.  
Therefore, both IEP genes were cloned and sequenced. 
 
The upper and lower fragments from both Bacillus species were amplified for 
cloning using Phusion® DNA polymerase and 50ng of gDNA template.  B. 
caldovelox also produced fragments of approximately the correct size by 
comparison to a marker on an agarose gel (Figure 3.6).  The upper fragment 
was expected to be 495bp and the lower fragment was expected at 816bp. 
 
 
Figure 3.6:  An agarose gel showing the sizes of the upper and lower fragments 
of the IEP genes from B. caldovelox. 
 
98 
The PCR products were purified and the upper fragment digested with Nde I 
and EcoR I, while the lower fragment was digested with EcoR I and Sal I.  The 
two vectors, pET24a(+) and pET24a(+)NdeI6his, were digested with Nde I and 
Sal I RE and used in a ligation reaction with the two digested fragments.  0.5µl 
of the heat-treated and ethanol-precipitated ligation was transformed into 
electrocompetent E. coli KRX (pRARE2).  20 colonies from each transformation 
were then screened by PCR using the T7 promoter and terminator primers to 
identify those containing the insert of correct size.  Screening of the colonies 
revealed four B. caldovelox IEP clones in pET24a(+), three B. caldovelox IEP 
clones in pET24a(+)NdeI6his, and one B. caldotenax IEP clone in 
pET24a(+)NdeI6his. 
 
All positive colonies, along with one negative colony containing just vector with 
no insert, were selected for protein expression studies.  10ml of LB with 
appropriate antibiotics was inoculated with 100µl of an overnight culture and 
incubated at 37ºC with aeration at 225rpm.  Protein expression was induced 
with the addition of rhamnose and IPTG once an OD600 of 0.6 was reached.  
The cultures were incubated overnight (approximately 20h) at 25ºC, 225rpm, 
and then the cells harvested by centrifugation.  The cell pellet was re-
suspended in cell lysis buffer D and sonicated.  The sample was centrifuged 
and the supernatant retained as the soluble fraction.  The cell debris pellet was 
washed and re-suspended in 750µl cell lysis buffer D to be used as the 
insoluble fraction.  5µl of these cell fractions, equivalent to 67µl of the original 
culture, were electrophoresed on a 12.5%(w/v) SDS PAGE gel (Figure 3.7). 
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Figure 3.7:  12.5% SDS PAGE gel.  Lanes 1-4 show the soluble fraction of the 
protein expression of the IEP from B. caldotenax in pET24a(+); the arrow (a) 
marks the over-expressed protein expected to be the IEP due to its absence in 
the negative-control in lane 9.  Lanes 5-7 show the protein expression from four 
clones containing an IEP gene from B. caldotenax in pET24a(+)NdeI6his.  Lane 
8 shows the protein expression from the cloned IEP gene from B. caldotenax in 
pET24a(+)NdeI6his, arrow (b) marks the additional over-expressed protein, 
expected to be the tagged IEP, not seen in the negative-control.  Lane 9 is the 
protein expression from a pET24a(+) clone negative for any insert. 
 
The protein expression gel showed that clones 1-4 were expressing a protein in 
addition to those seen in the negative-control lane.  This band was running level 
with the 45kD marker, slightly lower than the expected size of 49kD for this IEP.  
No over-expressed protein was present in either the soluble or insoluble fraction 
for B. caldovelox IEP genes in pET24a(+)6his, seen in lanes 5-7.  The B. 
caldotenax IEP with the N-terminal 6his-tag did have an additional protein band 
from those seen in the negative-control ran slightly higher than that non-tagged 
protein suggesting that his-tagging had been successful.  In clones successfully 
expressing the IEP there was a small percentage of the over-expressed protein 
present in the insoluble fraction and this was increased with the N-terminal his-
tagged protein.  However, it was found that by inducing protein expression at 
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the lower temperature of 15ºC, the IEPs from these Bacillus species were 100% 
soluble. 
 
Sequencing analysis of the IEP genes from both Bacillus species showed them 
to be identical to the fully-sequenced G. kaustophilus GK1355-IEP.  This proved 
that the additional IEP fragment, previously unidentified in B. caldotenax ,was in 
fact identical to the IEP genes that found in both B. caldovelox and G. 
kaustophilus.  Given that G. kaustophilus is found to have three seperate IEPs, 
B. caldotenax has been identified to have two IEPs and B. caldovelox has one 
IEP it is unlikely that this occurence of the same IEP within all three bacteria is 
due to a contamination with the same bacteria being studied.  It is more likely 
that this repeated occurence of the same intron is due to the mobile nature of 
the introns themselves with each different bacterium acquiring the same 
retroelement containing an identical IEP.   
 
B. caldovelox IEP Manipulation 
Since the IEP from B. caldovelox was expressing with 100% solubility it was 
chosen for further manipulation experiments in an attempt to enhance the 
properties of the enzyme.  This involved the fusing of the DNA-binding protein, 
Sac7d, onto either the C-terminus or the N-terminus of the IEP. 
 
Initially, site-directed mutagenesis (SDM) had to be carried out to remove the 
internal Nde I site towards the 3’ end of the gene to utilize an Nde I site that had 
been incorporated into the start of the gene.  Primers were designed (Appendix 
I) to flank this Nde I site and to alter the CAT ATG recognition site to CCT ATG.  
This mutation was silent to avoid alteration of the amino acid residue that would 
be incorporated on translation.  Phusion® DNA polymerase was used along with 
the two SDM primers to extend from the primer sites around the pET vector 
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containing the IEP gene.  The reaction was then treated with Dpn I which 
ensured the removal of the parental pET vector template whilst leaving the 
mutated PCR product intact.  After purification, 1µl of this mutated DNA was 
used in a transformation into E. coli strain KRX (pRARE2).  Transformed 
colonies were screened for a successful mutation by first running a screening 
PCR with T7 promoter and terminator.  This PCR product was then used directly 
in an Nde I digest to test for the removal of the recognition site.  Any PCR 
products that were digested into two fragments would contain an Nde I site and 
therefore indicated that SDM had been unsuccessful.  Positively mutated 
colonies were then sequenced using the ABI3100 sequencing protocol to 
ensure that no additional errors had been introduced into the IEP gene 
sequence. 
 
To create the Sac7d fusion protein, an overlap extension PCR method had to be 
used.  Primers were designed (Appendix I) to incorporate the Sac7d domain 
onto either the C-terminus or the N-terminus of the protein (Figure 3.8), joined 
with a 3 amino acid linker, GTV.  
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Figure 3.8:  A diagram to show the relative positions of the overlap extension 
PCR to incorporate a Sac7d domain at either the N-terminus or the C-terminus 
of the B. caldovelox IEP.  The primers (Appendix I) were as follows: 
 
P1:  Sac7d_NterF_Nde I 
P2:  Sac7d_NterR 
P3:  B.cv_CterF 
P4:  B.cv_CterR_Xho I 
 
 
P5:  B.cv_NterF_Nde I 
P6:  B.cv_NterR 
P7:  Sac7d_CterF 
P8:  Sac7d_CterR_Xho I 
 
 
The template used to amplify the Sac7d gene was a vector, donated by 
GeneSys Ltd, containing the Sac7d gene that had been artificially synthesized 
to allow optimized codon usage for E. coli (Appendix III).  2ng of this vector was 
used in a PCR with Phusion® DNA polymerase with the following primer 
combinations: 
• P1 with P2 where the Sac7d was required at the N-terminus of the 
fusion protein. 
• P7 and P8 where Sac7d was required at the C-terminus of the fusion 
protein. 
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The amplified products were visualized on an agarose gel to ensure the correct 
size of 250bp for the N-terminal Sac7d and 255bp for the C-terminal Sac7d 
had been achieved (Figure 3.9a). 
The cloned B. caldovelox IEP gene, with removed internal Nde I site, was also 
amplified with Phusion® DNA polymerase and the following primer 
combinations: 
• P3 and P4 where the B. caldovelox IEP was required at the C-terminus 
of the fusion protein. 
• P5 and P6 where the B. caldovelox IEP was required at the N-terminus 
of the fusion protein. 
These PCR products were visualized on an agarose gel to ensure that 
approximately the correct sized products of 1292bp for the C-terminal IEP and 
1307bp for the N-terminal IEP were achieved (Figure 3.9b). 
 
Figure 3.9:  An agarose gel showing Phusion® DNA polymerase amplified 
products of: 
(a) Sac7d gene for overlap extension PCR for both N and C-terminal 
fusion products. 
(b) B. caldovelox IEP gene product for both C and N-terminal fusion 
products. 
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Once confirmed as being approximately the correct size, the four PCR products 
were treated with Dpn I to remove parental plasmid template, and then purified.  
Overlap extension PCRs were set up with 100ng of each template as follows: 
• To create Sac7d-IEP fusion product:  N-terminal Sac7d PCR product 
and C-terminal IEP PCR product used as template with primer pair P1 
and P4. 
• To create IEP-Sac7d fusion product:  N-terminal IEP PCR product with 
C-terminal Sac7d PCR product with primer pair P5 and P8. 
The product sizes from these overlap extension PCRs were expected to be 
1495bp.  Gel purification had to be carried out to ensure only the correct size 
product was present (Figure 3.10). 
 
Figure 3.10:  A 1% (w/v) agarose gel showing the overlap extension PCR 
products.  Lane 1 contains the IEP gene with a C-terminal Sac7d domain (IEP-
Sac7d) and lane 2 shows the IEP gene with an N-terminal Sac7d domain 
(Sac7d-IEP). 
 
The purified overlap extension PCR products were digested with REs Nde I 
and Xho I and ligated into pET24a(+).  Once the ligation reactions had been 
heat-treated and ethanol-precipitated, 0.5µl was transformed into 
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electrocompetent E. coli KRX (pRARE2) and 100µl plated onto LB plates with 
kanamycin and chloramphenicol.  Colonies were screened using a colony-
screening PCR and T7 promoter and terminator primers, colonies giving the 
correct size PCR product were assumed to be positive for the fusion protein. 
 
Positive colonies were selected for protein expression studies along with a 
pET24a(+) vector containing no insert to be used as a negative-control.  Cells 
were harvested from 10ml LB culture expressed at 15ºC with a 20h rhamnose 
and IPTG induction.  The cell pellet was re-suspended in 750µl cell lysis buffer 
D and then sonicated.  5µl of both the soluble and insoluble fractions, 
equivalent to 67µl of original culture, were electrophoreses on a protein gel 
(Figure 3.11). 
 
Figure 3.11:  12.5%(v/v) SDS PAGE gels showing the soluble (1) and insoluble 
fraction (2) of: 
(a) The expression of the fusion product with Sac7d at the C-terminus 
with arrow (a) marking the over-expressed fusion product not seen in 
the negative-control lane (-ve).  
(b) The expression of fusion protein with Sac7d at the N-terminal of the 
IEP with arrow (b) showing the over-expressed protein not seen in the 
negative-control lane (-ve). 
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Both Sac7d fusion clones showed over-expression of a protein that was not 
present in the negative-control.  By plotting log Mr values of the size standard 
against the distance travelled it was possible to estimate the protein size at 
52kD.  This was slightly lower than the expected 57kD as predicted from the 
protein sequence.  No over-expressed protein was present in the insoluble 
fraction suggesting that the protein was 100% soluble.  DNA sequence analysis 
of these fused genes showed a successful read through in one ORF and no 
errors present in either the Sac7d or the IEP domain. 
 
Thermosinus carboxydivorans Gene Cloning and Protein Expression 
A BLAST search for IEPs revealed T. carboxydivorans to contain a fully 
sequenced IEP, from a draft genome, with 63% protein sequence identity to that 
of G. kaustophilus HTA426 GK1355-IEP.  Cloning primers (Appendix I) were 
designed to amplify this gene to allow its cloning into a vector and its 
subsequent protein expression.  Two lower primers were designed, one to alter 
the stop codon from TGA to TAA making it a stronger stop codon in E. coli and 
then finishing in an Xho I recognition site, and the second primer to replace the 
stop codon with an Xho I site so that cloning into pET24a(+) allowed the 
addition of a C-terminal his-tag. 
 
T. carboxydivorans, DSMZ Number 14886, was ordered from the DSMZ as a 
lyophilized sample.  The gDNA was extracted using the method by Götz et al. 
(2002), detailed in Chapter 2, and then the yield further enhanced by using 
GenomiPhi™V2 DNA amplification kit.  A Phusion® PCR was set up to amplify 
the gene using both primer sets.  The PCR product was electrophoresed on a 
1%(w/v) agarose gel to ensure the correct-sized product had been amplified 
(Figure 3.12).  A size of 1248bp was expected for the C-terminal his-tagging 
product and 1251bp for the product not to be his-tagged or for N-terminal his-
tagging. 
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Figure 3.12:  An agarose gel of the IEP gene amplified from T. carboxydivorans.  
Lane 1 shows the product that will allow N-terminal his-tagging and non-his 
tagging of the protein and lane 2 shows the product that will enable C-terminal 
his-tagging. 
 
Once the correct size was confirmed, the PCR product was digested with Nde I 
and Xho I and ligated into either pET24a(+) or pET24a(+)NdeI6his that had 
been digested with the same REs.  Heat-treated and ethanol-precipitated 
ligation products were transformed into electrocompetent E. coli KRX (pRARE2) 
and plated onto LB agar plates with kanamycin and chloramphenicol.  Colonies 
were screened by PCR and assumed as positive by the presence of a band of 
the correct size on an agarose gel. 
 
Positive colonies were selected for gene expression studies along with one 
negative colony.  Protein expression was induced according to KRX protocol 
instructions with induction temperatures set at 15ºC.  The cell pellet from a 10ml 
induced culture was re-suspended in 750µl of cell lysis buffer D and sonicated.  
5µl, equivalent to 67µl of original culture, was electrophoresed on a protein gel 
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for expression analysis.  Of the three versions of the IEP gene cloned, the non-
tagged, the C-terminal his-tag and the N-terminal his-tag, only the C-terminal 
his-tagged IEP showed any over-expression of a protein different from that in 
the negative-control (Figure 3.13). 
 
 
Figure 3.13:  12.5% SDS PAGE gels showing:  
(a) The soluble fraction of the over-expression of T. carboxydivorans IEP.  
(b) The insoluble fraction.  The arrow marks the expected IEP protein 
band present in all clones (lane 1-6) and which is not present in the 
negative-control lane (-ve). 
 
The IEP gene in pET24a(+)NdeI6his vector clone had an additional over-
expressed protein, not present in the negative-control lane, which was 
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estimated by using the marker standards to be 43kD, slightly lower than the 
expected size of 47Kd predicted from the protein sequence.  This extra band, 
suggestive of the IEP was also present, at low levels, in the insoluble fraction 
(Figure 3.13b). 
 
To achieve a maximum yield of soluble protein, an attempt was made to reduce 
the level of the insoluble fraction.  Initially, rhamnose concentrations were 
reduced; however, this resulted in a reduction in the level of protein expressed 
with no affect on the ratio of soluble to insoluble protein.  Another option was to 
try a different E. coli expression strain and ArcticExpress™ (DE3) RIL was 
selected as an alternative.  Positive colonies were grown overnight in 5ml LB 
with appropriate antibiotic and the plasmid purified using the Promega Wizard® 
Plus SV mini-prep DNA purification system.  Purified plasmids were transformed 
into electrocompetent ArcticExpress™ (DE3) RIL and plated on LB with 50µg/ml 
kanamycin, 20µg/ml gentamycin and 75µg/ml streptomycin.  ArcticExpress™ 
colonies were then used to inoculate 250ml LB with antibiotic and protein 
expression induced according to the protocol.  A 10ml sample from the 250ml 
culture was collected and the cells harvested to analyse for protein expression.  
Protein expression using ArcticExpress™ (DE3) RIL cells was lower than that 
seen from KRX (pRARE2) with no change in the ratio of insoluble protein.  
Therefore, with higher a higher expression yield, KRX (pRARE2) would be used 
with the standard expression protocol when this IEP was to be expressed on a 
larger scale. 
 
Petrotoga mobilis IEP Gene Cloning and Protein Expression 
The three IEP genes identified from P. mobilis were very similar in sequence to 
each other with IEP1 and 2 being 98% identical, 2 and 3 being 95% identical 
and 1 and 3 being 94% identical (Appendix IV).  However, these slight 
differences on a DNA level did alter the amino acid composition (appendix IV) 
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so attempts were made to clone all three IEPs.  Primers were designed 
(Appendix I) to try to amplify the individual genes by making use of DNA base 
changes at the last nucleotide of the 3’ end of the primers.  This allowed the 
design of two forward primers, one for IEP1 and 2 and a separate one for IEP3 
and three individual reverse primers, each with a different 3’ end nucleotide.  It 
was hoped that these primers would be selective enough to allow the 
amplification of all three individual IEPs.  
 
P. mobilis, DMSZ number 10674, was ordered from the DSMZ as a lyophilized 
sample.  The gDNA was extracted and the yield enhanced using 
GenomiPhi™V2 DNA amplification kit.  Phusion® DNA polymerase was used to 
amplify the three IEPs in separate reactions.  The PCR products were then gel 
purified to remove non-specific products and analysed on an agarose gel to 
ensure the correct size of 1452bp, for each IEP, had been achieved (Figure 
3.14). 
 
 
Figure 3.14:  A 1%(w/v) agarose gel showing the PCR products from the P. 
mobilis IEP gene amplification.  The products are running at approximately the 
expected size of 1452bp. 
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The IEP gene PCR products were digested with Nde I and Xho I and ligated into 
pET24a(+) vector.  0.5µl of ligated, ethanol-precipitated reactions were 
transformed into electrocompetent KRX (pRARE2) and plated onto LB plates 
with antibiotic.  Colonies were screened using colony PCR and positive colonies 
containing the correct-size insert were selected for protein expression studies.  
The cell pellet from 10ml LB cultures, with protein expression induced at 15ºC 
with IPTG and rhamnose, were harvested and re-suspended in 750µl cell lysis 
buffer D.  5µl of both the soluble (Figure 3.15, 3.16 and 3.17) and insoluble 
protein fractions were loaded on to a protein gel 
. 
 
Figure 3.15:  12.5%(v/v) SDS PAGE gel showing the soluble fraction of the 
protein induction of P. mobilis IEP 1 in pET24a(+).  All 8 clones are positive for 
an over-expressed protein not seen in the negative-control lane (-ve).  The 
arrow on the gel marks the over-expressed protein. 
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Figure 3.16:  12.5%(v/v) SDS PAGE gel showing the soluble fraction of the 
protein induction of P. mobilis IEP 2 in pET24a(+).  Three of the colonies, 
numbers 10, 11 and 12 showed positive for an extra over-expressed protein not 
present in the negative-control lane (-ve).  The arrow on the gel marks the over-
expressed protein. 
 
 
Figure 3.17:  12.5% SDS(v/v) PAGE gel showing the soluble fraction of the 
protein induction of P. mobilis IEP in pET24a(+).  Four of the colonies, numbers 
15, 16, 17 and 18 showed positive for an extra over-expressed protein not 
present in the negative-control lane (-ve).  The arrow on the gel marks the over-
expressed protein. 
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The expression studies of all three P. mobilis IEPs showed a positive band not 
present in the negative-control lane.  Plotting the markers as standard size 
against distance travelled, this additional protein band was estimated to be 
52kD in size, very slightly lower than the expected protein size of 54kD 
predicted from the IEP amino acid sequence.  The positive colonies were grown 
on a 5ml scale and the plasmid purified using the Promega mini-prep kit.  The 
eluted plasmid was sequenced using the ABI 3100 sequencing protocol to verify 
the correct sequence was present.  All the clones sequenced for IEP1 and 2 
were correct.  However, the sequencing results showed that out all the possible 
IEP3 clones, only the clone not expressing any soluble or insoluble protein, 
clone 19, was in fact IEP3.  Sequencing analysis of the other clones from this 
expression trial revealed them all to be identical to IEP2.  This was most likely 
explained by the nature of the primers used in the gene amplification.  The fact 
that the specific primers for each IEP differed by very few bases led to the 
possibility of them annealing to the incorrect gene resulting in the wrong gene 
being cloned and therefore the wrong protein expression.  The lack of actual 
expression of the correct IEP3 could not be explained as sequencing revealed it 
to be correct.  No further work was carried out to express the IEP3. 
 
New Zealand Strain 11 B. stearothermophilus Gene Cloning and 
Protein Expression  
The full Gene-Walking of the IEP from the New Zealand strain 11 B. 
stearothermophilus was not successfully completed.  However, an alignment 
using ClustalX showed 96% DNA sequence similarity to the B. 
stearothermophilus trt gene.  Cloning primers were therefore based on this fully-
sequenced gene and designed in such a way to ensure that the terminal 3’ base 
of the primer did not end in the third base of an amino acid codon as this was 
the most likely base to differ across different strains.  Phusion® DNA polymerase 
was used to amplify the IEP from strain 11 and the product analysed on an 
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agarose gel (Figure 3.18).  Based on the trt gene, the product was expected to 
be 1294bp in length. 
 
Figure 3.18:  A 1%(w/v) agarose gel showing the amplified IEP gene product 
from a New Zealand strain of B. stearothermophilus. 
 
The amplified IEP gene product was purified and digested with Nde I and Xho I 
and ligated into pET24a(+).  The overnight ligation reaction was then heat-
treated, to denature the ligase, ethanol-precipitated and 0.5µl transformed into 
electrocompetent KRX (pRARE2).  Transformed colonies were screened using 
colony PCR and positives selected for protein expression studies. 
 
The cell pellets from positive colonies and one negative-control were harvested 
from 10ml cultures after overnight expression of the protein with IPTG and 
rhamnose at 15ºC.  These pellets were re-suspended in 750µl cell lysis buffer D 
and 5µl of the soluble and insoluble cell fraction was loaded on to a protein gel 
(Figure 3.19). 
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Figure 3.19:  A 12.5% SDS PAGE gel showing over-expressed IEP from a New 
Zealand B. stearothermophilus strain.  The arrow marks the over-expressed 
protein not present in the negative-control lane (-ve). 
 
The protein gel showed the presence of a band that was absent from the 
negative control.  Plotting log Mr values of the marker standard against the 
distance travelled this protein was estimated to be 39kD in size.  This was lower 
than the expected 48kD protein predicted based on the Trt protein.  The colony 
that was over-expressing a protein not present in the negative-control was 
sequenced using the ABI3100 sequencing protocol to discover the entire IEP 
gene sequence that was yet to be fully identified.  The sequencing analysis 
revealed that this New Zealand strain of B. stearothermophilus IEP gene had 
96% sequence identity to the trt gene and 97% identify once translated into a 
protein sequence (Appendix IV).  The discrepancy that is seen with this IEP 
could be due to an incorrect protein being expressed.  Although sequencing 
reveals an IEP within this clone problems are encountered, and discussed later 
on in this report, with the large scale expression of this protein.  Since the 
protein is the incorrect size and is difficult to express, mass spectrometry 
analysis would be required to verify if this protein is indeed correct.  
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3.4 – DISCUSSION 
 
The previous chapter outlined the identification of IEPs within different 
thermophiles.  This chapter outlines their successful cloning and expression 
even in situations where the full sequence had not been fully identified. 
 
Primers based on the GK1355-IEP from G. kaustophilus allowed the 
amplification of an identical gene within B. caldovelox.  It was also revealed that 
the additional IEP within B. caldotenax, that was previously unidentified, was 
capable of being amplified using these same primers and was revealed to be 
identical to GK1355-IEP.   Gene expression studies of these IEPs revealed an 
over-expressed protein running at approximately 45kD and which was not 
present in the negative-control lane.  This was expected to be the IEP although 
the protein size was lower than the expected size of 49kD.  This protein was 
100% soluble when using KRX (pRARE2), providing expression temperatures 
were maintained at 15ºC.  
 
The successful protein expression of the IEP from B. caldovelox allowed further 
manipulations to the protein.  Sac7d, a dsDNA-binding protein, was selected for 
the possibility of enhancing the enzyme.  It was hoped that the addition of a 
Sac7d domain would enhance the processivity of the enzyme and reduce the 
amount of truncated products, which can be a problem with mesophilic RTs.  
Overlap extension PCR was used to create a fusion product of a codon 
optimized Sac7d at either the N- or C-terminus of the IEP.  This fusion 
experiment was successful, allowing two genes to occur in a single ORF.  The 
proteins were tested for expression using KRX (pRARE2).  Protein expression 
studies of these two fusion products revealed an over-expressed protein, 
running higher than that of the IEP on its own, at approximately the correct size 
of 57kD.  Having an N-terminal or C-terminal Sac7d domain fused to the IEP 
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seemed to have no effect on the folding of the protein, with 100% solubility 
being seen using 15ºC protein induction temperatures. 
 
Chapter 2 showed that a BLAST search, using the G. kaustophilus HTA426 
GK1355-IEP as the query sequence, revealed two thermophiles that contained 
fully sequenced IEPs: T. carboxydivorans and P. mobilis. 
 
T. carboxydivorans, which has an optimum growth temperature of 55ºC, 
contained an IEP with 63% amino acid identify to the GK1355-IEP.  Primers 
were designed based on the sequence in the database and allowed the 
successful cloning of this IEP gene.  Protein expression studies using KRX 
(pRARE2) with 15ºC induction temperature, revealed the over-expression of a 
protein, of approximately 60% solubility, running at a size slightly lower than the 
expected 47kD.  Sequencing of these clones revealed that the IEP contained no 
mutations.  Attempts were made to reduce the level of insoluble protein, 
including varying the levels of rhamnose and altering the expression strain to 
ArcticExpress™(DE3) RIL.  However, no improvements were seen in the ratio of 
soluble protein to insoluble.  Although the protein was at approximately 60% 
solubility, the overall expression yield of the protein was in fact high so it was 
deemed unnecessary to pursue any further work to enhance solubility as 
enough protein would be present for purification. 
 
P. mobilis, with an optimum growth temperature of 55ºC, was found to contain 
three IEPs, two with 54% amino acid identity and one with 53% amino acid 
identity to the GK1355-IEP within G. kaustophilus.  Cloning primers were 
designed to amplify all three IEPs allowing their insertion into a pET vector.  
Colonies positive for an insert were grown up for protein expression studies 
revealing the presence of a protein, with 100% solubility, at approximately the 
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correct size of 54kD.  However, sequencing analysis revealed that only IEP1 
and 2 were successfully expressing and, despite the fact that there were no 
errors in the sequence, IEP3 failed to be successfully expressed. 
 
A B. stearothermophilus strain from New Zealand was revealed to contain an 
IEP.  Gene-Walking failed to completely identify the full-length IEP gene 
sequence; however, the similarity of the gene to the B. stearothermophilus trt 
gene allowed the design of cloning primers.  The IEP gene from this New 
Zealand strain was successfully amplified, allowing its insertion into a pET 
vector.  Protein expression was carried out using KRX (pRARE2) with a 15ºC 
expression temperature.  The protein expression revealed the presence of an 
over-expressed protein, not present in the negative-control lane, running a 10kD 
lower than the expected size at approximalty 39kD.  Sequence analysis of this 
gene revealed it to have 96% identity to the trt gene with 97% identify to the Trt 
protein. 
 
This report has shown the identification of several different IEPs from 
thermophiles with growth temperatures ranging from 55-70ºC.  Two groups have 
shown that an IEP from B. caldolyticus EA1 and the Trt from B. 
stearothermophilus are expressed in low yields with a very percentage of 
insolubility, leading to difficulty in the purification and subsequent enzyme 
characterisation (Ng et al. 2007 and Vellore et al. 2004).  Unlike these previous 
studies on IEPs, the IEPs from this report have high expression levels and only 
the IEP from T. carboxydivorans showing some degree of insolubility.  These 
high yields of protein should enable the purification and characterization of the 
IEPs as RT enzymes. 
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Chapter 4 – Intron-Encoded Protein Purification 
 
4.1 – INTRODUCTION 
 
Unlike many other enzymes, the RT activity of IEPs could not be assayed 
directly from cell extracts.  This is due to the fact that un-fractionated extracts 
are likely to contain contaminating RNases and DNases naturally produced by 
the E. coli expression strain.  The RNases will degrade the RNA template 
required for cDNA synthesis, while the DNases will degrade both the cDNA 
produced and inhibit any subsequent PCR steps.   DNases pose less of a 
problem where heat treatment of the cell extract can be applied.  For example, 
commercially available DNases such as DNase I are denatured by heating at 
70ºC for 10min as seen in the manufacturing protocol (NEB, DNase I [online]).  
RNases, however, can be more problematic to inactivate.  RNases are 
notoriously heat stable;  for example, RNase A, while not exhibiting any activity 
at 90ºC, will show activity once the reaction is quickly cooled to 25ºC (Zale and 
Klibanov 1986).   There are also reports of RNases being able to withstand 
autoclaving at 121ºC, 15psi for 15min (Pasloske and William, 1998). Purification 
of the IEP from these contaminants will therefore be necessary before assaying 
for activity and characterisation of the RT.  Several different purification 
approaches can be adopted to purify the IEP and will be discussed in this 
introduction 
 
Affinity Chromatography – Ni2+ Charged Column 
The his-tag incorporated on the N- and C-termini of some of the IEPs should 
provide a simple purification step.  The his-tag, if exposed on the surface of the 
protein, should bind to a Sepharose column that has been charged with Ni2+ 
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allowing non-tagged proteins to pass straight through.  Elution can then be 
carried out by an imidazole gradient, allowing pure protein to be achieved.   
 
Affinity Chromatography – Heparin Column 
This column will make use of the nucleic acid binding properties of the IEP.  
This protein, along with other nucleic acid binding proteins in the protein sample 
should bind to the column whilst the other E. coli proteins will pass through.  
Elution can be carried out with an NaCl gradient in an attempt to separate the 
IEP from the other nucleic acid binding proteins.  However, a heparin column 
can also bind contaminating nucleases, which could potentially be eluted with 
the IEP. An additional problem could occur if the IEP has a higher affinity to the 
nucleic acids in the sample over the affinity to the heparin column, a situation 
that will prevent the IEP from binding.  Nucleic acid removal might be required 
before use of this column as a purification step. 
 
Ion Exchange Chromatography – Cation Exchange Column 
The high isoelectric point (pI) of all the IEPs in this report, ranging from 9.8-10.6, 
pose an advantage for purification from background E. coli proteins.  Most E. 
coli proteins have a theoretical pI value around 6 (Figure 4.1) and therefore will 
not be positively charged at pH6.8.  At pH6.8 the IEPs should bind the cation 
exchange column while the majority of the E. coli proteins come straight through 
or elute at low NaCl concentrations. 
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Figure 4.1:  A scatter graph plotting the theoretical Mw against the theoretical pI 
values of E. coli proteins.  The majority of the proteins have a theoretical pI 
value of 6. (EcoProDB 2006 [online]). 
 
 
Ion Exchange Chromatography – Anion Exchange Column 
Due to their high pI values it is unlikely the IEPs will bind to this column at pH8.  
However, the majority of the E. coli proteins should bind, along with the 
negatively-charged nucleic acids.  This method could serve as a purification 
step whereby the nucleic acids are removed from the protein sample along with 
many of the contaminating proteins, and the IEP should be present in the flow-
through. 
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Ceramic Hydroxyapatite Column (CHT) 
Type I CHT, with a higher binding capacity for proteins than Type II, offers an 
alternative purification method.  CHT should offer a method to separate the IEP 
from nucleic acids, but where this fails a second protocol can be followed.  In 
some situations nucleic acids may have to be removed from the sample, 
involving high NaCl concentrations, before purification steps can be carried out.  
Lowering the salt concentration runs the risk of the IEP and other proteins 
becoming insoluble.  Since the CHT is unaffected by high salts, the nucleic acid 
precipitated sample can be loaded directly onto the column and the NaCl 
maintained throughout purification, eliminating the risk of precipitation.   
 
Nucleic Acid Removal 
Nucleic acids will also need to be absent from the final purified enzyme sample.  
This will be necessary to avoid any contamination of reactions used to assay the 
enzyme and to reduce the likelihood of non-specific cDNA synthesis and false 
results.  If the protein purification steps do not separately remove the nucleic 
acids, or the nucleic acids interfere with the purification, then the removal of 
nucleic acids may have to be carried out as an initial step prior to downstream 
purification methods.  The use of DNases and RNases would need to be 
avoided to prevent contamination of the protein sample with these enzymes, 
which will inhibit subsequent reactions.  
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4.2 – MATERIALS AND METHODS 
 
Large-Scale Protein Expression 
Terrific Broth (TB):  24g yeast extract, 12g tryptone and 4ml glycerol in 900ml 
Milli-Q water.  Once autoclaved 100ml sterile 0.17M KH2PO4, 0.72M K2HPO4 
(Fisher Scientific, Leicestershire, UK) was added prior to use. 
 
4x 2 litre baffled shake flasks containing 1 litre of either LB or TB media were 
inoculated with 10ml of overnight culture.  The cultures were incubated at 37ºC 
at 225rpm until an OD600 of 0.4-0.5 (0.8-1.0 for TB) was reached.  The 
temperature was then reduced to 15ºC and once an OD600 of 0.5-0.6 (1.0-1.5 for 
TB) was reached protein expression was induced with the addition of 0.1%(w/v)  
rhamnose and 1mM IPTG.  Cultures were incubated for approximately 20h at 
15ºC with aeration at 225rpm.  A 10ml sample was removed from the culture to 
verify protein expression and the remainder of the cultures were centrifuged at 
5,000xg, to pellet the cells, which were then stored at -70ºC until required. 
 
Heat-Treatment of Un-Fractionated Cell Extract 
A 10ml sample from the large-scale protein expression was removed and the 
cells harvested by centrifugation at 5,000xg for 10min.  The sample was re-
suspended in cell lysis buffer D (chapter 3) and sonicated on ice for 30s at 
15micron.  After centrifugation at 14,000xg for 5min 100µl aliquots were 
incubated at 50°C for 0, 5, 10 and 15min and centrifuged as before.  10µl of the 
soluble fractions were electrophoresed on a 12.5%(v/v) SDS PAGE gel to verify 
the presence of soluble IEP before and after heat treatment.  
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Polyethylenimine Precipitation 
Polyethylenimine (PEI) (Sigma, Gillingham, UK) was used to precipitate 
contaminating nucleic acids from cell extracts where they would otherwise 
interfere with purification methods.  The level of PEI to be used had to be 
determined for each new cell extract. 
 
In order to test levels required, typically 0.2g of cell pellet was re-suspended in 
2ml of a column bind buffer [mentioned below (with 25mM NaCl)].  The sample 
was sonicated for 30s at 15microns.  100µl aliquots of the sonicated sample 
were removed and treated with varying concentrations of PEI ranging from 0-
0.6%(v/v) and incubated on ice for 1h.  The samples were then centrifuged at 
14,000xg for 10min.  10µl of the supernatant was electrophoresed on an 
agarose gel to verify the level of PEI required to precipitate all contaminating 
nucleic acids.  A 12.5%(v/v) SDS PAGE gel was also run in parallel to analyse 
the level of protein that remains soluble at the required PEI level, as proteins 
often precipitate out at higher PEI concentrations. 
 
If the protein became insoluble at the required PEI concentrations then 
additional experiments had to be carried out.  The PEI precipitation protocol was 
repeated using the confirmed level of PEI for that cell extract but with altering 
NaCl concentrations.  Incubation and centrifugation were carried out as before 
and a 12.5%(v/v) SDS PAGE gel used to confirm the level of NaCl required to 
allow the protein to stay in solution, whilst an agarose gel ensured all nucleic 
acids had still been removed. 
 
Once the correct PEI and NaCl levels were determined, the reaction could be 
scaled up to remove all nucleic acids from a protein sample before loading on to 
an appropriate column. 
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Protein Sample Preparation for Purification 
With PEI treatment  
Cell pellets were re-suspended in the appropriate bind buffer equivalent to 
0.1mg/ml of cells.  Normally 2g of cells were re-suspended in 20ml of buffer and 
sonicated for 3x 1min.  The total protein fraction was exposed to the appropriate 
level of PEI, as per the previous protocol, and then centrifuged at 14,000xg for 
10min.  The supernatant was filtered using a 0.22µm Millipore syringe filter 
(Fisher Scientific, Leicestershire, UK) and was ready to load on the appropriate 
column in the same buffer. 
 
Without PEI treatment 
The cell pellet from a 250ml expression culture was re-suspended in 5ml of the 
appropriate bind buffer.  The sample was sonicated for 3x 1min on ice and then 
centrifuged at 14,000xg for 20min.  The supernatant was filtered using a 0.22µm 
Millipore syringe filter and was ready to load on the appropriate column in the 
same buffer. 
 
If partially purified proteins were to be loaded onto an additional column, the 
fractions containing the correct protein were pooled and dialysed against the 
new buffer required for the subsequent purification step. 
 
Bench-Top His Purification 
His-bind buffer A:  50mM Tris-HCl pH8.0, 300mM NaCl, 20mM imidazole 
(Fisher Scientific, Leicestershire, UK). 
His-elute buffer B:  50mM Tris-HCl pH8.0, 300mM NaCl, 1M imidazole. 
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1ml of metal-chelating cellulose (Bioline, London, UK) was loaded onto a 
column and washed twice with 5ml sterile Milli-Q water.  The column was 
charged with 2ml 40mM NiCl2 (Sigma, Gillingham, UK) and washed with Milli-Q 
water to remove the excess.  The column was equilibrated with 2x 5ml his bind-
buffer A.  The cell pellet from a 100ml expressed culture was treated as 
mentioned above with no PEI treatment.  The filtered supernatant was loaded 
onto the nickel charged cellulose and the flow-through collected.  The column 
was then washed with 5ml of his-bind buffer A and bound protein eluted using a 
step gradient of the his-elute buffer B.  5ml steps of 7%, 14% and 40% his-elute 
buffer B were performed and 1ml fractions collected.  A wash of 100% his-elute 
buffer B was carried out as a final step and the flow-through collected. A sample 
of each fraction was electrophoresed on a 12.5%(v/v) SDS PAGE gel, along 
with an aliquot of both the load and the flow-through to verify the presence of 
the correct-sized protein.  In addition, an activity assay could also be performed 
to test for active protein in the fractions. 
 
Heparin Column 
Heparin-bind buffer:  20mM Tris-HCl pH8.0, 0.1mM EDTA, 0.1%(v/v) Tween-20, 
25mM NaCl  
Heparin-elution buffer:  20mM Tris-HCl pH8.0, 0.1mM EDTA, 0.1%(v/v) Tween-
20, 2M NaCl. 
 
A 5ml HiTrap™ Heparin HP column (GE Healthcare, Chalfont St. Giles, UK) 
was equilibrated with 5 column volumes (cv) of heparin-bind buffer.  A protein 
sample, prepared in the appropriate buffer as per the protocol, was loaded onto 
the column at 1.5ml/min.  The flow-through was collected, and the column 
washed with an additional 2cv of heparin-bind buffer.  The proteins were eluted 
from the column using a gradient of 0.025M to 2M NaCl over 20cv at 1.5ml/min.  
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1.4ml fractions were collected.  A sample of each fraction corresponding to a 
peak of A280 on the purification traces was electrophoresed on an SDS PAGE 
gel along with an aliquot of both the load and the flow-through to verify for the 
presence of the correct-size protein.  In addition, an activity assay could also be 
performed to test for activity in the protein fractions. 
 
Cation Exchange – SP Column 
SP-Load Buffer:  25mM sodium phosphate (Fisher Scientific, Leicestershire, 
UK), 0.1mM EDTA, 25mM NaCl, pH6.8. 
SP-elute buffer:  25mM sodium phosphate, 0.1mM EDTA, 2M NaCl. 
 
5x 1ml HiTrap™ SP Hp column (GE Healthcare, Chalfont St. Giles, UK) were 
equilibrated with 5cv of SP load buffer.  A protein sample, prepared in the SP 
load buffer, was loaded onto the column and the flow-through collected.  The 
column was then washed with an additional 2cv of SP load buffer.  Proteins 
were eluted from the column with a gradient of 0.025M to 2M NaCl over 20cv at 
1ml/min and collected in 1.4ml fractions.  A sample of each fraction, 
corresponding to an A280 peak on the purification trace, was electrophoresed on 
a 12.5%(v/v) SDS PAGE gel along with a sample of the load and the flow-
through to verify the presence of the correct-size protein.  An activity assay 
could also be performed to test for active proteins in the fractions. 
 
Anion Exchange – Q Column 
Q-bind buffer:  25mM Tris-HCl, 0.1mM EDTA, 0.1%(v/v) Tween-20, 25mM 
NaCl, pH8.0. 
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Q-elute buffer:  25mM Tris-HCl, 0.1mM EDTA, 0.1%(v/v) Tween-20, 2M NaCl, 
pH8.0. 
 
A 5ml HiTrap™ Q HP column (GE Healthcare, Chalfont St. Giles, UK) was 
equilibrated with Q-bind buffer.  A cell pellet prepared in the same buffer was 
loaded onto the column at 1.5ml/min and the flow-through collected.  The 
column was washed with 2cv of Q-bind buffer and the proteins eluted using a 
gradient of 0.025M-2M NaCl over 20cv and 1.4ml fractions collected. A sample 
of each fraction corresponding to an A280 peak on the purification trace was 
electrophoresed on an SDS PAGE gel along with a sample of the load and the 
flow-through to verify the presence of the correct-size protein.  An activity assay 
could also be performed to test for active proteins in the fractions. 
 
Large-Scale His Purification 
His-bind buffer C:  20mM Tris-HCl pH7.9, 500mM NaCl, 5mM Imidazole. 
His-elute buffer D:  20mM Tris-HCl pH7.9, 500mM NaCl, 400mM imidazole. 
 
A 14ml IDA Sepharose column was charged with Ni2+ by loading 2cv of 50mM 
NiCl2.  The column was then washed with sterile Milli-Q water, to remove the 
excess and equilibrated with his-bind buffer C.  A cell pellet prepared in same 
buffer was loaded onto the column at 2ml/min and the flow-through retained.  
The his-tagged proteins were eluted from the column using a gradient of 5-
400mM imidazole over 10cv at 2ml/min.  2ml fractions were collected.  A sample 
of each fraction corresponding to an A280 peak on the purification trace was 
electrophoresed on a 12.5%(v/v) SDS PAGE gel along with a sample of the load 
and the flow-through to verify the presence of the correct sized protein.  An 
activity assay could also be performed to test for active proteins in the fractions. 
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Ceramic Hydroxyapatite Column 
CHT-bind buffer:  20mM potassium phosphate pH6.8, 25mM NaCl, 0.1%(v/v) 
Tween-20. 
CHT-elute buffer:  400mM potassium phosphate pH6.8, 25mM NaCl, 0.1%(v/v) 
Tween-20. 
 
A 19ml type I CHT column (BioRad, Hemel Hempstead, UK) was equilibrated 
with CHT-bind buffer.  A prepared protein sample in CHT-bind buffer was 
loaded onto the column and the flow-through collected.  The proteins were 
eluted using a phosphate gradient of 20 to 400mM over 10cv at 1.5ml/min.  2ml 
fractions were collected. A sample of each fraction corresponding to an A280 
peak on the purification trace was electrophoresed on a 12.5%(v/v) SDS PAGE 
gel along with a sample of the load and the flow-through to verify the presence 
of the correct sized protein.  An activity assay could also be performed to test for 
active proteins in the fractions. 
 
Basic Enzyme Activity Assay 
Samples and fractions were tested for RT activity using two steps; the first 
generated a cDNA strand from an RNA template and the second step involved a 
PCR to amplify the cDNA to allow its detection on an agarose gel. 
 
cDNA Synthesis Step 
The cDNA synthesis reaction contained 1x RT buffer (GeneSys Ltd, Camberley, 
Surrey), 0.5mM dNTPs, 15pmol MS2:3395_R primer (Appendix I), 20ng MS2 
RNA (Roche, Welwyn Garden City, UK), 0.35µl of enzyme sample and the 
volume made to 20µl with nuclease-free water.  Reactions were incubated at 
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45ºC for 30min to allow cDNA synthesis to occur, followed by 95ºC to denature 
the RT enzyme.  This product could then be used as a template in a PCR. 
 
cDNA Amplification 
The PCR was set up with the final reaction containing 1x Taq master mix 
(GeneSys Ltd, Camberley, Surrey), 12.5pmol MS2:3231_F primer (Appendix I) 
and 12.5pmol MS2:3395_R primer, 0.5µl of the completed cDNA synthesis 
reaction and the final volume made up to 25µl with nuclease-free water.  The 
reactions were cycled as follows: 
 
94ºC  3min 
 
94ºC  10s 
55ºC  10s   30 cycles 
72ºC  20s 
 
72ºC  7min 
 
5µl of the reactions were loaded on an agarose gel with the presence of the 
correct-size band of 164bp indicating RT activity. 
 
Enzyme Storage 
Enzyme storage buffer:  20mM Tris-HCl pH7.6, 0.2mM EDTA, 2mM DTT, 
400mM NaCl, 0.02% Igepal, 50%(v/v) glycerol.  All reagents were nuclease-
free. 
 
Once purified, the enzyme was concentrated using a Millipore Amicon Ultra-15 
centrifugal filter (Fisher Scientific, Leicestershire, UK).  This filter was also used 
to buffer exchange the enzyme into a 2x enzyme storage buffer with no glycerol.  
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Once concentrated to approximately 750µl in the 2x storage buffer, an equal 
volume of 100% glycerol was added.  The protein could then be stored at either 
-20 or -70ºC. 
 
Protein Concentration 
2ml Protein Assay Dye Reagent Concentrate (BioRad, Hemel Hampstead, UK) 
was diluted with 7ml of Milli-Q water and 900µl dispensed into six 1cm path-
length cuvettes.  Bovine Serum Albumin (BSA) (BioRad, Hemel Hampstead, 
UK) was diluted to 100µg/ml stock,  volumes of 0, 20, 50, 80 and 100µl were 
added to the cuvettes and each solution was made up to 100µl with Milli-Q 
water.  The final cuvette had 1µl of the purified protein sample added and the 
volume made up to 100µl with Milli-Q water.  The cuvettes were incubated at 
room temperature for 10min and then measurements taken at A595.  The 
measurements from the known BSA concentrations can be plotted onto a graph 
(Figure 4.2) allowing an estimation of the unknown concentration of the purified 
protein. 
 
 
Figure 4.1:  A standard curve showing the results from a typical assay to 
estimate protein concentrations.  Known concentrations of BSA were measured 
at A595 and plotted on the graph (blue) allowing an estimation of the 
concentration of a protein sample (red). 
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4.3 – RESULTS 
 
B. caldovelox IEP Purification 
 
Heat Treatment 
Large-scale expression of the IEP and the N-terminal his-tagged IEP from B. 
caldovelox was successful using TB medium with OD600 reaching approximately 
6.6.  No IEP was present in the insoluble fractions (Figure 4.3).  Given that the 
IEP is from a bacterium with an optimum growth temperature of 70ºC, the cell 
extract was heat-treated as a clean-up step to remove some of the background 
E. coli proteins.  The clarified cell lysate from the his-tagged protein was heated 
at 5min intervals at 50ºC and both soluble and insoluble fractions 
electrophoresed on a protein gel (Figure 4.3). 
 
 
Figure 4.3:  12.5% SDS PAGE gel showing the total cell lysate fractions, the 
soluble and insoluble protein fractions, and the effect of various intervals of 
50ºC on the N-terminal his-tagged IEP from B. caldovelox. 
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The protein gel showed that, even after 5min at 50ºC, most of the IEP had 
become insoluble.  This experiment was repeated for the non-tagged IEP to 
ensure that the his-tag was not having an effect on the stability of the protein; 
however, the results were the same.  Therefore heat treatment of the cell extract 
could not be used to reduce the background of E. coli proteins in the sample. 
 
Nickel Column 
The N-terminal his-tag on the IEP was created to enable an easy purification 
step allowing the his-tagged protein to bind to a Ni2+ charged column whilst the 
majority of the background proteins would come out in the flow-through.  The 
cell pellet from a 250ml expression sample was prepared and the soluble 
fraction loaded onto a 1ml bench-top, metal-chelating column charged with Ni2+.  
The flow-through was collected along with 5x 1ml fractions from the step 
gradient of 5%, 7%, 14%, 40% and 100% his-elute buffer.  When the fractions, 
along with the flow-through and initial load, were loaded on a protein gel, it 
became apparent that no proteins had bound to the column and that the his-
tagged IEP had come out in the flow-through (Figure 4.4). 
 
 
Figure 4.4:  A 12.5% SDS PAGE gel showing lane 1: the total cell fraction, lane 
2: the filtered soluble fraction loaded onto the column, and lane 3: the flow-
through from the Ni2+ charged column. 
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This experiment was also repeated with a cell pellet from 100ml of expressed 
culture in case overloading of the column was preventing the protein from 
binding; however, still no protein bound to the column.   
 
No further purification steps were attempted on the his-tagged IEP; instead, all 
further purification steps were performed on the non-tagged protein. 
 
SP Cation Exchange Column 
The pI value of the protein was calculated from the amino acid composition of 
the protein and determined to be 10.14.  Therefore at a pH6.8 the protein would 
carry a net positive charge, allowing it to bind to an SP cation exchange column.  
The cell pellet from 100ml of expressed culture was prepared and loaded onto a 
1ml SP column and eluted using a 0.025M-2M NaCl gradient.  However, the 
protein trace revealed no protein to elute from the column as all proteins had 
come through in the initial flow-through. 
 
Anion Exchange Q column 
Since the protein failed to bind to a cation exchange column, it was decided to 
use an anion exchange column as a purification step.  At pH8.0 the IEP would 
still have a net positive charge and it was expected that this protein would come 
out in the flow-through purer than the load sample since the majority of the E. 
coli background proteins would bind to the column.  The pellet from a 250ml 
expressed culture was prepared as before and loaded onto a 5ml HiTrap™ Q 
column with a gradient of 0.025-2M NaCl performed over 20cv.  Although the 
IEP was expected to be found in the flow-through, fractions from the protein 
peaks seen on the purification trace (Figure 4.5) were also electrophoresed on a 
protein gel (Figure 4.6).  Unexpectedly, it was found that all the IEP had bound 
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to the column and eluted at a high NaCl concentration of approximately 1.3M, 
suggesting tight binding of the protein to the column. 
 
 
Figure 4.5:  The purification profile of the B. caldovelox IEP loaded on and 
eluted from a 5ml HiTrap™ Q column.  The protein eluted within the peak 
marked IEP at approximately 1.3M NaCl. 
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Figure 4.6:  12.5%(v/v) SDS PAGE gel showing a 1µl aliquot of the H1 fraction 
from the HiTrap™ Q column elution. 
 
Scanning fraction H1 over an absorbance range of A260-A280 revealed a large 
peak at A260 indicating a high degree of contaminating nucleic acids within the 
IEP elution fractions.  Although the IEP was relatively free of protein 
contaminations, the association with nucleic acids prevented the use of the Q 
column as a purification step. 
 
Heparin Column 
It was decided to use a different approach to purification and to take advantage 
of the nucleic acid binding properties of the protein.  A 5ml HiTrap™ Heparin 
column was used to allow nucleic acid binding proteins to bind and the 
remaining E. coli proteins to wash straight through.  However, when a 250ml 
expressed culture was prepared as before and loaded onto the column, the IEP 
did not bind to the column. 
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It was hypothesised that the IEP has a higher affinity for nucleic acids than for 
the heparin column.  This association with the nucleic acids might alter its 
charge, explaining why it would not bind to the cation exchange column and 
why, when bound to the anion exchange column, it eluted at a high NaCl 
concentration with the nucleic acid fraction.  Therefore, in order to purify this IEP 
it would seem necessary to remove the nucleic acids prior to any purification 
steps. 
 
PEI Precipitation 
The PEI precipitation had to be optimised for every new expression culture to 
ensure that the appropriate level of PEI is added to remove all nucleic acids 
and, if necessary, the correct concentration of NaCl is used to ensure all the IEP 
remained soluble.  In order to remove nucleic acids, a sample from a large 
expressed culture was removed and the pellet re-suspended in the equivalent of 
1ml/0.1g of cell pellet in the heparin-bind buffer.  After sonication, the total 
protein fraction was exposed to varying levels of PEI and electrophoresed on an 
agarose gel (Figure 4.7a), to detect removal of nucleic acids, and a protein gel 
(Figure 4.7b) to ensure that the IEP remained in solution. 
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Figure 4.7:   
a) A 1%(w/v) agarose gel showing the removal of nucleic acids from the 
protein sample with increasing levels of PEI.  
(b) A 12.5%(v/v) SDS PAGE gel showing the effect of increasing levels 
of PEI on the soluble IEP fraction. 
 
The agarose gel in Figure 4.7a showed that 0.05% PEI was necessary to 
remove the contaminating nucleic acids.  However, at this level of PEI the 
protein gel revealed that the IEP had become insoluble.  The protein became 
insoluble at the lowest levels of PEI; however, at higher PEI concentrations than 
necessary to remove all nucleic acids the protein reappeared in the soluble 
fractions.  Since high levels of PEI can interfere with subsequent purification 
steps it was necessary to repeat the experiment with increasing concentrations 
of NaCl to identify a level at which the IEP would remain in solution at the 
minimum level of PEI required to remove all nucleic acids.  0.05% PEI was used 
with varying concentrations of NaCl and the soluble fraction electrophoresed on 
a protein gel (Figure 4.8). 
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Figure 4.8:  A 12.5%(v/v) SDS PAGE gel showing the effects on the soluble IEP 
at 0.05% PEI with varying concentrations of NaCl. 
 
Varying the concentration of NaCl with 0.05% PEI showed that 500mM NaCl 
precipitated the nucleic acids but to allow the majority of the IEP to remain 
soluble.   
 
Heparin Column – After PEI Precipitation 
The cell pellet from 250ml of an expression culture was re-suspended in a 
heparin-bind buffer containing 500mM NaCl, sonicated and treated with 0.05% 
PEI.  After incubation at 4ºC for 1h the sample was centrifuged and the 
supernatant filtered and loaded onto the heparin column and the flow-through 
collected.  To ensure that the IEP remained in solution after PEI precipitation, 
and also to see if it had bound to the column, fractions from each stage were 
electrophoresed on a protein gel (Figure 4.9). 
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Figure 4.9:  12.5%(v/v) SDS PAGE gel showing:  Lane 1: the soluble protein 
before PEI precipitation, lane 2: the soluble fraction after PEI precipitation and 
filtering and lane 3: the flow-through from the heparin column. 
 
Once it was verified that the IEP had bound to the heparin column proteins were 
eluted using a gradient of 0.5-2M NaCl.  Fractions corresponding to A280 peaks 
on the purification trace (Figure 4.10) were electrophoresed on a protein gel to 
reveal where the protein had eluted.  It was shown that the fractions of the A280 
peak corresponding to approximately 1.6M NaCl contained a protein at the 
expected size for the IEP (Figure 4.11a).  The peak protein fraction D12 was 
also electrophoresed on an agarose gel (Figure 4.11b) which confirmed the 
absence of nucleic acids from the sample. 
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Figure 4.10:  A purification profile of the B. caldovelox IEP loaded onto a 
heparin column after precipitating with PEI to remove nucleic acids.  The IEP 
was located in the final protein peak at approximately 1.6M NaCl. 
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Figure 4.11:   
a) A 12.5% SDS PAGE gel showing 5µl of the fractions from the IEP 
elution peak. 
b) A 1.5%(w/v) agarose gel with fraction D12 confirming the absence of 
nucleic acids from the sample. 
 
To confirm that these fractions did contain the IEP, it was tested for RT activity 
in a two step assay.  A dilution equivalent to 0.0625µl of the D12 fraction was 
used in a cDNA synthesis step with MS2 RNA and MS2:3193_R primer 
(Appendix I).  A no-enzyme control (NEC) was run in parallel to ensure that any 
DNA amplified in the second step using PCR was only due to the RT activity of 
the fraction.  Loading an aliquot of each PCR on an agarose gel confirmed the 
presence of the correct size band of 718bp from using fraction D12 compared to 
no band on the NEC (Figure 4.12).  This indicated the presence of RT activity 
and therefore the correct IEP within this protein peak.  
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Figure 4.12:  A 1.5%(w/v) agarose gel showing the result of a PCR using the 
cDNA synthesis reaction as a template.  Lane 1:  no RT enzyme control, and 
lane 2:  When a 0.0625µl aliquot of the D12 fraction was used as the RT 
enzyme. 
 
 
SP Column – After PEI Precipitation and Heparin Purification 
Fractions D9-D13 were pooled and dialysed into the cation-bind buffer.  This 
protein sample was loaded onto 5x 1ml HiTrap™ SP columns and eluted using 
a 20cv gradient of 0.025-2M NaCl.  This time the IEP did bind to the column and 
eluted at approximately 1.6M NaCl.  Therefore the nucleic acids were previously 
interfering with the enzyme preventing its binding to the cation exchange 
column.  However, the cation exchange column lowered the yield of the enzyme 
without any increase in purity.  It was therefore decided that the heparin column 
alone was enough to purify the IEP to allow its characterisation as an RT 
enzyme. 
 
The heparin purification step was repeated on a 250ml protein expressed 
culture and the appropriate fractions concentrated and buffer exchanged into a 
storage buffer.  This gave approximately 1.5ml of very pure IEP (Figure 4.13) 
with a protein concentration of 6.4mg/ml estimated using a standard curve of 
known concentrations of BSA. 
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Figure 4.13:  A 12.5% SDS PAGE gel showing 1µl of the heparin purified IEP 
from B. caldovelox. 
 
This protein band was excised from the gel and sent off for mass spectrometry 
analysis which confirmed the identity of the protein as being a correct match to 
the GK1355-IEP as expected. 
 
IEP-Sac7d and Sac7d-IEP Fusion Protein Purification 
The two different Sac7d fusion proteins were successfully expressed on large-
scale using TB media, with the cultures reaching an OD600 between 6.5-6.6. 
 
Heat Treatment 
The soluble protein fractions from the Sac7d fusion protein expression cultures 
were heated to 50ºC for 5min.  After centrifugation, the soluble fraction was 
electrophoresed on a protein gel (Figure 4.14) which showed that the protein, 
like the wild-type IEP, had become insoluble and therefore heat treatment was 
not a method that could be used to reduce background E. coli  proteins. 
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Figure 4.14:  A 12.5%(v/v) SDS PAGE gel showing the soluble and insoluble 
protein fraction from the large-scale expression and the effect on the soluble 
IEP of incubation for 5min at 50ºC.  The arrow indicates soluble IEP-Sac7d that 
is not present in the negative-control lane (-ve). 
 
 
IEP-Sac7d    
PEI Precipitation 
IEP-Sac7d was over-expressed on a large-scale, a sample removed and the 
cell pellet from the sample re-suspended in heparin-bind buffer equivalent to 
1ml/0.1g of cells.  The cell sample was sonicated and the total protein fraction 
tested, as before, with varying levels of PEI to remove nucleic acids.  After 
incubating for 1h at 4ºC the samples were centrifuged and electrophoresed on 
an agarose gel (Figure 4.15a) to see the concentration required to remove all 
the nucleic acids from the sample, and onto a protein gel (Figure 4.15b) to see 
the effect of the PEI on the soluble IEP-Sac7d  protein. 
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Figure 4.14:   
a) A 1%(w/v) agarose gel showing the effect on the nucleic acids within 
the protein sample with increasing levels of PEI. 
b) A 12.5%(v/v) SDS PAGE gel showing the effect of the increasing PEI 
concentration on the solubility of the IEP-Sac7d. 
 
The agarose gel showed that 0.2% PEI was required to remove the nucleic 
acids from this sample; however, at this level, all the IEP-Sac7d protein was 
precipitated.  Therefore it was necessary repeat the experiment with varying 
concentrations of NaCl and the soluble fraction was electrophoresed on a 
protein gel (Figure 4.16). 
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Figure 4.16:  A 12.5% SDS PAGE gel showing the effect on the soluble IEP-
Sac7d protein at 0.2% PEI with increasing concentration of NaCl. 
 
Even at 0.1M NaCl, the majority of the IEP remained soluble.  However, in order 
to obtain maximum yield, it was decided that 0.5M NaCl could be used. 
 
Heparin Column – After PEI Precipitation 
PEI precipitation was scaled up to be used with a cell pellet from a 250ml 
expressed culture.  The pellet from this culture was re-suspended in heparin-
bind buffer (0.5M NaCl) equivalent to 1ml/0.1g of cells.  After sonication the 
protein sample was treated with 0.2% PEI, incubated at 4ºC for 1h and then 
centrifuged.  The soluble fraction was filtered and loaded onto a 5ml heparin 
column and the flow-through collected.  Samples of the protein fraction pre-PEI 
precipitation, after PEI precipitation, and the flow-through from the column were 
electrophoresed on a protein gel (Figure 4.17). 
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Figure 4.17:  A 12.5% (v/v) SDS PAGE gel showing: lane 1: the total protein 
fraction before PEI precipitation, lane 2: the filtered soluble protein fraction after 
PEI precipitation, and lane 3: the flow-through from the heparin column. 
 
After precipitation with PEI, all the IEP-Sac7d protein remained soluble and 
bound to the heparin column.  Proteins were eluted from the column using a 
gradient of 0.5-2M NaCl over 20cv and 1.4ml fractions collected which revealed 
a purification trace very similar to that from the IEP with no Sac7d domain 
(Figure 4.18). 
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Figure 4.18:  The purification trace of the load and elution of the IEP-Sac7d 
protein from a heparin column. 
 
15µl aliquots of the fractions from the A280 protein peak as marked on the trace, 
C7-D1, were electrophoresed on a protein gel which showed pure protein of the 
correct size for Sac7d-IEP (Figure 4.19).  This peak corresponded to an NaCl 
concentration of approximately 1.35M. 
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Figure 4.19:  A 12.5% (v/v) SDS PAGE gel showing 15µl of the fractions across 
the peak at 1.25M NaCl M expected to contain the IEP-Sac7d. 
 
Fractions C8-C14 were pooled, concentrated and the 1.5ml sample stored in 
enzyme storage buffer.  To analyse the purity of the sample, 1µl was 
electrophoresed on an SDS PAGE gel (Figure 4.20) and, by using a standard 
curve, the protein concentration was estimated at 3mg/ml.  
 
 
Figure 4.20:  12.5% SDS PAGE gel showing 1µl of the heparin purified IEP-
Sac7d fusion protein. 
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Sac7d-IEP 
PEI Precipitation 
The Sac7d-IEP fusion protein was over-expressed on a large-scale and a 
sample removed for titration with PEI for nucleic acid removal.  A cell pellet was 
re-suspended in heparin-bind buffer, equivalent to 1ml/0.1g of cells, and 
sonicated.  Aliquots of the sonicated sample were subjected to varying 
concentrations of PEI.  After incubation at 4ºC the samples were centrifuged 
and the soluble fraction loaded on to an agarose gel (Figure 4.21a) to identify 
the required level of PEI to remove all nucleic acids, and onto a protein gel to 
monitor the solubility of the Sac7d-IEP (Figure 4.21b). 
 
 
Figure 4.21:   
a) A 1%(w/v) agarose gel showing the removal of nucleic acids from the 
protein sample with increasing concentrations of PEI. 
b) A 12.5% SDS PAGE gel showing the effect of PEI on the solubility of 
the Sac7d-IEP. 
 
The agarose gel showed that 0.05% PEI was required to remove all the nucleic 
acids from this sample; however, at this level all the Sac7d-IEP had become 
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insoluble.  The experiment was repeated with 0.05% PEI and varying the 
concentration of NaCl.  5µl of the soluble fraction from this experiment was 
electrophoresed on a protein gel (Figure 4.22) to monitor the concentration of 
NaCl required to allow the Sac7d-IEP to remain in solution. 
 
 
Figure 4.22:  A 12.5% SDS PAGE gel showing the effect on the solubility of 
Sac7d-IEP when exposed to 0.05% PEI with varying concentrations of NaCl. 
 
The protein gel showed that 500mM NaCl should allow the Sac7d-IEP to remain 
in solution when exposed to 0.05% PEI. 
 
Heparin Column – After PEI Precipitation 
The cell pellet from a 250ml expressed culture was re-suspended in heparin-
bind buffer (500mM NaCl) equivalent to 1ml/0.1g of cells.  The re-suspended 
pellet was sonicated and 0.05% PEI added and incubated as before.  The 
sample was then centrifuged and the supernatant filtered and loaded onto a 5ml 
heparin column.  Proteins were eluted from the heparin column using a gradient 
of 0.5-2M NaCl over 20cv, and 1.4ml fractions were collected.  The purification 
profile (Figure 4.23) was similar to that of the IEP and the IEP-Sac7d with the 
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protein expected to be found within the A280 protein peak that corresponded to 
approximately 1.2M NaCl. 
 
 
Figure 4.23:  Purification profile showing the load and the elution of the Sac7d-
IEP expression sample using a heparin column. 
 
An SDS PAGE gel was loaded with 5µl samples of the protein fraction before 
PEI precipitation, the column load, the column flow-through and 15µl of the 
fractions across the 1.2M NaCl protein peak (Figure 4.24). 
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Figure 4.24:  A 12.5%(v/v) SDS PAGE gel showing the total protein fraction 
before PEI precipitation, the PEI precipitated and filtered column load, the 
column flow-through and samples from the expected Sac7d-IEP peak. 
 
Although some of the Sac7d-IEP had precipitated out along with the nucleic 
acids, some still remained and bound to the column; none of the protein came 
out in the flow-through.  The fractions electrophoresed on the protein gel did 
contain the correct-size protein from Sac7d-IEP.  However, there was the 
presence of low levels, approximately <10% of the entire sample, of an 
additional protein at approximately the same size as would be expected for the 
wild-type IEP. 
 
Fractions C7-C12 were pooled and concentrated to a final volume of 1ml.  1µl of 
this sample was electrophoresed on a protein gel to analyse its purity (Figure 
4.25) and the concentration was estimated, based on a BSA concentration 
standard curve, at 4.9mg/ml. 
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Figure 4.25:  A 12.5%(v/v) SDS PAGE gel with 1µl of heparin purified Sac7d-
IEP. 
 
 
SP Column – After PEI Precipitation and Heparin Column 
It was decided that an additional purification step would be required to remove 
the impurity that could be seen on the protein gel.  The partially purified protein 
was dialysed into cation-bind buffer and loaded onto a 1ml SP column.  The 
protein was eluted from the column with a gradient of 0.025-2M NaCl over 20cv 
and 1ml fractions were collected.  Samples from all the protein peaks observed 
on the trace (Figure 4.26) were electrophoresed on a protein gel and it was 
found that the protein eluted in the major protein peak at 1.4M NaCl (Figure 
4.27). 
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Figure 4.26:  The purification trace of the heparin purified Sac7d-IEP loaded and 
eluted from a 1ml SP column. 
 
 
Figure 4.27:  A 12.5% SDS PAGE gel showing 15µl samples of the fractions 
from the Sac7d-IEP protein peak at 1.4M NaCl. 
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The protein gel showed that the majority of the protein was present in fractions 
D5, D6 and D7 although the IEP had still co-purified with a contaminating 
protein.  These fractions were pooled, concentrated and stored in enzyme 
storage buffer and 1µl electrophoresed on a protein gel (Figure 4.28). 
 
 
Figure 4.28:  A 12.5%(v/v) SDS PAGE gel showing 1µl of the heparin and SP 
column purified Sac7d-IEP 
 
The concentration of the Sac7d-IEP was estimated at 0.8mg/ml however, this 
was a combined concentration of both the Sac7d-IEP and the contaminant. 
 
The co-purifying protein contaminant still seen after the two columns was not 
present in the purification of the IEP-Sac7d protein.  This protein ran at the 
same size as would be expected for the wild-type IEP, and also has similar 
purification properties.  It was therefore expected that this product was created 
due to the Sac7d linker being vulnerable to proteolytic cleavage.  The 
purification was repeated using the protease inhibitor cOmplete, Mini, EDTA-
free protease inhibitor cocktail (Roche, Welwyn Garden City, UK); however, the 
degradation product was still present suggesting that the cleavage was 
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occurring before cell lysis.  It was therefore decided to remove the GTV linker 
allowing the two proteins to be fused together with no joining linker. 
 
Linker Removal 
New primers were designed (Appendix I) to allow the fusion of the two domains 
together into one ORF.  Overlap extension PCR was successful producing the 
expected size fragment of 1461bp (Figure 4.29).  
 
 
Figure 4.29:  A 1% (w/v) agarose gel showing the final overlap extension PCR 
product fusing the gene products of B. caldovelox IEP and S. acidocaldarius 
Sac7d. 
 
This overlap extension fragment was digested with Nde I and Xho I, ligated into 
pET24a(+) and transformed into electrocompetent E. coli KRX (pRARE2).  
Positive colonies were detected using a screening PCR with T7 promoter and 
terminator primers.  Positive colonies, along with one negative-control, were 
grown in 10ml LB at 37°C until an OD600 of 0.4 was reached.  The temperature 
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was then reduced to 15°C and protein expression induced according to the KRX 
protocol.  After 20h of protein induction the cultures were centrifuged and the 
pellets re-suspended in 750µl cell lysis buffer D.  The samples were then 
sonicated and 5µl of the soluble and insoluble fractions electrophoresed on a 
protein gel (Figure 4.30). 
 
 
Figure 4.30:  A 12.5% SDS PAGE gel showing the soluble and insoluble 
fractions from the over-expression of Sac7d-IEP (lanes 1) and a negative-
control containing just pET24a(+) with no insert (lanes 2).  The arrow marks the 
expected Sac7d-IEP. 
 
The protein gel showed the appearance of a protein band, at the expected size 
of 56kD for Sac7d-IEP that was not present in the negative-control lane.  This 
protein was 100% soluble and was then expressed on large-scale to allow 
purification. 
 
PEI Precipitation 
A sample from the expressed Sac7d-IEP culture was removed and re-
suspended in heparin-bind buffer (0.5M NaCl) equivalent to 1ml/0.1g of cells.  
The sample was then centrifuged and exposed to varying concentrations of PEI 
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to precipitate the nucleic acids.  These samples were then centrifuged and the 
soluble fraction loaded on to an agarose gel to verify the concentration required 
for removal of all the nucleic acids (Figure 4.31a), and onto a protein gel to 
analyse whether the Sac7d-IEP was precipitated with the required level of PEI 
(Figure 4.31b). 
 
 
Figure 4.31:   
a)  A 1% (w/v) agarose gel showing the precipitation of nucleic acids from 
the sonicated protein sample with increasing concentrations of PEI.  
b) A 12.5%(v/v) SDS PAGE gel showing the effect of increasing PEI on 
the solubility of Sac7d-IEP (marked with an arrow) in 500mM NaCl. 
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Heparin Column - After PEI Precipitation 
At 0.15% PEI all the nucleic acids were precipitated from the sample; however, 
most of the Sac7d-IEP was also precipitated.  Since the Sac7d-IEP with GTV 
linker eluted from the heparin column at a high NaCl concentration, it was 
decided that PEI precipitation would be carried out with an increased level of 
NaCl.  The cell pellet from a 250ml expressed culture was re-suspended in 
heparin-bind buffer (0.7M NaCl) with protease inhibitor cocktail and loaded onto 
a heparin column.  The protein was eluted from the column with a 20cv gradient 
of 0.7-2M NaCl.  As before, the Sac7d-IEP was eluted at 1.4M NaCl.  Samples 
from before PEI precipitation, the column load and flow-through along with the 
peak protein fractions were electrophoresed on a protein gel (Figure 4.31a and 
b). 
 
 
Figure 4.31:   
a) A 12.5% SDS PAGE gel showing lane 1: the total protein sample 
before PEI precipitation, lane 2: PEI precipitated and filtered column load, 
and lane 3: the flow-through from the heparin column.   
b) 12.5% SDS PAGE gel showing 15µl fractions of the protein peak 
containing Sac7d-IEP eluted at 1.4M NaCl. 
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Despite removing the linker from between the Sac7d and IEP domains, there 
was still an additional product co-purifying with the full-length protein. 
 
Mass spectrometry analysis of this co-purify contaminant would reveal its 
identity and allow new approaches to be made to try to remove it or prevent it 
from occurring.  If it was a random co-purifitying protein then efforts would need 
to be made to remove it, preventing its interference with the enzymatic activity of 
the Sac7d-IEP.  However, It was expected that this product was due to either 
low level proteolytic cleavage, removing the Sac7d domain, and leaving a small 
percentage of wild type IEP or due to low level expression of the wild type IEP, 
without the Sac7d domain, from to a start codon further downstream.  These 
were considered most likely due to the absence of this contaminant in the IEP-
Sac7d purification.  In either of these scenarios the Sac7d-IEP would be 
contaminated with wild type IEP which could show RT activity.  Therefore, 
without removing this contaminant, it would not be possibly to separate activity 
and enzyme characteristics from the two proteins and no further work was 
carried out on this fusion product. 
 
T. carboxydivorans IEP Purification 
The IEP from T. carboxydivorans could not be expressed using TB medium 
instead LB medium was used for all large-scale expression with the OD600 
reaching 6.7.   
 
Heat-Treatment 
In order to remove some background E. coli proteins, it was decided to heat 
treat the sample in the hope that the IEP from the thermophilic bacterium would 
remain soluble.  Cells from 10ml of the over-expressed culture were harvested 
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and re-suspended in 1ml of cell lysis buffer D.  The sample was sonicated and 
100µl aliquots of the supernatant heated to 50°C for 5, 10 and 15min and the 
soluble fraction loaded on a protein gel (Figure 4.32). 
 
 
Figure 4.32:  A 12.5% SDS PAGE gel showing the effect of 50°C incubation on 
the soluble IEP. 
 
Despite the fact that the T. carboxydivorans has an optimum growth 
temperature of 55°C, the IEP could not be heated at 50°C for 5min without the 
protein becoming insoluble.  Therefore, heat treatment could not be used to 
reduce the background level of E. coli proteins. 
 
Nickel Column 
 A cell pellet harvested from 100ml of expressed culture was re-suspended in 
5ml his-bind buffer A.  The sample was sonicated, the soluble fraction filtered 
and loaded onto a 1ml bench-top cellulose column charged with Ni2+.  The flow-
through and wash were collected and proteins eluted from the column using a 
step gradient of 5, 7, 14, 40 and 100% his-elute buffer B.  Each step of the 
gradient was collected in 5x 1ml fractions.  5µl samples of the load, flow-
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through, wash and third fraction from each step of the gradient were 
electrophoresed on a protein gel (Figure 4.33). 
 
 
Figure 4.33:  A 12.5% SDS PAGE gel showing the load and flow-through of the 
over-expressed T. carboxydivorans IEP loaded on a 1ml bench-top nickel 
column and samples of the elution fractions from the step gradient. 
 
The protein gel of the load and flow-through showed that none of the IEP 
actually bound to the nickel column and came straight out in the collected flow-
through. 
 
PEI Precipitation 
Nucleic acids could be interfering with the purification of the T. carboxydivorans 
IEP as is seen with the IEP from B. caldovelox.  A cell pellet from large-scale 
protein expression was removed and re-suspended in heparin buffer A 
equivalent to 1ml/0.1g of cells.  The sample was sonicated and 100µl aliquots 
treated to varying concentrations of PEI and incubated for 1h at 4ºC.  After 
incubation, 10µl of the soluble fractions were electrophoresed on an agarose gel 
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to see the concentration required to remove all nucleic acids (Figure 4.34a), and 
onto a protein gel to see the effect of the PEI on the soluble IEP (Figure 4.34b). 
 
Figure 4.34:   
a) A 1%(w/v) agarose gel showing the removal of nucleic acids from the 
expressed IEP culture with increasing concentrations of PEI  
b) A 12.5% (v/v) SDS PAGE gel of the effects of increasing PEI on the 
IEP in the soluble fraction. 
 
The agarose gel showed that 0.2% PEI was required to precipitate all the 
nucleic acids from the sample; however, at this concentration all the IEP had 
also precipitated.  It was therefore necessary to repeat the experiment with 
0.2% PEI with varied concentrations of NaCl.  After incubation at 4ºC for 1h, 
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samples of the soluble fraction were electrophoresed on a protein gel (Figure 
4.34). 
 
Figure 4.34:  A 12.5%(v/v) SDS PAGE gel showing the effect of PEI on the 
soluble fraction of the IEP expression culture with increasing concentrations of 
NaCl. 
 
The protein gel of the soluble fraction from the PEI precipitation showed that 
even increasing the NaCl up to 0.8M did not prevent the IEP from also 
precipitating. 
 
Heparin Column – After PEI Precipitation 
Three attempts were made to purify the IEP after 0.2% PEI precipitation in the 
hope that a small fraction of the protein had remained soluble.  In each case a 
pellet equivalent to 250ml of expressed culture was re-suspended in heparin-
bind buffer equivalent to 1ml/0.1g of cells.  The attempts used the same protocol 
but altered the concentration of NaCl present in the bind buffer.  These included 
600mM NaCl heparin bind buffer, as shown to work for the B. caldovelox IEP, 
and 800mM NaCl.  No protein was seen to bind to the column and it is possible 
that, if any IEP had remained soluble, the protein could not bind the column at 
such high NaCl concentrations and would therefore come straight out in the 
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flow-through.  Additionally, an attempt was made with 100mM NaCl.  Although it 
was expected that all the protein would be precipitated with the PEI exposure at 
such a low NaCl concentration it was thought that, if any protein had remained 
soluble, this NaCl concentration should be low enough to allow the IEP to bind 
and be eluted from the heparin column.  Unfortunately all three of these 
attempts at purifying the IEP using the heparin column failed.  
 
Q Column 
In theory, the IEP from T. carboxydivorans, with a pI value of 10.35, should not 
bind to a Q column.  However, nucleic acids interfered with the charge of the B. 
caldovelox IEP allowing it to bind to this anion exchange column.  It was 
therefore decided to load the T. carboxydivorans IEP onto a Q column in the 
hope that it would be eluted in separate fractions from the major nucleic acid 
peaks.  The cell pellet from a 250ml expressed culture was re-suspended in Q-
bind buffer, sonicated and the soluble fraction filtered.  This was then loaded 
onto a 5ml Q column and the flow-through collected.  Proteins were eluted from 
this column using a 0.025-2M NaCl gradient over 20cv with 1.4ml fractions 
collected.  Samples of the fractions for each protein peak observed on the trace 
(Figure 4.35) were tested for RT activity. 
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Figure 4.35:  Purification trace of the IEP expression sample loaded onto a 5ml 
Q column.  Proteins were eluted using a gradient of 0.025-2M NaCl. 
 
0.25µl of each peak fraction was used as the enzyme in a cDNA synthesis step 
using 20ng MS2 RNA and MS2:3395_R (Appendix I) and incubation for 30min 
at 45ºC.  An aliquot of this reaction was then used as a template in a PCR with 
MS2:3395_F and MS2:3231_R.  5µl of this reaction was electrophoresed on an 
agarose gel (Figure 4.36). 
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Figure 4.36:  A 2%(w/v) agarose gel showing the amplification of cDNA 
generated using aliquots of the peak protein fractions as seen on the trace. 
 
The agarose gel showed that there was no activity in the flow-through and that 
the most activity was seen in the A280 peak B10 which eluted at 665mM NaCl.  
Fractions across this peak were electrophoresed on an SDS PAGE gel (Figure 
4.37a) to analyse the purity of the protein and onto an agarose gel to assess the 
level of nucleic acids present in each fraction (Figure 4.37b). 
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Figure 4.37:   
a) 12.5% (v/v) SDS PAGE gel showing 5µl aliquots of the fractions from 
the protein peak with RT activity.  
b) A 1%(w/v) agarose gel showing nucleic acids within the main RT 
activity peak. 
 
The protein gel showed that the IEP eluted with a high proportion of additional 
E. coli proteins.  However, the agarose gel showed that the main three fractions, 
B9-11, eluted with a low percentage of contaminating nucleic acids.  It was 
hoped that enough nucleic acids had been removed from the sample to allow 
additional purification steps. 
 
Heparin Column – After Q Column 
Fractions B9-B11 were pooled and dialysed into heparin-bind buffer (25mM 
NaCl).  Once filtered, the sample was loaded onto a 5ml heparin column, the 
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flow-through collected and proteins eluted using a 0.025-2M NaCl gradient over 
20cv.  Protein peaks were present at the beginning of the trace, between 140-
660mM NaCl, but no peak was seen at higher NaCl concentrations where other 
IEPs had previously eluted (Figure 4.38). 
 
 
Figure 4.38:  A purification trace showing the elution of T. carboxydivorans IEP 
from a 5ml Heparin column after partial purification using a Q column.  Proteins 
were eluted using a gradient of 0.025-2M NaCl.  Main protein peaks, later 
electrophoresed on a protein gel, are labelled in red. 
 
Fractions from each protein peak were electrophoresed on a protein gel to 
assess where the IEP eluted (Figure 4.38a) and each peak was assayed for RT 
 
172 
activity by using 0.25µl of each fraction as the enzyme in a DNA synthesis step 
followed by a PCR to amplify the cDNA (Figure 4.38b). 
 
 
Figure 4.38:   
a) A 12.5%(v/v) SDS PAGE gel showing 15µl samples of the peak 
fractions as seen on the purification trace. 
b) A 2%(w/v) agarose gel showing RT activity of the peak protein 
fractions.  
 
The protein gel showed that most of the peaks contained some of the IEP as it 
had eluted very broadly with other proteins.  However, the main activity was 
seen in the later peaks in A14-B6.  These fractions did not appear to contain 
more IEP than the other fractions and it was possible that there was something 
inhibitory in the earlier fractions or that the enzyme was more active in higher 
concentrations of NaCl. 
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SP Column – After Q Column and Heparin Column Purification 
Fractions A14-B6 were pooled and dialysed into SP-bind buffer and loaded onto 
a 1ml SP column.  Proteins were eluted from the column using a gradient of 
0.025-2M NaCl over 100cv and 1ml fractions were collected. All the proteins 
eluted from the column at the beginning of the gradient between 100-525mM 
NaCl (Figure 4.39). 
 
 
Figure 4.39:  Purification trace showing the elution profile of IEP on an SP 
column after Q and heparin purification.  Main protein peaks, later 
electrophoresed on a protein gel, are labelled in red. 
 
 
174 
15µl of each of the main protein peaks were electrophoresed on a protein gel 
which showed that the IEP eluted very broadly and was found across all of the 
peaks (Figure 4.40).  
 
 
Figure 4.40:  A 12.5%(v/v) SDS PAGE gel showing 15µl samples of the main 
protein peaks of the elution of the IEP from the SP column. 
 
The three purification steps performed on the T. carboxydivorans IEP did not 
result in pure protein and each step reduced the overall yield.  Therefore 
alternate purification methods were required. 
 
Ni2+ Charged Sepharose Column – After Q Column Purification 
A second attempt was made to utilise the N-terminal his-tag on this IEP.  It was 
hoped that the Q column would separate the IEP from the majority of the nucleic 
acids, thereby preventing their interference with the protein binding to the Ni2+ 
charged column.  The IEP was purified using a Q column as before and the 
fractions containing the IEP were pooled and dialysed into his-bind buffer C.  A 
14ml IDA Sepharose column was charged with Ni2+ and equilibrated with his-
bind buffer C.  The partially purified IEP was loaded onto the nickel column and 
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the protein eluted with a gradient of 5-300mM Imidazole over 10v.  One peak 
was seen on the purification trace (Figure 4.41) corresponding to an elution of 
proteins at 100mM imidazole. 
 
 
Figure 4.41:  A purification trace showing the elution profile of T. 
carboxydivorans IEP from a 15ml Ni2+ charged IDA Sepharose column after 
partial purification using a Q column.  The protein was eluted using an imidazole 
(Imd) gradient of 5-300mM. 
 
Fractions from the protein peak were electrophoresed on a protein gel to assess 
the purity of the sample (Figure 4.42a) and 0.25µl used in a reaction to assay 
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the RT activity (Figure 4.42b).  The protein gel showed that the IEP eluted within 
this peak but was also contaminated with the original proteins loaded on to the 
column.  These fractions did show RT activity with the peak activity being found 
in the peak fraction B10.  However, the sample still contained contaminating 
proteins that could interfere with the assay of enzyme activity and therefore 
prevent accurate characterisation of the enzyme.  
 
 
Figure 4.42:   
a) 12.5%(v/v) SDS PAGE gel showing the fractions from the elution peak 
of the nickel charged column. 
b) RT activity in the fractions from the protein peak. 
 
 
SP Column – After Q Column 
It was hoped that by removing some of the nucleic acids from the protein 
sample, by use of a Q column, that the IEP would then bind to an SP column as 
would be expected with the high pI value of the protein.  A cell pellet harvested 
from a 250ml expressed culture was re-suspended in 5ml Q-bind buffer, 
sonicated and filtered.  The IEP was loaded and eluted from the Q column, as 
before, and fractions containing the IEP were pooled and dialysed into SP-bind 
buffer, filtered and loaded onto 1x 5ml SP columns.  Samples of the pre-filtered 
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load, the column load and the flow-through were analysed on a protein gel 
which showed the IEP to be present in the flow-through and not to bind to the 
column (Figure 4.43).  It was likely that the nucleic acids that were still present 
were affecting its ability to bind to the SP column. 
 
 
Figure 4.43:  A 12.5% SDS PAGE gel showing the load and flow-through 
collected from an SP column after loading with an IEP expression culture 
previously partially purified on a Q column.  
 
 
Ceramic Hydroxyapatite Column 
A cell pellet equivalent to 250ml cell culture was re-suspended in 20ml CHT-
bind buffer, sonicated, filtered and loaded onto a 19ml CHT column.  The flow-
through was collected and proteins eluted from the column using a gradient of 
20-400mM potassium phosphate pH6.8 over 10cv.  The purification profile 
showed mainly one broad protein peak (Figure 4.44). 
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Figure 4.44:  A purification trace showing the elution profile of the IEP protein 
expression sample from a CHT column with an elution gradient of 20-400mM 
potassium phosphate, pH6.8. 
 
Initially, 0.25µl samples of fractions within the protein peaks were assayed for 
RT activity and two peaks of activity were found (Figure 4.45). 
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Figure 4.45:  A 1%(w/v) agarose detecting the amplification of cDNA produced 
using 0.25µl of the fractions as the RT enzyme, 20ng MS2 RNA and 
MS2:3395_R and with MS2:3231_F in the PCR.  
 
Fractions from the activity peaks were electrophoresed on a protein gel to 
analyse the IEP purity (Figure 4.46). 
 
 
Figure 4.46:  A 12.5%(v/v) SDS PAGE gel showing 5µl samples of the fractions 
with  RT activity. 
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None of the fractions that showed RT activity had a large amount of the 
expected size IEP.  By running protein samples out on an agarose gel (Figure 
4.47) it was revealed that the activity seen actually corresponds to where 
nucleic acids were eluted from the column.  It was hypothesised that the activity 
seen was in fact due to a low level of IEP that associates and elutes with the 
nucleic acids. 
 
Figure 4.47:  A 1%(w/v) agarose gel showing the elution of nucleic acids from 
the CHT column. 
 
In order to locate the main protein peak it was necessary to load fractions on a 
protein gel instead of using the activity assay (Figure 4.48).   
 
181 
 
Figure 4.48:  A 12.5%(v/v) SDS PAGE gel showing 5µl aliquots of the fractions 
from the elution of the IEP from the CHT column. 
 
By analysis of the protein gel alone it was difficult to assess where the protein 
had eluted and there was a possibility that it had eluted at either 120mM 
phosphate at fractions B12,-13 140mM phosphate at fraction C1-5 or 180mM 
phosphate at fraction C10-12.  A second RT assay reaction was performed, 
diluting the fractions further to enable inhibitors to be reduced and 40 PCR 
cycles carried out (Figure 4.49). 
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Figure 4.49:  A 2%(w/v) agarose gel showing the result of an RT assay on 
fractions believed to contain the IEP.  The assay shows the amplification of 
cDNA synthesised from the MS2 RNA template. 
 
The results of the assay revealed very low level of activity in the expected 
fractions B11-14 and higher activity in the later fractions.  It is possible that there 
are still inhibitors present in these earlier fraction affecting their activity.  The fact 
that there are clear activities across the fractions, even where no clear IEP is 
present, suggest that this enzyme is in fact very active, detectable by the 
sensitivity of the assay.   Unfortunately the fractions where the IEP was detected 
were not stable, even at 4ºC, and after several hours a large volume of 
precipitate had formed and these fractions no longer showed any RT activity. 
 
CHT Purification – After PEI Precipitation 
Since CHT columns are not affected by high NaCl concentration, it was decided 
to attempt to precipitate the nucleic acids at 2M NaCl before CHT column 
purification.  A cell pellet from a 250ml expressed culture was re-suspended in 
CHT-bind buffer with 2M NaCl at the equivalent of 1ml/0.1g of cells.  PEI at 
0.2%(w/v) was used to precipitate the nucleic acids.  It was not possible to 
assess whether the precipitation of the nucleic acids had been successful, as 
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adding the sample to an agarose gel loading buffer reduced the NaCl 
concentrations resulting in protein precipitation within the sample.  After 
centrifugation and filtering the PEI precipitated sample was loaded onto a CHT 
column and proteins eluted using an phosphate gradient of 20-400mM over 
10cv.  The purification trace (Figure 4.50) revealed three protein peaks and 
samples from each peak were assayed for activity. 
 
 
Figure 4.50:  The purification trace showing the elution profile of an IEP 
expression sample after precipitation with PEI.  Proteins were eluted from the 
column using a gradient of 20-400mM potassium phosphate. 
 
There were only three protein peaks present on the purification trace.  The first 
major peak corresponded to fractions A14-C1, peaking at B7, the second spans 
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C9-D15, peaking at C3, and the third spanning E3-F6 peaking at E9.  The main 
activity was seen in the protein peak eluting at 80mM potassium phosphate with 
the major activity in B7 (Figure 4.51).  However, the activity fluctuated across 
the fractions and was seen in all the protein peaks   
 
 
Figure 4.51:  A 2%(w/v) agarose gel showing the level of RT activity within each 
fraction when 0.25µl was used to synthesise cDNA from a MS2 RNA template. 
 
When the a sample of the column load was run on the gel (Figure 4.52) it 
showed a very low level of IEP possibly due to the fact that the IEP had 
precipitated during the PEI step.  The fractions corresponding to the major 
activity, B7-14, were also electrophoresed on the same protein gel there was 
the presence of a partially purified protein but with comparison to the IEP 
present in the load, it appeared to be slightly larger than expected (Figure 4.52). 
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Figure 4.52:  12.5% SDS gel with samples of the fractions showing the peak RT 
activity. 
 
The fractions that did show activity were loaded on an agarose gel and revealed 
a high degree of nucleic acid contamination, suggesting that the PEI step had 
not been completely successful (Figure 4.53).  It is likely that the activity seen is 
due to a low level of IEP that becomes associated and elutes with the nucleic 
acids. 
 
 
Figure 4.53:  A 1%(w/v) agarose gel showing the nucleic acid contamination of 
fractions from the elution of the IEP from the CHT column.  Fractions B1-13 
were previously shown to contain the peak activity. 
 
In order to assess whether the IEP was associating with DNA or RNA or both, 
8µl of the fraction was mixed with 1µl of the appropriate 10x buffer and 1µl of 
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either DNase or RNase and incubated at room temperature for 1h.  The sample 
was then loaded on an agarose gel (Figure 4.54) which showed that the IEP 
activity seen elutes with the RNA fractions. 
 
 
Figure 4.54:  A 1%(w/v) agarose gel showing the effect on the nucleic acids in 
the fraction (lane 1) when exposed to DNase (lane 2) and RNase (lane 3). 
 
No further attempts to purify the T. carboxydivorans IEP were carried out, and 
therefore no characterisation of the enzyme could be performed.  However, the 
fact that the IEP did show activity showed that it has the potential, once purified, 
to be useful thermostable RT enzyme. 
 
P. mobilis IEP2 Purification 
Initially the P. mobilis IEP was over-expressed on a large-scale using TB 
medium.  However, the protein gels from this expression culture revealed no 
protein at the expected size in either the soluble or insoluble fraction.  Large-
scale expression therefore had to be carried out using LB media where OD600 
reached 2.6 and the expressed IEP was 100% soluble. 
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Heat Treatment 
A sample of the large-scale IEP expression culture was removed, sonicated and 
centrifuged.  The supernatant was then exposed to 50ºC for 5, 10 and 15min 
and the soluble fraction electrophoresed on a protein gel (Figure 4.55).  The 
results of this gel showed that the IEP behaved the same as the previous IEPs 
and was not stable even after 5min at 50ºC.  Heat treatment was therefore not 
an option for purification to remove some background E. coli proteins from the 
protein sample. 
 
 
Figure 4.55:  A 12.5%(v/v) SDS PAGE gel showing the effect of 50ºC heat 
treatment on the soluble fraction of the IEP. 
 
 
Heparin Column 
The cell pellet from a 250ml expression culture was re-suspended in 10ml 
heparin-bind buffer and loaded onto a 5ml heparin column.  Protein was eluted 
from the column with a gradient of 0.025M-2M NaCl over 20cv.  Samples of the 
load and flow-through were electrophoresed on a protein gel (Figure 4.56).  This 
gel showed that the IEP did not bind to the column and was found in the flow-
through.  Presumably the IEP has a higher affinity for nucleic acids than for the 
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column and therefore could not bind.  In order to use a heparin column it would 
be necessary to remove the nucleic acids from the sample. 
 
 
Figure 4.56:  A 12.5%(v/v) SDS PAGE gel showing the IEP sample loaded onto 
a heparin column followed by the flow-through.  The IEP did not bind the column 
and came out in the flow-through. 
 
 
PEI Precipitation 
A sample from the over-expressed IEP culture was removed and the pellet re-
suspended in heparin-bind buffer equivalent to 1ml/0.1g of cells.  The sample 
was sonicated and 100µl aliquots exposed to varying concentrations of PEI.  
After incubation, the soluble fractions were electrophoresed on an agarose gel 
to assess the level required to remove all nucleic acids (Figure 4.57a), and onto 
a protein gel to see the effect of PEI on the soluble IEP (Figure 4.57b). 
 
 
189 
 
Figure 4.57:   
a) A 1%(w/v) agarose gel showing the required level of PEI needed to 
remove all the nucleic acids from the IEP expression sample 
b) A 12.5%(v/v) SDS PAGE gel showing the effect of increasing PEI 
concentrations on the soluble IEP. 
 
0.1% PEI was required to remove all the nucleic acids from the sample; 
however, at this concentration, all the IEP was also precipitated.  The 
experiment was repeated with a 0.1% PEI and varying the concentration of 
NaCl.  After incubation, the soluble fraction was electrophoresed on a protein 
gel (Figure 4.58). 
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Figure 4.58:  A 12.5%(w/v) SDS PAGE gel showing the effect on the IEP with 
0.1% PEI and increasing concentrations of NaCl. 
 
The protein showed that, even after 900mM NaCl was used, very little of the IEP 
remained soluble.  Despite the very low level of soluble IEP it was decided to 
use this method to try to remove nucleic acids in the hope that any remaining 
IEP could still bind to a column and would allow enough IEP to be purified for 
characterisation. 
 
Heparin Column – After PEI Precipitation 
Initially it was decided to purify the IEP using the same method that was shown 
to work for the B. caldovelox IEP.  A cell pellet from a 250ml expressed culture 
was re-suspended in heparin-bind buffer (600mM NaCl) equivalent to 1ml/0.1g 
of cells.  The sample was sonicated and incubated with 0.1% PEI at 4ºC for 1h.  
The sample was centrifuged, the supernatant filtered, loaded onto a heparin 
column and eluted with a gradient of 0.6-2M NaCl over 20cv.  Unfortunately, 
when electrophoresed on a protein gel, no IEP could be seen in either the load 
or any of the protein peaks from the purification trace.  It was likely that all the 
IEP had been removed at the PEI precipitation step and the purification was 
repeated as before but with a heparin-bind buffer containing 900mM NaCl.  
 
191 
Again, no IEP could be seen in the load, flow-through or protein peaks.  It is 
possible that if low levels of IEP remained soluble after the PEI precipitation that 
900mM NaCl was too high to allow the IEP to bind and the protein would be 
present in the flow-through. 
 
The heparin purification was also repeated with PEI precipitation carried out at 
100mM NaCl.  It was hoped that if any IEP remained soluble, 100mM NaCl 
would be low enough to allow the protein to bind to the column.  However, there 
was no IEP present in the load, flow-through or any of the protein peaks. 
 
Q Column 
Like the other IEPs the P. mobilis IEP has a very high pI value of 9.82 and 
should therefore not bind to a Q column at pH8.  However, it was thought that 
the association with nucleic acids would alter the properties of the protein 
allowing it to bind to the column as is seen with the other IEP mentioned in this 
report.  It was decided that a Q column could be used, as with T. 
carboxydivorans IEP, to separate the nucleic acids from the IEP.  The cell pellet 
from a 250ml expressed culture was re-suspended in 5ml Q-bind buffer, 
sonicated and centrifuged.  After filtering, the sample was loaded onto a 5ml Q 
column and the flow-through collected.  The proteins were eluted from the 
column with a gradient of 0.025-2M NaCl.  Fractions from the protein peaks 
seen on the purification trace (Figure 4.59) were electrophoresed on an agarose 
gel to assess where the nucleic acids had eluted (Figure 4.60). 
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Figure 4.59:  A purification trace showing the elution of the soluble fraction from 
an IEP expression culture from a 5ml Q column. 
 
 
Figure 4.60:  A 1%(w/v) agarose gel showing nucleic acid contamination in peak 
protein fractions from the elution of the IEP expression sample from a Q column. 
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When loading all the peak fractions onto a protein gel it became apparent that 
the P. mobilis IEP eluted with the fractions that contain the nucleic acids (Figure 
4.61).  This IEP eluted very broadly and was seen at low levels across fractions 
B15-C13. 
 
 
Figure 4.61:  12.5%(v/v) SDS PAGE gel showing fractions from the Q column 
that contain the P. mobilis IEP. 
 
These fractions were assayed for activity using 0.25µl of the fraction as the RT 
enzyme in a cDNA synthesis reaction using MS2 RNA as template.  The PCR 
used to amplify this cDNA revealed that activity could be found within all these 
fractions (Figure 4.62).  The IEP therefore did successfully bind and elute from 
the Q column; however, there was a high concentration of nucleic acids 
contaminating the sample. 
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Figure 4.62:  A 2%(w/v) agarose gel showing RT activity in the IEP purification 
fractions from a Q column. 
 
No further attempts were made to purify the P. mobilis IEP; however, the 
enzyme did exhibit activity showing its potential use commercially as an RT 
enzyme. 
 
B. stearothermophilus IEP 
Attempts were made to over-express the IEP from the New Zealand B. 
stearothermophilus using both TB and LB media.  However, despite the fact that 
both media could be used on a 10ml scale, no over-expression of the correct 
size protein product was seen in either the soluble or insoluble fraction.  The 
expression was repeated several times reducing the culture size to 250ml; 
however, no over-expression of the IEP on a large-scale was achieved.  
Therefore, no purification was attempted on this protein. 
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4.4 – DISCUSSION 
 
 
This chapter outlined the attempts to purify previously uncharacterised IEPs 
from thermophilic bacteria.  Although not all attempts were successful, RT 
assays on partially purified enzymes showed that the IEPs from B. caldovelox, 
T. carboxydivorans and P. mobilis all showed activities with cDNA being created 
from an MS2 RNA template.  
 
B. caldovelox IEP 
Initially the purification of the IEP from B. caldovelox proved to be very difficult.  
Despite the thermophilic nature of the organism from which this IEP was cloned 
the IEP itself did not appear to display thermostable properties in un-
fractionated cell extracts.  The soluble protein fraction could not be heated for 
5min at 50ºC, in an attempt to reduce background E. coli proteins, without the 
IEP becoming insoluble. 
 
Additional attempts at purification involved utilising an N-terminal his-tag 
artificially fused to the protein; however, the IEP would not bind to a Ni2+ 
charged column.  It was then decided to take advantage of the high pI value of 
the protein and purify the IEP using an SP column.  At pH6.8 the majority of the 
E. coli proteins were not expected to bind the column allowing the IEP to be 
purified with an NaCl gradient.  Unexpectedly, the IEP did not bind to this 
column and was present in the flow-through.  As an alternative method a 
heparin column was selected to utilise the nucleic acid binding properties of the 
enzyme; however, once again, the IEP did not bind to the column   
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It was then found that the protein could bind to an anion exchange Q column 
even though at pH8 the IEP should have been completely positively charged.  
The elution of this protein from the Q column revealed it to contain a high level 
of contaminating nucleic acids and it was hypothesised that the IEP was binding 
the nucleic acids with very high affinity, preventing it from binding to a heparin 
column and altering the charge so that it could not bind to the SP column. 
 
PEI was selected as a method to remove nucleic acids, but it was found that a 
high concentration of NaCl was required to prevent the IEP from precipitating 
with the nucleic acids.  Fortunately, once the nucleic acids were removed, this 
high NaCl concentration did not interfere with the binding to a heparin column 
and the IEP could be eluted at approximately 1.6M NaCl.  It was also shown 
that, after nucleic acids were removed, the IEP would bind tightly to the SP 
column as would be expected with the high pI value of the protein.  However, 
the SP column was not used as a purification step.  The preferred method that 
yielded pure IEP was therefore removal of nucleic acids with PEI at a relatively 
high NaCl concentration followed by binding and elution, with an NaCl gradient, 
from a heparin column. 
 
Fractions of the eluted IEP did show RT activity when using MS2 RNA as the 
template, allowing the potential characterisation of this enzyme as a 
thermostable RT.  The fractions were concentrated and stored in enzyme 
storage buffer which yield 1.5ml of pure protein, from a 250ml TB expression 
culture, at 6.4mg/ml. 
 
Sac7d Fusion Proteins 
Like the wild-type IEP, the Sac7d fusion proteins could not be heat treated as a 
method to reduce background proteins without becoming insoluble.  Since the 
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B. caldovelox IEP could only be purified once nucleic acids were removed the 
same nucleic acids precipitation approach was adopted for the two Sac7d fusion 
proteins, IEP-Sac7d and Sac7d-IEP.   
 
The IEP-Sac7d fusion behaved very similarly to the wild-type IEP eluting at a 
high NaCl concentration in fractions free of other contaminating proteins.  Once 
pooled and concentrated into enzyme storage buffer, a 250ml expression 
sample yielded approximately 1.5ml of IEP-Sac7d at an estimated concentration 
of 3mg/ml. 
 
The Sac7d-IEP proved more difficult to purify.  The fusion product behaved the 
same as the wild-type IEP and the IEP-Sac7d protein; however, when it eluted 
from the heparin column, it was found to co-purify with an additional protein.  
This co-purifying contaminant could not be separated by running an additional 
SP column.  It was expected that the product was a result of cleavage of the 
Sac7d domain as the contaminating protein was approximately the same size 
as the wild-type IEP and the product was not seen in the IEP-Sac7d purification.  
Attempts were made to prevent this cleavage both by using protease inhibitors 
in the lysis buffers and the purification buffers and by removing the linker 
domain from the enzyme. Despite these efforts the fusion protein was 
continually co-purified with this contaminating protein. 
 
In order to obtain pure protein future work would need to involve investigating 
whether the contamination was in fact due to cleavage of the Sac7d domain.  
Loading enough of the fractions on a higher percentage protein gel would 
possibly reveal the presence of a low percentage of the cleaved Sac7d domain 
running at 7kD.  Alternatively the contaminating fragment could be excised from 
a gel to be sent off for mass spectrometric analysis to give accurate Mr values.  
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Mass spectrometry analysis could also be carried out after a after a trypsin 
digest to give an indication of the composition of the contaminating protein.   If 
the contaminating protein was in fact the result of proteolytic cleavage then 
additional attempts could be made to reduce this occurrence for example by 
increasing the length of the linker, as the junction of the C-terminus of Sac7d 
and the N-terminus of the IEP could be providing a proteolytic cleavage site. 
 
Alternatively, the additional product could be due to the presence of another 
start codon further downstream, possible at the start of the IEP domain.  Low 
level translation could be occurring producing the wild-type IEP lacking the 
Sac7d domain.  This could be eliminated by removal of the natural start codon 
within the IEP allowing a single read through to be produced. 
 
T. carboxydivorans IEP 
Despite the fact that T. carboxydivorans grows at an optimum temperature of 
55ºC, the IEP in un-fractionated cell extracts could not be heat treated at 50°C 
without becoming insoluble, so the background level of E. coli  proteins could 
not be reduced.   
 
Since nucleic acids proved to be a problem with the purification of the B. 
caldovelox IEP, PEI precipitation was also adopted as a method to remove the 
nucleic acids from the sample.  However, this IEP was more sensitive to PEI 
precipitation and was precipitated even at high concentrations of NaCl.  
Attempts were made to PEI precipitate the nucleic acids in various different 
NaCl concentrations before binding to a heparin column, but all attempts were 
unsuccessful.  The reasons for failure were most likely either due to all the IEP 
precipitating with the PEI or due to the high NaCl concentration preventing any 
of the un-precipitated IEP from being bound to the column.  Several alternative 
columns including Ni2+ charged cellulose, SP, Q, heparin and CHT were 
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adopted and were also used in combined purification steps but no methods 
proved successful in obtaining pure protein.   
 
It is possible that the T. carboxydivorans IEP is not stable in the absence of 
nucleic acids.  Attempts to remove the nucleic acids also precipitated the protein 
and in some situations, where the nucleic acids were completely removed, the 
IEP within the fractions quickly precipitated out.   
 
P. mobilis IEP 
As is seen for the other IEP outlined in this chapter, the IEP from P. mobilis also 
could not be heat treated in cell extracts in an attempt to reduce background 
proteins as an initial purification step.  Fewer purification methods were 
attempted on this IEP, than used for T. carboxydivorans IEP; however, the 
same problems were encountered. 
 
Future Attempts 
In order to characterise the IEPs as RT enzymes, it was necessary to purify 
them from proteins that could interfere with the activity, as well as to remove 
nucleic acids that would contaminate any reactions.  This chapter outlined the 
attempts to purify previously uncharacterised IEPs from thermophilic bacteria.  
Although not all attempts were successful, RT assays on partially purified 
enzymes showed that the IEPs from B. caldovelox, T. carboxydivorans and P. 
mobilis all showed RT activity with cDNA being created from an MS2 RNA 
template.  
 
It is possible that PEI precipitation could be carried out at higher NaCl in the 
case of T. carboxydivorans and P. mobilis.  The IEP from B. caldovelox eluted 
from the heparin at a very high NaCl concentration and if the PEI precipitation 
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was carried out at 1.2-1.4M NaCl it might prevent the IEP from precipitating, but 
the high affinity to nucleic acids might allow the protein still to bind to the heparin 
column. 
 
It was also shown in one case that the IEP was associating with RNA rather 
than DNA and removing the RNA could be achieved using a column with 
immobilised RNase and therefore preventing any contamination into the sample.  
However, there is the possibility that removing the RNA could render the protein 
insoluble, although nucleic acid removal in other cases leaves the IEP in 
solution. 
 
Purified samples of B. caldovelox IEP and the IEP with a C-terminal Sac7d 
domain were selected for further characterisation of RT activity and will be 
discussed in the following chapter. 
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Chapter 5 – Enzyme Characterisation 
 
5.1 – INTRODUCTION 
 
Various assays to characterise the B. caldovelox IEP and the Sac7d fusion 
protein can be carried out and often involve the comparison to retroviral RTs.  
The backgrounds of these techniques are outlined in the introduction to this 
chapter. 
 
Quantitative Real Time Polymerase Chain Reaction (qPCR) 
qPCR offers a sensitive method for detecting changes in activity of the RTs 
under differing conditions.  The initial first-strand reaction, the RT step, can be 
performed using a standard thermal cycler allowing accurate incubation time 
and temperature, followed by a heat denaturation step of the enzyme to prevent 
any DNA-dependent DNA polymerase activity of the RT from interfering with the 
qPCR.  The cDNA produced by the RT can then be detected using qPCR. Cq 
values from the qPCR data represent the quantification cycle, also referred to as 
the cycle threshold, and represents the fluorescence level within the exponential 
phase of the reaction that is initially detectable above the background.   A lower 
Cq value represents more copies of cDNA being initially present and therefore a 
more active RT enzyme (Bustin, 2004).  Using this sensitive method it is 
possible to detect subtle changes in RT activity, allowing buffer and reaction 
temperature optimisation, analysis of enzymatic activity at higher than optimum 
temperatures, investigation of how the enzyme reacts when given more 
complex targets, and the thermostability of the enzyme. 
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Retroviral Activities 
The RTs within retroviruses actually have three different activities aiding in the 
lifecycle of the retrovirus.  The RNA genome is synthesised into a DNA strand 
by the RNA-dependent DNA polymerase activities of the enzyme.  The RNase 
H domain of these RTs is then responsible for degradation of the RNA in the 
RNA:DNA hybrid, allowing the DNA-dependent DNA polymerase activities of the 
RT to create dsDNA (as reviewed by Herschhorn and Hizi, 2010).  It is known 
from previous chapters of this report that the IEP shows RNA-dependent DNA 
polymerase activity and the lack of an RNase H domain presumably prevents 
the enzyme from degrading the RNA in a RNA:DNA duplex.  However, it is not 
known whether the IEP, like the retroviral RTs, will exhibit DNA-dependent DNA 
polymerase activity.  This activity can be detected using an assay involving a 
ssDNA template and a FAM (6-carboxy-fluorescein) labelled primer (Wang et al. 
2004).  If an extension event occurs from the FAM-labelled primer, these larger 
extension products can be detected using an ABI3100 sequencer and 
GeneScan software.  Any products detected that are larger than the 23bp FAM-
labelled primer are indicative of DNA-dependent DNA polymerase activity. 
 
Processivity 
Processivity of DNA polymerases has been enhanced by the fusion of DNA-
binding proteins, such as Sso7d and Sac7d, to either the N- or C-terminus of the 
proteins.  Using the extension assay mentioned above, it was shown by Wang 
et al. (2004) that the presence of an N-terminal Sso7d domain on Taq DNA 
polymerase increases the incorporation of nucleotides, in a single enzymatic 
event, from 22 to 104 nucleotides.  Similarly, the incorporation of Sso7d on the 
C-terminus of Pfu DNA polymerases enhances the processivity of this enzyme 
to incorporate 6 nucleotides for wild-type Pfu to 55 nucleotides with the Sso7d 
domain.  The presence of this DNA-binding domain therefore significantly 
enhances the processivity of the enzyme.  This idea has not yet been adapted 
for retroviral RTs.  In order to test whether Sac7d could have the same effect on 
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the B. caldovelox IEP, the extension assay can be adopted and optimised to 
allow the measurement of a single enzymatic event.  This involves a dilution of 
the enzyme and a reduction in the reaction time significantly enough to ensure 
that a single enzymatic event is recorded.  As above, a FAM-labelled primer can 
be used.  However, an RNA template would be required to measure the 
processivity of the RNA-dependent DNA polymerase activity.   
 
Alternatively, a more basic method can be used to measure the processivity.  
Incorporation of more nucleotides in a single enzymatic event can lead to either 
shorter extension times required to synthesise a set length of cDNA or to a 
longer cDNA fragment being created.  By recording the time required to 
synthesise cDNA of specific lengths and comparing wild-type IEP to IEP-Sac7d 
it would be possible to detect whether the Sac7d is having an influence on the 
processivity of the enzyme. 
  
Fidelity 
DNA-dependent DNA polymerase fidelity assays in the past were often based 
on the lacI system.  This blue/white screening system (Brown, 2001) relies on 
the presence of a fully functional lacZ gene coding for β-galactosidase.  This is 
achieved by complementation of two lacZ fragments, one from the host strain 
and the other from a vector.  The E. coli host strain, TOP10, has the genotype 
lacZ∆M15, which allows complementation with lacZα provided by the pUC 
vector.  The β-galactosidase gene’s normal role is to cleave lactose; however, it 
will also cleave X-Gal producing a blue pigment.  When the lacI gene is present 
the cells have a white LacI+ phenotype in the presence of X-Gal.  The Lac 
repressor (LacI) will bind the lac operon, blocking the RNA polymerase from 
transcribing lacZ mRNA and therefore preventing production of β-galactosidase.   
Mutation of lacIq by the polymerase can lead to the blue LacI- phenotype, where 
β-galactosidase transcription is not blocked and colonies will cleave X-Gal 
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producing blue colonies.  The lacI gene has been mapped and it is known that, 
of the 1080bp within the gene, 349 single base substitutions at 179 codons will 
cause a phenotypic change of white to blue colonies on X-Gal (Provost 1993, 
cited by Frey 1995). 
 
The error rate (f) of the DNA polymerase can be measured by calculating the 
number of DNA duplications (d) during the PCR, the fraction of white colonies 
(F) and with the knowledge that there are 349 phenotypically identified 
mutations that can occur in the 1080bp lacI.  The error rate can be calculated 
using these figures and the equation from Frey et al. (1995): 
f= (-InF / d) x 349 
This system could be adapted to give an idea of the accuracy of RTs.  An RNA 
strand of lacIq can be created with T7 RNA polymerase.  However, this step will 
itself incorporate errors into the lacIq.  Providing the same template is used for 
all RTs, this error rate should be constant and therefore not influence the 
difference in ratio of the white colonies seen with the different RTs.  A PCR step 
would also be necessary, after the cDNA synthesis, to allow lacIq ligation into a 
vector.  It would be necessary to ensure that the concentration of cDNA 
template provided by each RT was identical.  This would mean that the 
duplication rate for each template will be consistent therefore reducing an 
influence on the error rate by the DNA polymerase.  Cycle numbers were kept 
low and a high-fidelity DNA polymerase used to further reduce any errors 
produce by the PCR step. 
 
The ligation step can also add an extra problem; if the ligation was 
unsuccessful, colonies could still grow on the antibiotic medium completely 
lacking the lacI gene and therefore produce a background of false blue colonies.  
In order to prevent this, a selection technique can be incorporated so that only 
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colonies positive for lacIq would be present on the agar plates.  A sucrose 
lethality system was set up where the Bacillus subtilis sacB gene was 
incorporated into a pUC vector.  The sacB gene encodes levansucrase that, 
when expressed by B. subtilis, is normally secreted in the culture medium after 
induction by sucrose (Gay et al. 1985).  Levansucrase is involved in two main 
physiological reactions: levan synthesis and sucrose hydrolysis.  When Gram-
negative bacteria containing sacB are grown on media containing 5-10% 
sucrose, levansucrase is expressed and it is believed that it becomes trapped in 
the periplasmic space (Bramucci and Nagarajan, 1996).  Accumulation of levans 
in the periplasm proves lethal by causing lysis of the cell (Recorbet et al. 1993).  
The fidelity system was designed so that the lacIq would be inserted into a sacB 
gene within pUC19 and plated onto sucrose plates.  Where lacIq failed to ligate 
into the vector, sacB will remain intact resulting in lethality on sucrose plates 
and therefore no background blue colonies.  A positive insertion of lacIq into 
sacB interrupts this gene, preventing levansucrase expression and therefore 
preventing lethality on sucrose.  This system will ensure that only colonies 
positive for the lacIq will be present on the agar plates. 
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5.2 – MATERIALS AND METHODS 
 
Nuclease Assay 
An optimum enzyme concentration was added to 1x RT buffer and 500ng of 
either MS2 RNA, lambda DNA (Fermentas, York, UK) or pET24a vector DNA 
and the volume made up to 15µl with nuclease-free water.  The reaction was 
incubated for 10h at 37ºC and then the entire sample electrophoresed on an 
agarose gel to assess for nuclease activity.  A control was run in parallel 
containing nucleic acids but no enzyme.                                                                    
 
qPCR 
This reaction used cDNA, synthesised by the RT enzyme, as a template for the 
PCR.  The final reaction contained 1x MESA Green [no ROX] Mastermix 
(Eurogenetic, Belgium), 15pmol of primers MS2:3231_F and MS2:3395_R 
(Appendix I), 1µl of the cDNA synthesis reaction and the volume made to 50µl 
with nuclease-free water.  A LightCycler®480 (Roche, Welwyn Garden City, UK) 
was used with the following cycling conditions: 
94ºC 4min 
   
95ºC 3s   
60ºC 1min  45 cycles 
 
The cycling conditions were then directly followed with a melt curve analysis 
from 60-95ºC at 0.04ºC/s. 
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Reaction Buffer optimisation 
A proprietary RT buffer (GeneSys Ltd, Camberley, UK) was altered, one 
component at a time, to analyse the best concentrations required for optimum 
cDNA synthesis by the IEP and IEP-Sac7d.  The following components were 
tested during the cDNA synthesis step with the following final concentrations: 
Tris: pH 7.9, 8.0, 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 8.8. 8.9, 9.0 
Ammonium sulphate: 0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50mM  
KCl: 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100mM 
K2SO4: 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100mM 
MgSO4: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10mM 
All reactions were performed in duplicates and 1µl of the above reaction was 
used as template in a qPCR and the protocol followed as above. 
 
Optimum Reaction Temperature and High Reaction Temperatures 
The final cDNA synthesis reaction contained 1x optimum RT reaction buffer, 
0.5mM dNTPs, 15pmol MS2:3395_R, 1ng MS2 RNA, optimum RT enzyme 
concentration, and the final volume made up to 20µl with nuclease-free water.  
Using a Veriti® thermal cycler (Applied BioSystems, UK) samples were 
incubated for 30min at various set temperatures.  The temperatures varied from 
42-76ºC in increments of 2ºC and were followed by a heat denaturation step at 
95ºC for 20min.  All reactions were performed in duplicate.  1µl of this reaction 
was used as a cDNA template in a qPCR as mentioned earlier. 
 
 
 
208 
Metal Ion Assay 
cDNA Synthesis Step 
The cDNA synthesis reaction contained 1x optimum buffer (with no MgSO4), 
0.2mM dNTPs, 15pmol MS2:3395_R, 20ng MS2 RNA, optimum RT enzyme 
concentration, 0-10mM divalent cation and the final volume made to 20µl with 
nuclease-free water.  The reaction was incubated at the optimum enzyme 
temperature for 30min and then heated to 95ºC for 20min to irreversibly 
denature the RT enzyme. 
 
PCR Step 
2µl of the above reaction was used as template in a PCR that also contained 1x 
Taq mastermix, 25pmol MS2:3231_F, 25pmol MS2:3395_R and the volume 
made up to 50µl with nuclease-free water.  The reaction was cycled as follows: 
95ºC  3min 
 
95ºC  10s 
55ºC  10s  30cycles 
72ºC  20s 
 
72ºC  7min 
 
10µl of the reaction was analysed on an 2%(w/v) agarose gel. 
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Thermostability Assay 
Temperature Incubation 
4 different reactions were set up containing 1x optimum reaction buffer (with no 
MgSO4), 0.5mM dNTPs and RT enzyme.  Once the basic mastermix was set up, 
the components were added to the four individual reactions as follows: 
1) 2mM MgSO4 
2) 2mM MgSO4 and 1ng MS2 RNA 
3) 2mM MgSO4 and 1µg yeast tRNA 
4) 1ng MS2 RNA 
The reactions did not contain any MS2:3395_R and therefore no cDNA would 
be synthesised during the incubation steps.  The reactions were heated to 60ºC 
for time intervals of 0, 5, 10, 15, 20, 25, 30, 40, 50, 60, and 90min.  All reactions 
were performed in duplicate. 
 
cDNA Synthesis Step 
Following the incubations as described above, 15pmol MS2:3395_R and, if 
necessary, 1ng MS2 RNA and 2mM MgS04 were added to each reaction and 
incubated for 30min at the optimum enzyme reaction temperature, followed by a 
denaturation step of 95ºC for 20min.  1µl of this template was then used as the 
DNA template in a qPCR as mentioned above. 
 
Fidelity Assay – Set Up and Proof of Principle 
Creating pCR®2.1_lacIq - Gene Amplification 
lacIq was amplified from pTTQ18NHK vector (GeneSys Ltd, Camberley, UK) 
using PCR.  The reaction contained 1x HF buffer, 0.2mM dNTPs, 25pmol of 
primers lacIq_F_SacII and lacIq_R_SacII  (Appendix I), 10ng pTTQ18NHK, 1U 
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Phusion® DNA polymerase and made up to 50µl with nuclease-free water.  The 
reaction was cycled as follows: 
98ºC  30s 
 
98ºC  10s 
55ºC  10s   20 cycles 
72ºC  1min 
 
72ºC  7min 
The reaction was purified using the Promega Wizard® SV Gel and PCR Clean-
up system and eluted in 50µl nuclease-free water. 
 
Creating pCR®2.1_lacIq – A-Tailing 
7µl of the purified PCR was added to 1x Taq buffer (GeneSys Ltd, Camberley, 
UK), 0.2mM dATP (Roche, Welwyn Garden City, UK), 5U Taq DNA polymerase 
and the final volume made up to 10µl with nuclease-free water.  The reaction 
was incubated at 70ºC for 15-30min. 
 
Creating pCR®2.1_LacIq – General Methods 
The protocols followed to allow TA cloning and sequencing of the pCR®2.1 
vector can all be found in Chapter 2 methods. 
 
Creating pUC19_sacB – Gene Amplification 
sacB was amplified from pET24a_sacB (GeneSys Ltd, Camberley, Surrey) in a 
PCR containing 1x HF buffer, 0.2mM dNTPs, 25pmol of primers sacB_F_AatII 
and sacB_R_AatII (Appendix I), 1U Phusion® DNA polymerase and the final 
volume made to 50µl with nuclease-free water.   
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The reaction was cycled as follows: 
98ºC  30s 
 
98ºC  10s 
55ºC  10s             20 cycles 
72ºC  1min 45s    
 
72ºC  7min 
 
The reaction was cleaned up using Promega Wizard® SV Gel and PCR Clean-
up system and DNA eluted in 50µl nuclease-free water. 
 
Creating pUC19_sacB - General Methods 
The protocols followed to allow the ligation of the sacB gene into pUC19 and the 
sequencing of the construct are all detailed in Chapter 2 methods. 
 
Proof of Principle 
PCRs were set up using three different polymerases, Taq, Taq:Pfu (20:1) and 
Phusion®.  The reactions contained 1x recommended reaction buffer, 0.2mM 
dNTPs, 50pmol lacIq_F_SacII, 50pmol lacIq_R_SacII, 5ng pCR®2.1_lacIq, 
optimum DNA polymerase concentration and the volume made up to 50µl with 
nuclease-free water.  The reactions were cycled as follows 
 
Taq/Taq:Pfu 
  Phusion®  
 
 
95ºC 
 
95ºC 
55ºC 
72ºC 
 
72ºC 
 
3min 
 
10s 
10s 
1min 20s 
 
7min 
 
 
 
 
 18 cycles 
 
98ºC 
 
98ºC 
55ºC 
72ºC 
 
72ºC 
 
30s 
 
10s 
10s 
50s 
 
7min 
 
 
 
 
18 cycles 
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A 5µl aliquot of each reaction was electrophoresed on an agarose gel with 
0.5µg 2-log ladder marker (NEB, Hitchin, UK) to allow an estimation of the yield.   
 
The lacIq amplified gene was purified, digested with Sac II and ligated into Sac II 
digested pUC19U_sacB following protocols as detailed in chapter 2.  The 
construct was then transformed into electrocompetent TOP10 (Appendix II) and 
spread onto LB plates containing 80µg/ml methicillin, 20µg/ml ampicillin, 
40µg/ml X-Gal and 10%(w/v) sucrose.  After incubation for 24h at 37ºC the 
number of blue and white colonies could be counted. 
 
RT Fidelity Assay 
Generating lacIq RNA 
PCR®2.1_lacIq was linearised in a RE reaction containing 1x NEB RE buffer 4, 
10U Bgl II (NEB, Hitchin, UK), 1µg pCR®2.1_lacIq and the volume made to 
100µl with nuclease-free water.  The reaction was incubated for 1h at 37ºC and 
then purified using Promega Wizard® SV Gel and PCR Clean-up system with 
the DNA eluted in 50µl nuclease-free water. 
 
AmpliScribe™T7 High Yield Transcription Kit (Cambio Ltd, Cambridge, UK) was 
used to generate RNA from pCR®2.1_lacIq plasmid.  The reaction components 
were added in the following order:  RNase-free water, 100ng linearised 
pCR®2.1_lacIq, 1x AmpliScribe T7 reaction buffer, 7.5mM ATP, CTP, GTP, UTP, 
10mM DTT, 0.5µl RiboGuard RNase Inhibitor, and 2µl Ampliscribe T7 Enzyme 
solution, with the final reaction volume equalling 20µl.  The reaction was then 
incubated for 2h at 37ºC.  1µl (1MBU) RNase-free DNase I was added, 
incubated for 15min at 37ºC and then heat-inactivated at 75ºC for 10min.   
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cDNA Synthesis Step 
Four separate first-strand reactions were set up, each for a different RT 
enzyme.  Each reaction contained 1x optimum RT buffer, 0.5mM dNTPs, 
15pmol LacIq_F_SacII, lacIq template RNA (estimated at 50ng), optimised RT 
enzyme concentration and the volume made to 20µl with nuclease-free water.  
The reactions were incubated for 30min at the optimum enzyme reaction 
temperature followed by a denaturation step at 95ºC for 20min 
 
PCR step 
Initially, dilutions of the cDNA synthesis reaction were set up and used in a PCR 
containing 1x HF buffer, 0.2mM dNTPs, 25pmol LacIq_F_SacII and 
LacIq_R_SacII, cDNA synthesis reaction as template, and 1U Phusion® DNA 
polymerase and the volume made to 50µl with nuclease-free water.  The 
reaction was cycled as follows: 
98ºC  30s 
 
98ºC  10s 
55ºC  10s  18 cycles 
72ºC  50s 
 
72ºC  7min 
 
Once the same concentration of starting template had been determined, the 
reaction was repeated to ensure the same amount of cDNA had been amplified. 
 
Cloning Step 
The protocols followed to allow the purification, digestion and ligation into 
pUC19_sacB are detailed in Chapter 2.  The ligated constructs were 
transformed into electrocompetent TOP10 and plated onto LB with methicillin, 
ampicillin, X-Gal and 10%(w/v) sucrose.  After 24h incubation at 37ºC the white 
and blue colonies could be counted. 
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DNA-Dependent DNA Polymerase Assay 
The FAM-labelled primer, -40M13LFF (Wang et al. 2004 and Appendix I) was 
initially annealed to the template in a reaction buffer that contained 1x optimum 
reaction buffer, 0.25mM dNTPs, 1x BSA, 100nM M13mp8 template, 50nM  -
40M13LFF, and the volume made to 18µl with nuclease-free water.  The 
reaction buffer was placed into a glass beaker with 95ºC water and allowed to 
cool to room temperature. 
 
Taq DNA polymerase was used as a control reaction with 0.1U of the 
polymerase added to the reaction, incubated at 72ºC for 5min and the reaction 
stopped with the addition of EDTA to a final concentration of 20mM. 
 
For the RT experiment, the optimum enzyme concentration was added and the 
reaction incubated at the RT optimum reaction time for 30min before being 
stopped with the addition of EDTA to the final concentration of 20mM. 
 
The reactions were ethanol-precipitated with the addition of 10µl 125mM EDTA, 
and 112µl of 100%(v/v) ethanol, and incubated at -20ºC for 20min.  After 
incubation the reactions were centrifuged at 14,000xg for 20min, the 
supernatant discarded and the pellet washed with 100µl 70%(v/v) ethanol.  The 
ethanol wash was discarded and the pellets dried using a vacuum centrifuge.  
The pellets were re-suspended in 10µl ABI Hi-Di™ formamide.    A second buffer 
was made up to contain 4µl GeneScan™350 ROX™ size standard and 140µl of 
fresh formamide.  9µl was dispensed into wells of a sequencing plate along with 
1µl of the reaction in Hi-Di™ formamide and the plate gently mixed. 
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The assay reaction was analysed using the GeneScan programme of an 
ABI3100 sequencer. 
 
RNA-Dependent DNA Polymerase Activity – Processivity Assay 
This experiment measures the extension event occurring from a FAM-labelled 
primer, FAM_MS2:3193R (Appendix I), annealed to MS2 RNA, by RNA-
dependent DNA polymerase activity.  The basics of this method were the same 
as those for the above assay; however, several adjustments were made that will 
be detailed in the results section. 
 
Basic Processivity Assay 
cDNA Synthesis Step 
The final reaction contained 1x optimum reaction buffer, 0.5mM dNTPs, 15pmol 
MS2:3339_R, 20ng MS2 RNA, and an optimum enzyme concentration, and the 
volume made up to 20µl with nuclease-free water.  Samples were incubated at 
the enzyme optimum reaction temperature for 0, 1, 2, 3, 4, 6, 8, 10, 12, 14, 16, 
18, 20, 25, 30min and then immediately incubated at 95ºC for 20min.  The 
reactions then had an additional 20µl of nuclease-free water added. 
 
PCR step 
The final reaction contained 1x Taq:Pfu (20:1) mastermix, 15pmol MS2:3395_R 
and 15pmol of either  MS2:13_F (Appendix I) or MS2:1868_F (Appendix I), and 
1µl of the above reaction as template and the volume made to 25µl with 
nuclease-free water.   
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The reaction was cycled as follows 
94ºC 3min 
 
94ºC 10s 
55ºC  10s   20 cycles 
72ºC 1min/kb 
 
72ºC 7min 
5µl of the reaction was then analysed on an agarose gel. 
 
Complex Target Assay 
 
cDNA Synthesis 
The reaction used either random nonamers, Oligo (dT) or specific primers to 
amplify targets from total human placental RNA (Ambion, Warrington, UK).  The 
specific primers were designed to create cDNA from 28S rRNA, ATP Synthase, 
glyceraldehydes-3P dehydrogenase (GAPDH) and β-2-microglobulin mRNAs.  
The reaction contained 1x optimum RT reaction buffer, 0.5mM dNTPs, 50pmol 
primer mix, RNA (100, 10, 1, 0.1, 0.01, and 0ng), and an optimum enzyme 
concentration, and the final volume made up to 20µl with nuclease-free water.  
The reaction was heated to the optimum RT reaction temperature for 30min 
followed by an enzyme denaturation step at 95ºC for 20min. 
 
qPCR 
1µl of the above template was used in a reaction with 1xMESA [no ROX] 
Mastermix, 1.5µm specific primer [either 28S, ATP Synthase, GAPDH or β-2-
microglobulin (Appendix I), and the volume made to 50µl with nuclease-free 
water.  
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 A LightCycler®480 was used with the following cycling conditions: 
94ºC 4min 
 
95ºC 3s   
60ºC 1min  45 cycles 
 
followed by a melt curve analysis from 60-95ºC at 0.04ºC/s. 
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5.3 – RESULTS 
 
Purification was not successful for the IEPs from P. mobilis, T. carboxydivorans 
and the New Zealand strain of B. stearothermophilus; therefore, no 
characterisation of these enzymes could be performed.  All the characterisation 
was carried out on the IEP from B. caldovelox and the same IEP with a C-
terminal Sac7d domain, with comparisons to each other where necessary and 
also, in some assays, comparisons to other RTs. 
 
Optimum Enzyme Level 
The purified IEP and IEP-Sac7d were stored in enzyme storage buffer at 
concentrations of 6.4mg/ml and 3mg/ml, respectively.  In order to find the 
optimum level of enzyme required, an RT-qPCR was performed with a 
proprietary RT buffer and 1:10 dilutions of the enzyme.  Once an optimum level 
was found using this dilution series, this was repeated with 1:2 dilutions of the 
enzyme and it was found that, for both IEP, 1ng of enzyme was optimal for a 
20µl RT reaction. 
 
Nuclease Assay 
Once the working concentration of the enzyme had been optimised, it was 
necessary to test for any nuclease activity that might inhibit or interfere with the 
enzyme characterisation.  It was important that the samples did not contain any 
RNase activity as this would degrade the template for the cDNA synthesis step, 
and DNase activity would interfere with both the cDNA synthesised and any 
subsequent PCR step.  1ng of the enzyme was incubated at 37ºC for 10h,  with 
RT buffer and 500ng of either MS2 RNA, lambda DNA or pET24a vector DNA 
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and the reaction electrophoresed on an agarose gel (Figure 5.1).  A control with 
no enzyme present was also run in parallel. 
 
 
Figure 5.1:  A 1.5%(w/v) agarose gel showing the results for the nuclease 
activity assay with lane 1: 1ng enzyme and lane 2: no-enzyme control (NEC). 
The results shown are for the wild-type IEP. 
 
The results for both IEP and IEP-Sac7d showed no DNase activity in the 
enzyme sample compared to the NEC.  The results initially looked as if there 
was slight RNase activity when incubating the RNA with the purified enzyme.  
However, there is some fluorescence seen in the well of the gel suggesting that 
the enzyme was binding some of the RNA and preventing it from entering the 
gel.  This was much more apparent when using higher concentrations of 
enzyme so it was concluded that no nuclease activity was present in the 
sample. 
 
Reaction Buffer Optimisation 
In order to characterise the enzymes it was important that they were being 
assayed in an optimum reaction buffer allowing their comparison to other 
optimised RTs.  This was performed using a proprietary RT buffer and altering 
 
220 
the concentration of one component at a time.  A first-strand reaction was 
performed followed by qPCR to detect the difference in the enzymatic activity.  
The optimisation was carried out on both IEP and IEP-Sac7d. 
 
Both enzymes proved to be very broad with respect to their pH preference with 
only very slight changes in activity detected across the tested pH range.  
However, it was noted that the Sac7d domain increased the requirement for 
salts in the form of ammonium sulphate and potassium sulphate.  The final 
optimised 1x reaction buffers were as follows: 
 
 IEP IEP-Sac7 
50mM Tris 
Ammonium Sulphate 
Potassium Sulphate 
Magnesium Sulphate 
DMSO 
pH8.3 
15mM 
30mM 
2mM 
2% 
pH8.3 
25mM 
80mM 
2mM 
2% 
 
Optimum Reaction Temperature 
Once the reaction buffer was optimised, it was also necessary to optimise the 
reaction temperature.  Using an RT step, with MS2 RNA as template, it was 
possible to vary the temperature of the first-strand reaction and then analyse the 
enzymes activity using qPCR.  This assay was also used to compare the IEPs 
to MMLV-RT to analyse the difference between a mesophilic RT and an RT 
isolated from a thermophilic organism. 
 
The first-strand reaction was performed at various temperatures and the qPCR 
data compared for IEP, IEP-Sac7d and MMLV-RT (Figure 5.2).  The Cq values 
can be seen in Table 5.1. 
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Figure 5.1:  qPCR data showing the activity of the IEP, IEP-Sac7d and MMLV-
RT at 42ºC(blue), 54ºC(red) and 64ºC (green).  The black line corresponds to a 
no-enzyme control (NEC). 
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Reaction 
Temperature (ºC) 
IEP  
(Cq value) 
IEP-Sac7d  
(Cq value) 
MMLV-RT  
(Cq value) 
42 16 17 11 
54 14 15 16 
64 17 19 24 
NEC 36 36 36 
 
Table 5.1:  A table showing the number of cycles required for the fluorescence 
to becomes significantly above the background (Cq value) using different RT 
enzymes at different reaction temperatures. 
 
Both IEPs gave very similar results, putting their optimum reaction temperature 
at 54 ºC, 12ºC higher than that recommended for MMLV-RT.  The IEP had more 
activity, as seen by an earlier Cq value, at the lower temperature range than at 
the temperature above its optimum.  The Sac7d domain did not appear to have 
a major influence on the optimum reaction temperature although Cq values 
were slightly higher at each temperature for IEP-Sac7d.  For example at 64ºC 
the Cq value for the IEP was 17 but was later at 19 cycles for IEP-Sac7d.  
Comparison of MMLV-RT with the IEPs revealed that increasing the 
temperature above the optimum has more of a detrimental effect on the 
retroviral RT than the IEPs.  At 64ºC a Cq value of 24 cycles was detected for 
MMLV-RT, compared to 16 cycles seen when using the IEP. 
 
Higher cDNA Synthesis Reaction Temperatures 
An additional test was carried out to measure the activity of the RT enzymes, 
both MMLV-RT and IEPs, at reaction temperatures higher than their optima.  
The RT step was performed at increasingly higher temperatures, with MS2 RNA 
as the template, and the enzyme activity analysed using qPCR (Figure 5.3 and 
Table 5.2). 
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Figure 5.3:  qPCR data showing the result of increasing high temperature for 
cDNA synthesis with IEP, IEP-Sac7d and MMLV-RT.  The black line 
corresponds to an NEC. 
 
 
Reaction 
Temperature (ºC) 
IEP  
(Cq value) 
IEP-Sac7d  
(Cq value) 
MMLV-RT  
(Cq value) 
66 19 19 23 
76 21 21 27 
NEC 37 37 37 
 
Table 5.2:  A table showing the number of cycles required for the fluorescence 
to becomes significantly above the background (Cq value) using the different RT 
enzymes at different reaction temperatures. 
 
The two reaction temperatures shown on these qPCR data are higher than the 
optimum reaction temperature of all three enzymes.  The IEP and IEP-Sac7d 
both perform very similarly to each other at 66ºC and at 76ºC, with the Sac7d 
domain appearing to have no effect on the enzymatic activity at these 
temperatures.  MMLV-RT, however, is more affected by the increasing 
temperature and this can be seen in two ways from these graphs.  Firstly, the 
enzyme is less active at 66ºC than the IEPs at 76ºC.  This can be seen by the 
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measured Cq value of 23 cycles for MMLV-RT at 66ºC compared to a Cq value 
of 21 cycles with IEP at 76ºC.  Secondly, the effect of increasing the 
temperature is greater with MMLV-RT as a 10ºC rise in reaction temperature 
results in an increase of 4 cycles required until the fluorescence is detectable 
above the background compared to an increase of only 2 cycles as seen with 
the IEPs.   
 
The difference in the two enzymes activities can be seen more clearly on this 
second qPCR data graph (Figure 5.4). 
 
 
Figure 5.4:  qPCR data showing the RT activity of MMLV-RT (red) and IEP 
(blue) at 76ºC.  The black line corresponds to an NEC. 
 
Since IEP and IEP-Sac7d performed the same at this temperature only the wild-
type IEP data were included on the graph.  These data show a marked 
difference in the enzymes’ activity with a Cq value of 21 cycles for IEP 
compared to 27 cycles for MMLV-RT, indicating that the IEPs have a much 
greater RT activity at 76ºC than MMLV-RT.  
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Ion Usage 
Normally, retroviral RTs require either Mn2+ or Mg2+ ions for optimum activity 
and an assay was carried out to analyse how broad or specific the IEPs were in 
terms of their preferred source of divalent cations.  The optimum buffer used 
had MgSO4 removed and this was replaced with increasing concentrations of 
one of the following: 
(a)  MgCl2 
(c)  MgSO4 
(e)  MnCl2 
(g)  ZnSO4 
(b)  CoSO4 
(d)  CaCl2 
(f)   NiCl2 
(h)  CuCl2 
 
2µl of the cDNA synthesis step was then used in a 50µl PCR with 30 cycles 
performed and 10µl electrophoresed on an agarose gel (Figure 5.5). 
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Figure 5.5:  A 2.5% agarose gel showing the amplification of cDNA produced by 
the IEP with increasing concentrations of varying divalent cation sources.  C 
corresponds to an NEC. 
 
MgCl2 and MgSO4 were acting as controls and no variations in enzymatic 
activity were detected.  After Mg2+ the RTs next preferential ion was Co2+, at low 
concentrations, followed by Mn2+ at higher concentrations and then, to a lesser 
extent, the lower concentrations of Ni2+.  There was also low level activity 
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detected when 1-2mM Zn2+ was supplied.  There did not appear to be any 
activity when Ca2+ and Cu2+ were the divalent cation source. 
 
To test whether this was a true reflection of the divalent cations used by the RT, 
and not a result of inhibition of the PCR step, the 10mM divalent cation cDNA 
synthesis reaction was added to a known working PCR to amplify a 500bp 
fragment from lambda DNA (Figure 5.6).  The final concentration of each ion in 
the sample corresponded to 0.4mM, the maximum that would be found in the 
previous assay. 
 
 
Figure 5.6:  A 1%(w/v) agarose gel showing the effect, on a 500bp lambda PCR, 
of the addition of 0.4mM divalent cations from a first-strand cDNA synthesis 
reaction.  C1 contained cDNA synthesis reaction with 0mM divalent cation and 
C2 was a standard 500bp PCR sample with no first-strand reaction added. 
 
The two controls showed the same level of amplification, so that it was clear any 
differences observed in the test was due to ion concentration and not due to 
interference from a separate component from the cDNA synthesis reaction.  
0.4mM MgCl2, MgSO4 and MnCl2 appeared to have no effect on the 500bp 
lambda PCR.  CoSO4 and NiCl2 were showing a partial inhibitory affect, while 
CaCl2, CuCl2 and ZnSO4 were completely inhibitory to the PCR.  Therefore, the 
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results seen with these ions on the RT step could be due to the inhibitory affect 
on PCR rather than the RT not being able to utilise these ions.  An additional 
lambda PCR showed that diluting the ions to 0.04mM was enough to prevent 
complete inhibition of the PCR.  The RT ion usage experiment was repeated 
using those ions that inhibited the PCR with the cDNA synthesis reaction diluted 
10-fold before adding to the PCR to ensure that no more than 0.04mM of the 
ions were carried over to the PCR step (Figure 5.7). 
 
 
Figure 5.7:  A 2.5% agarose gel showing the amplification of cDNA produced by 
the IEP with increasing concentrations of varying divalent cation sources.  c1 
corresponds to an NEC and c2 corresponds to a first-strand reaction carried out 
with MgSO4. 
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The results of the second ion usage assay showed that the RT could utilise Zn2+ 
at low levels before it presumably becomes inhibitory to the enzyme.  Although 
the IEP is not able to utilise Cu2+, unless specifically at 9mM, it was able to use 
Co2+, Ca2+ and Ni2+, and it is possible that the decrease in activity seen with 
increasing ion concentration is an artefact due to increasing inhibition in the 
PCR.  While these results appear that this type of RT is very broad in terms of 
its divalent cation usage, it does not appear to be uncommon for reverse 
transcriptases.  Unpublished data performed in parallel to this experiment 
revealed MMLV-RT to display a similar pattern while Filler and Lever (1997) 
reported HIV-1 RT to be capable of utilising a range of different cations with Mg, 
Mn, Cu and Co all being utilised by the enzyme with differing efficiencies. 
 
Thermostability 
To test the thermostability of the IEPs compared to MMLV-RT, the enzymes 
were heated, in their reaction buffer, at 60ºC for various time intervals before 
primers were added to allow cDNA synthesis to take place.  The cDNA 
synthesis step was carried out at each enzymes optimum reaction conditions for 
30min and then analysed using qPCR. 
 
Initially, the 60ºC incubation step was carried out with no RNA present to avoid 
the effect of RNA degradation at the higher temperatures (Figure 5.8 and Table 
5.3). 
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Figure 5.8:  qPCR data showing the result of cDNA synthesis once the IEP had 
been incubated for set time intervals at 60ºC. 
 
Incubation 
Time (min) 
Cq value 
0 15 
5 27 
30 30 
90 32 
NEC 36 
 
Table 5.3:  A table showing the Cq values for an RT reaction with IEP after 
incubation at set times at 60ºC.  No RNA was present in the incubation prior to 
the cDNA synthesis reaction. 
 
The initial results of thermostability seemed to show a large decrease in 
enzymatic activity even after just 5min at 60ºC.  This was indicated by a 
decrease in Cq value from 15 cycles with no incubation to 27 cycles after 5min.  
This was unexpected as the IEP had been isolated from B. caldovelox with an 
optimum growth temperature of 70ºC.  Further decrease in activity could be 
seen with increasing length of incubation at 60ºC.   
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It was decided to repeat the experiment in the presence of RNA to see if it 
would act to stabilise the enzyme during the incubation step.  The experiment 
was repeated both with template MS2 RNA as well as yeast tRNA (Figure 5.9 
and Table 5.4). 
 
 
Figure 5.9:  qPCR data showing the enzymatic activity of the IEP after 5min and 
90min at 60ºC with and without the presence of RNA. 
 
Incubation 
Time (min) 
MS2 RNA 
(Cq value) 
Yeast tRNA 
(Cq value) 
No RNA 
(Cq value) 
NEC 
(Cq value) 
5 17 22 31 37 
90 19 27 33 37 
 
Table 5.4:  A table showing the Cq values for an RT reaction using IEP after 
incubation of the enzyme for 5 and 90min at 60ºC in the presence of either MS2 
RNA, yeast tRNA or no RNA. 
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The results showed that the RT reaction was stabilised by MS2 RNA with a Cq 
value of 17 cycles compared to that of 31 cycles when no RNA was present.  
The yeast tRNA also prevented reduction in enzymatic activity; however, the 
MS2 RNA seemed to have a greater stabilising effect on the RT.  Since MS2 
RNA stabilised the RT better than yeast tRNA and, due to the absence of 
primers during the incubation step, no cDNA synthesis could occur during the 
60ºC incubation, the additional experiments were carried out in the presence of 
MS2 RNA.  
 
MMLV-RT, IEP and IEP-Sac7d were all incubated in a cDNA synthesis reaction 
buffer, in the absence of primer, at 60ºC for varying time intervals.  As before, 
primer was added and the first-strand reaction carried out at the RTs optimum 
reaction temperature for 30min followed by a 20min 95ºC heat denaturation 
step.  The cDNA synthesis reaction was then analysed using qPCR (Figure 5.10 
and Table 5.5). 
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Figure 5.10:  qPCR data showing the effect on enzyme activity of heating 
MMLV-RT, IEP and IEP-Sac7d for various times at 60ºC before being 
used to synthesise cDNA. 
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Incubation Time 
(min) 
IEP  
(Cq value) 
IEP-Sac7d  
(Cq value) 
MMLV-RT  
(Cq value) 
0 13 13 16 
5 14 18 29 
30 17 19 30 
90 19 22 30 
NEC 37 37 37 
 
Table 5.5:  A table showing the Cq values for RT reaction using IEP, IEP-Sac7d 
and MMLV-RT after incubation at set time intervals at 60ºC prior to the cDNA 
synthesis step. 
 
The qPCR results for the 0min incubation differs from that seen in table 5.1 with 
lower Cq values being reported during this experiment.  This is most likely due 
to a different set of primers being used, as primers with a high annealing 
temperature were selected for the earlier experiment, and due to a slightly 
different experimental conditions being carried out.  Each reaction was set up at 
the same time before the 60ºC incubation occurred.  It is possible that a slight 
loss of enzyme activity or RNA degradation was seen in the 0min control as the 
reaction was stored for 90mins before cDNA synthesis was allowed to occur.  
However, each enzyme in this experiment was treated the same and therefore 
any loss of activity seen would be consistent across the experiment.   
 
The qPCR results show that the IEP’s activity seems to be less affected by 
incubating at 60ºC than MMLV-RT.  Using the IEP as the RT sees the Cq value 
increase by 1 cycle after 5min incubation; however, the Cq value for MMLV-RT 
under the same conditions increases by 13 cycles compared to no incubation.  
There is therefore a large reduction in the amount of cDNA being synthesised 
after the MMLV-RT has been incubated suggesting a loss of activity.  The loss 
of activity with increasing incubation is progressive for the IEP, but even after 
90min at 60ºC the Cq value for the IEP is at 19 cycles, lower than that seen for 
MMLV-RT after just 5min where the Cq is 29. 
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This experiment also shows that the Sac7d domain appears to be having a 
detrimental effect on the thermostability of the enzyme.  This can be seen by 
analysis of the data after 5min incubation at 60ºC.  The level of cDNA 
synthesised by the wild-type IEP was detected above the background level after 
14 cycles; however, the addition of the Sac7d domain reduces the level of 
cDNA, increasing the Cq value to 18 cycles.  The IEP-Sac7d is however still 
more thermostable than MMLV-RT and after 90min of incubation the amount of 
cDNA produced by the IEP is detectable after 22 cycles compared to 30 cycles 
for MMLV-RT.  The most thermostable of the three RTs is the wild-type IEP, 
which produces cDNA after a 90min incubation that is detectable after 19 cycles  
A control experiment was run in parallel with those mentioned here with the 
same temperature and time intervals but with no MgSO4 present in the buffer.  
The relationships and trends mentioned above were the same, suggesting that 
the decline in cDNA synthesised with increasing incubation time was due to the 
loss of enzymatic activity and not Mg2+ catalysed hydrolysis of the RNA 
template.  In addition, another experiment included 10µg BSA but no 
enhancement of enzymatic activity or reductions in the loss of activity were 
seen.  
 
Fidelity Assay 
To test the fidelity of the polymerases it was necessary to create two plasmids.  
The first plasmid, pCR®2.1_lacIq would contain the lacIq gene cloned into 
pCR®2.1.  The T7 promoter site within pCR®2.1 would allow the production of 
lacIq RNA to serve as a template for cDNA synthesis by the RTs.  The second 
plasmid, pUC19_sacB, would contain the B. subtilis sacB gene, which would 
prove lethal when E. coli containing this construct was grown on LB containing 
10%(w/v) sucrose. 
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Creating pCR®2.1_lacIq Vector 
The lacIq gene was amplified using Phusion® DNA polymerase, pTTQ18NHK 
vector as template and primers designed to introduce Sac II sites at either end 
of the gene.  Analysis on an agarose gel revealed a PCR product of 
approximately the correct size of 1298bp (Figure 5.11). 
 
Figure 5.11:  A 1%(w/v) agarose gel showing LacIq gene amplified from 
pTTQ18NHK. 
 
The amplified gene was purified and A-tailed to allow TA cloning into pCR®2.1.  
Blue-white screening on IPTG and X-Gal plates allowed the selection of positive 
colonies.  These colonies were used to inoculate 5ml LB (with kanamycin) and 
grown overnight; the plasmid was then extracted using a Promega mini-prep kit.  
The plasmid DNA was sequenced using the ABI3100 protocol as it was 
essential that no errors were present in lacIq. 
 
Creating pUC19_sacB 
sacB was amplified from pET24a_sacB using Phusion® DNA polymerase and 
primers designed to incorporate Aat II sites at either end of the gene.  Analysis 
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on an agarose gel revealed a product approximately the correct size (1916bp) 
had been amplified (Figure 5.12). 
 
 
 
Figure 5.12:  A 1%(w/v) agarose gel showing SacB amplified from 
pET24a_sacB 
 
The purified sacB was digested with Aat II and ligated into pUC19 digested with 
the same enzyme.  This construct was then transformed into TOP10 and plated 
onto LB agar plates containing methicillin and ampicillin.  To ensure that 
sucrose lethality had been established, colonies were cross gridded onto plates 
that contained an additional 10%(w/v) sucrose.  Colonies that would not grow on 
the sucrose plates were considered as positive for containing the sacB gene 
and were grown up on a 5ml scale; once their plasmids had been purified, the 
sacB gene was sequenced using the ABI3100 sequencing protocol to ensure no 
errors had been incorporated. 
 
Proof of Principle 
5ng of pCR®2.1_lacIq was amplified with Taq, Taq:Pfu and Phusion® DNA 
polymerases using the lacIq_SacII primer pair.  After 18 cycles, 5µl was 
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electrophoresed on an agarose gel with 0.5µg 2-log ladder to allow an 
estimation of the total yield (Figure 5.13). 
 
 
Figure 5.13:  A 1%(w/v) agarose gel showing LacIq amplification with lane 1: 
Taq DNA polymerase, lane 2: Taq:Pfu (20:1) DNA polymerase mix and lane 3: 
Phusion® DNA polymerase 
 
The purified lacIq was digested with Sac II and ligated into pUC19_sacB 
digested with the same enzyme.  This would allow the insertion of lacIq into 
sacB interrupting the gene, thereby preventing lethality when grown on sucrose 
plates.  This ensured that only constructs containing lacIq would survive and 
therefore preventing a false background of blue colonies.  The ligation 
constructs were transformed into electrocompetent TOP10 and plated on LB 
agar with antibiotic, X-Gal and sucrose.  A control ligation containing just 
digested plasmid and no insert was also set up and transformed.  No colonies 
appeared on the sucrose plates where no lacIq insert was provided in the 
ligation, which confirmed the success of the sucrose lethality gene and allowed 
the blue:white colony ratio to be an accurate representation of lacIq mutations.  
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Errors causing disruption of lacIq would lead to a LacI- phenotype and yield blue 
colonies on the X-Gal plates.  The error rate was calculated with the equation  
f = (-InF / d) x 349 (Frey and Suppmann, 1995) as detailed in the introduction to 
this chapter.  Table 5.6 shows the results of this proof of principle experiment 
and, as expected, the Taq polymerase had the highest error rate at 2.66x10-4, 
followed by the Taq:Pfu polymerase mix where the Pfu was providing some 
proof-reading and therefore reduced the error rate to 1.26X10-4.  Phusion® had 
the lowest error rate of 8.28x10-5 which was expected as Phusion® is marketed 
as a high-fidelity DNA polymerase. The error rates seen within this table are 
however higher than that reported for these enzymes.  Finnzymes report 
Phusion to have a fidelity of 4.4x10-7 and Taq to have a fidelity of 2.28x10-5.  
This discrepancy with error rate is quite large and possible due to a difference in 
the method used to measure fidelity.  However, the general trend is as expected 
with the system capable of detecting differences between the DNA polymerases 
allowing a comparison of the fidelity of these enzymes. 
 
Enzyme Starting 
template 
(ng) 
Yield 
(ng) 
Duplications White 
colonies 
Total 
colonies 
Fraction 
of white 
colonies 
Calculated 
error rate 
(per bp) 
Taq 5 250 5.64 4721 7967 0.5926 2.66x10-4 
Taq:Pfu 5 1000 7.64 6916 6988 0.7139 1.26x10-4 
Phusion® 5 4000 9.64 1261 1666 0.7569 8.28x10-5 
 
Table 5.6:  The results of the proof of principle fidelity assay carried out on 
various DNA polymerases. 
 
RT Fidelity 
This system was adapted to be used to measure the fidelity of the various RTs 
studied in this report with potential problems being assessed and attempts 
made to reduce them.  One problem incurred by this system stems from the fact 
that the T7 RNA polymerase could generate errors when generating the lacIq 
RNA template; however, all the RTs would be using the same concentration of 
template from the same reaction and therefore should have an identical 
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baseline of errors.  Additionally, the PCR step, after the cDNA synthesis, would 
introduce errors that could be magnified if more template was supplied from one 
RT than from another.  It was therefore important to find the level of cDNA from 
each RT reaction by using a dilution series, to ensure the same concentration 
was amplified by the polymerase.  It was also necessary to use a high-fidelity 
DNA polymerase, such as Phusion®, to minimise errors during this step. 
 
The pCR®2.1_lacIq vector was initially linearised with Bgl II before creating RNA 
using a T7 RNA polymerase.  The reaction was treated with DNase I to ensure 
all template DNA had been removed and, once the DNase I had been heat-
inactivated, a test PCR was carried out to confirm that no DNA remained in the 
RNA template sample.  50ng of the RNA was used in a first-strand reaction with 
AMV-RT, MMLV-RT, IEP and IEP-Sac7d for 30min at the optimum temperature, 
and then the reactions were heated to 95ºC for 20min to inactivate the RTs.  
PCRs were carried out on a dilution series of the cDNA template generated by 
each RT to ensure that the same amount of template would be amplified by the 
DNA polymerase, thereby reducing the effect of incorporated errors from the 
PCR.  Once the same concentration had been established, the lacIq was 
amplified from each cDNA template, purified and digested with Sac II.  The 
digested fragment was then ligated into the sacB gene of pUC19sacB.  
Successful ligations would interrupt the sacB gene, allowing the colonies to 
survive when plated on LB containing 10%(w/v) sucrose.  The constructs were 
transformed into electrocompetent TOP10 and plated on LB with antibiotic, 
sucrose and X-Gal and, after 24h at 37ºC, the number of blue and white 
colonies could be counted. 
 
Since there are several steps during this experiment that, while they should be 
consistent in all the RTs tested, will add to the number of mutations, it was not 
possible to assign an accurate error rate for individual enzymes.  However, the 
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percentage of white colonies could be calculated, allowing the RTs to be 
compared to each other.  Table 5.7 shows the results of the fidelity assay. 
Enzyme Blue colonies White colonies Total colonies  White colonies 
(%) 
AMV-RT 2490 4566 7056 64 
MMLV-RT 947 1612 2559 65 
IEP 2149 2825 4974 57 
IEP-Sac7 3023 2913 5939 49 
 
Table 5.7:  Results of the fidelity assay when carried out on RTs using 
pCR®2.1_lacIq as the RNA template. 
 
The results show that the percentage of white colonies found in AMV-RT and 
MMLV-RT were very similar at 64% and 65%, respectively.  However, the 
fidelity of the IEP and the IEP-Sac7d seems to be lower with 57% white colonies 
seen with IEP and 49% with IEP-Sac7d.  The IEP is therefore not as accurate 
as the retroviral RTs with the Sac7d domain appearing to have an additional 
detrimental effect on the fidelity.  
 
DNA-Dependent DNA Polymerase Activity 
Retroviral RTs are known to show DNA-dependent DNA polymerase activity 
allowing them to convert their RNA genome into dsDNA.  A FAM-labelled primer 
was used with a ssDNA template, M13mp8, and an extension event from the 
primer was measured using GeneScan software of an ABI3100 sequencer.  A 
size standard GeneScan™ 350 ROX™ was used to allow accurate sizing of the 
extension products.  As a positive control a known DNA-dependent DNA 
polymerase, Taq, was used to ensure that the system was working and that 
extension of the primer could be recorded.  The result using 0.3125U of Taq 
was analysed using ABI Peak Scanner software where each peak represented 
a single extension product (Figure 5.14). 
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Figure 5.14:  Processivity analysis of 0.3125U of Taq used to extend from a 
FAM-labelled primer annealed to M13mp8. 
 
The initial part of the trace shows a peak at 23bp, which represents the FAM-
labelled primer that has not been extended.  When calculating the average size 
of the extension product it was important to omit this 23bp primer product from 
the final figure.  From these results it was concluded that 0.3125U of Taq, one 
quarter of the amount that would normally be used in a PCR, extends on 
average 82 bases in 5min with a maximum extension event recorded of 179 
bases. 
 
It was important to run a negative-control with no enzyme to assess the base 
line that would be seen on a trace when no extension event occurs (Figure 
5.15). 
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Figure 5.15:  Processivity trace of the DNA-dependent DNA polymerase assay 
with no enzyme. 
 
The major peak seen on the NEC represents the un-extended FAM-labelled 
primer and no significant extension products could be detected after this peak.  
The peak seen at 22bp is most likely due to the detection of a low level of 
incomplete primer synthesis with the loss of a base at the 3’ end of the primer. 
 
The experiment was repeated with AMV-RT.  Since the retroviral RTs have low 
level DNA-dependent DNA polymerase activity, the reaction was carried out for 
30min to ensure that a measurable extension event could occur (Figure 5.16). 
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Figure 5.16:  Processivity analysis of AMV-RT extending from a 23bp FAM-
labelled primer for 30min using M13mp8 template. 
 
The results of AMV-RT clearly show extension events after the 23 base primer 
peak.  The 30min reaction showed that AMV-RT will extend, on average, 50 
bases from the primer, with the maximum product detected at 135 bases. 
 
The experiment was also repeated for MMLV-RT with a 30min extension time 
(Figure 5.17). 
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Figure 5.17:  Processivity analysis of MMLV-RT extending from a 23bp FAM-
labelled primer for 30min using M13mp8 template. 
 
MMLV-RT showed less DNA-dependent DNA polymerase activity than AMV-RT 
and, although a maximum extension product was detected at 303 bases (not 
seen on the above graph), the average size product was 16 bases after a 30min 
extension time. 
 
The experiment was repeated for both IEP and IEP-Sac7d with a 30min 
extension time (Figure 5.18 and Figure 5.19). 
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Figure 5.18:  Processivity analysis of B. caldovelox IEP extending from a 23 
base FAM-labelled primer for 30min using M13mp8 template. 
 
Figure 5.19:  Processivity analysis of IEP-Sac7d extending from a 23 base 
FAM-labelled primer for 30min using M13mp8 template. 
 
Both the IEP and IEP-Sac7d had profiles the same as that seen for the NEC 
and no significant peak could be detected after the 23 base primer.  This 
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suggested that the IEPs, unlike retroviral RTs, do not exhibit DNA-dependent 
DNA polymerase activity. 
 
RNA-Dependent DNA Polymerase Activity – Processivity 
The DNA-dependent DNA polymerase assay was altered to allow the detection 
of cDNA extension products from an MS2 RNA template.  The processivity can 
be calculated after repeated experiments altering both extension time and 
enzyme concentration until the median product length no longer changes (Wang 
et al. 2004).  This allows the detection of a single enzymatic event and therefore 
would allow a comparison of processivity of IEP to retroviral RTs and to assess 
whether the Sac7d domain was improving the processivity of the IEP. 
 
Initially, the experiment was set up using MMLV-RT as a control with an MS2 
FAM-labelled primer, keeping all conditions the same as for the DNA-dependent 
DNA polymerase activity assay.  However, no extension event could be 
detected on the trace.  The experiment was repeated in several ways to include 
an experiment with: 
• No primer annealing step in case the high 95ºC was degrading the RNA 
template. 
• A primer-template annealing step with no magnesium present to reduce 
the likelihood of magnesium-catalysed RNA hydrolysis at the high initial 
primer annealing step 
These attempts also failed to give any detectable extension product. 
 
To ensure that the FAM-labelled primer was not interfering with the cDNA 
synthesis step, it was used in a standard first-strand reaction and then any 
cDNA produced was amplified using PCR.  A correct sized product could be 
 
248 
detected both with the FAM-labelled primer and the same primer with no label 
suggesting that the primer was not inhibitory in any way.  These PCR products 
were also electrophoresed on an agarose gel that was not stained with ethidium 
bromide and, using a dark reader, fluorescence was detected where the FAM-
labelled primer was used, suggesting that this primer was correctly labelled so 
therefore should be detected by the sequencer. 
 
Alternative attempts were made to include different purification methods with 
passing the reactions through a G-50 column instead of ethanol precipitation, 
but again no extension was detected.  Additional attempts then included altering 
concentrations of the RNA template, both more dilute and more concentrated, 
different enzyme dilutions and altering incubation times.  All failed to extend 
from the 24 base FAM-labelled primer. 
 
No further attempts were made and this assay was not used to assess 
processivity of the RTs. 
 
Basic processivity 
Since the primer extension assay failed to produce processivity results, a more 
basic assay had to be developed.  One feature of incorporating more bases in a 
single enzymatic event can be a faster enzyme due to the reduction in the 
occurrence of dissociation and reassociation of enzyme to the template.  This 
was tested by incubating the IEPs at different time intervals and then using PCR 
to detect the length of product produced.  Two different size products were 
amplified, a 1552bp (Figure 5.20) and 3407bp (Figure 5.21). 
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Figure 5.20:  Results of the processivity assay of a) IEP and b) IEP-Sac7d when 
incubated with template for different time intervals and a 1552bp product 
amplified using PCR 
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Figure 5.21:  Results of the processivity assay of a) IEP and b) IEP-Sac7d when 
incubated with template for different time intervals and a 3407bp product 
amplified using PCR 
 
Both enzymes required 4min to synthesise a target of 1552bp as detected by 
PCR and both required 10min to synthesise cDNA of 3407bp in length.  The C-
terminal Sac7d domain therefore does not seem to have any influence on the 
processivity of the enzyme during this assay as it is not synthesising the target 
in a reduced time.  There is a possibility that the Sac7d is having a detrimental 
effect on the processivity of the enzyme as, when synthesising a 3407bp 
product, there is a very low level of full-length template detectable after 8min 
with the IEP that is not detectable with IEP-Sac7d.  This basic processivity 
assay is therefore offering preliminary data suggesting that a C-terminal Sac7d 
domain will not enhance the enzyme.  
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Complex Target Assay 
All the assays so far have been performed on basic MS2 RNA template, and 
therefore an additional assay was set up using total human placental RNA.  A 
dilution series was set up of total human placental RNA and, using random 
nonamers, a cDNA synthesis step was carried out for 30min at 54ºC and 42ºC 
for IEP and MMLV-RT respectively.  The cDNA template was then analysed in a 
qPCR.  The qPCR results for 28S rRNA (Figure 5.22) showed that the IEP was 
not as efficient at producing cDNA as MMLV-RT.  At 100ng of template the 
fluorescence became detectable above the background at 4 cycles with MMLV-
RT.  However, it is not until after 13 cycles that it becomes detectable for the 
IEP. 
 
 
Figure 5.22:  qPCR data comparing MMLV-RT (blue) to IEP (red) with 28S 
cDNA created from 100ng total human placental RNA. 
 
The melt curve analysis showed that, although IEP is producing a measurable 
product that is detected much later, the product is indeed correct (Figure 5.23). 
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Figure 5.23:  Melt curve analysis of the cDNA product created by both MMLV-
RT and IEP with 100ng human RNA template and 28S primers. 
 
Both the products from MMLV-RT and IEP melt at the same temperature of 
83ºC suggesting that they are the same product despite the fact that more 
cycles are required to detect this product when an IEP is used as the RT. 
 
The other three targets, GAPDH, ATP synthase and β-2-microglobulin mRNA all 
produce the same unusual results with IEP, from which GAPDH has been 
chosen as the example.  GAPDH specific primers were used in a qPCR to 
amplify cDNA produced from a dilution series of RNA template using MMLV-RT, 
which represents what would be expected of a typical RT-qPCR.  When 
compared to IEP it is clear that the amplification product with IEP is incorrect 
with no typical dilution series being seen (Figure 5.24).   
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Figure 5.24:  qPCR results of cDNA produced by MMLV-RT and IEP from an 
RNA dilution series with the qPCR primers used to target GAPDH. 
 
The melt curve analysis of the qPCR reveal that IEP has produced an amplicon 
with a melting temperature of 76ºc compared to the correct product with an 82ºC 
melting temperature as seen with MMLV-RT (Figure 5.25).  There is a low level 
of the correct product being synthesised by IEP as seen by the small peak at 
82ºC; however, this was not the dominant amplicon of the reaction. 
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Figure 5.25:  Melt curve analysis of the cDNA synthesis product from IEP and 
MMLV-RT using 100ng RNA and primers designed to target GAPDH 
 
The experiment was repeated using random nonamers and Oligo (dT) primers 
with the reaction temperature reduced to 42ºC, eliminating the possibility of the 
primer not being able to anneal to the template.  It was also repeated both at 
42ºC and 54ºC using the specific primers in the cDNA synthesis step, but the 
same results were seen.  This suggests that the IEP is unable to use complex 
targets such as total human placental RNA to produce cDNA unless the target is 
at a high-copy number as seen with 28S rRNA.  The same results were seen 
with IEP-Sac7d, suggesting that the Sac7d domain is not enhancing the IEPs 
ability to use more complex targets.  
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5.4 – DISCUSSION 
 
Characterisation of the IEP and IEP-Sac7d was carried out.  Where necessary, 
the enzymes were compared to each other or to alternative commercially 
available retroviral RTs. 
 
A nuclease assay showed that the purified IEP and IEP-Sac7d were free of any 
contamination that would interfere with the cDNA synthesis or subsequent PCR 
steps, and a dilution series of enzyme concentration revealed 1ng to be the 
optimum level of enzyme in a 20µl RT reaction. 
 
Experiments to optimise the reaction buffers for the two IEPs revealed them to 
have no clear pH optimum with activity over the range tested.  The main 
difference seen was that the Sac7d domain increased the IEPs requirement for 
salt with the optimum level of potassium sulphate increasing from 30mM for IEP 
to 80mM for IEP-Sac7d.  This is a trend that has been observed before by 
GeneSys Ltd when using a Sac7d domain on other polymerases (unreported 
data) and it has been shown by Wang et al. (2004) that an Sso7d domain will 
actually increase a polymerase’s tolerance to higher salt.   
 
A cDNA step-temperature gradient allowed an optimum reaction temperature of 
54ºC for both enzymes to be determined.  This optimum was 12ºC higher than 
the optimum reaction temperature recommended for MMLV-RT.  While the IEPs 
could function at higher temperatures, they showed more activity at 42ºC than at 
64ºC.  Although they did have a higher optimum reaction temperature than other 
retroviral RTs, this temperature was lower than expected as the bacterium B. 
caldovelox from which they were isolated has an optimum growth temperature 
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of 70ºC.  It had therefore been expected that the RT would function at higher 
optimum temperatures than these data show.  The IEPs however do have a 
higher optimum reaction temperature than current unmodified retroviral RTs. 
 
When the IEPs were used to synthesise cDNA at temperatures higher than their 
optimum, they produced more cDNA than that seen with MMLV-RT.  Although 
activity was still recorded at 76ºC for both IEPs and MMLV-RT, the IEPs were 
more active; the activity at 76ºC for the IEPs was higher than the recorded 
activity for MMLV-RT at 66ºC. 
 
The IEPs were also tested to analyse what sources of divalent cation they could 
use for cDNA synthesis.  Out of those tested, the IEP preferentially used 
sources of Mg2+ followed by CoSO4 and then MnCl2.  Once the effect of the ions 
inhibiting the subsequent PCR was shown and reduced, additional experiments 
showed the IEPs to be able to use NiCl2 and CaCl2.  At very low levels they 
could use ZnSO4 but were unable to use CuCl2 unless concentrations were 
specifically at 9mM.  The IEPs are therefore broad in terms of divalent cation 
use. 
 
To test for thermostability the enzymes were held under reaction conditions, but 
with no primer, for different time intervals at 60ºC.  It was seen that in the 
absence of RNA the IEPS show a large loss of activity after only 5min of 
incubation.  However RNA sources such as MS2 RNA or yeast tRNA improved 
the stability of the enzymes at higher temperatures, with MS2 RNA having a 
greater stabilising effect than tRNA.  In the presence of MS2 RNA, the IEPs 
were more thermostable than MMLV-RT with more activity after 90min at 60ºC 
than MMLV-RT exhibited after just 5min.  The IEPs were therefore acting as a 
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more thermostable RT enzyme capable of withstanding high temperatures for 
longer periods than MMLV-RT. 
 
Initially, in order to test for fidelity, a proof of principle test on the DNA-
dependent DNA polymerases was carried out.  This showed that the method 
was sensitive enough to detect differences in the polymerases fidelity, showing 
that as expected Taq introduced the most errors, Taq:Pfu was slightly less error 
prone and that Phusion® DNA polymerase introduced the least errors. 
 
The system was repeated for the retroviral RTs, AMV-RT and MMLV-RT, as 
well as for IEP and IEP-Sac7d.  The error rate of the AMV-RT and MMLV-RT 
were very similar with 64% and 65% white colonies seen respectively.  
However, the error rate for the IEPs appeared to be higher with 57% and 49% 
white colonies seen.  A low fidelity rate is expected for the retroviral RTs since 
mutations can be advantageous in allowing the virus to evolve and adapt, as 
seen with the low fidelity of HIV-1 RT (Ji and Loeb.  1992). However, Ng et al. 
(2007) expected the IEPs to have some level of fidelity to reduce the likelihood 
of the intron being unable to splice from the RNA transcript and therefore prove 
deleterious to the cell. 
 
The RTs were also tested for DNA-dependent DNA polymerase activity.  It is 
known that retroviral RTs do have this activity, enabling them to produce dsDNA 
from their RNA genome (as reviewed by Herschhorn and Hizi, 2010).  Our 
results showed detectable levels of this activity using retroviral RTs, with AMV-
RT showing more activity than MMLV-RT.  Testing the IEPs, however, revealed 
them not to exhibit any detectable DNA-dependent DNA polymerase activity 
even after 30min incubation time.  This is possibly due to the fact that the intron 
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can utilise the host cell DNA polymerase to allow its re-insertion back into the 
genome and therefore does not require this activity. 
 
In order to analyse the influence of a Sac7d domain on an IEP, an assay was 
attempted to measure RNA-dependent DNA polymerase activity, specifically the 
number of nucleotides incorporated in a single enzymatic event.  Despite the 
fact that this method worked on both DNA polymerases and RTs for DNA-
dependent DNA polymerase activity and the fact that all components were 
tested for inhibitory effect, this assay did not produce detectable extension 
events.  Several variables were altered including template preparation, template 
purification, enzyme concentration, incubation times and template 
concentrations.  However, it was not possible to measure processivity using this 
assay.  A more basic assay that measured the speed of the IEP revealed no 
significant difference when a Sac7d domain was present on the IEP. 
 
The characterisation of the B. caldovelox IEP has revealed the enzyme to be 
more thermostable than unmodified MMLV-RT and that, using basic targets, is 
more efficient at temperatures above its optimum than MMLV-RT.  However, the 
enzyme is unable to synthesise cDNA efficiently when more complex templates 
are used, as seen with assays to amplify specific regions from total human 
placenta RNA.  Interestingly, unlike retroviral RTs, this IEP shows no DNA-
dependent DNA polymerase activity and due to a lack of RNase H domain 
presumably shows no RNase H, activity reflecting the difference in biological 
function of the IEP compared to the retroviral RTs.  
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Chapter 6 – Summary, Discussion and Future 
Aspects 
 
6.1 – REPORT SUMMARY 
 
This Ph.D report introduces the problems that can be incurred when using 
currently available RTs for research and diagnostic purposes.  In order to 
reduce these problems it was decided that an RT with a high optimum reaction 
temperature would be required.   A search for thermophilic RTs was carried out 
from both un-sequenced environmental bacteria and by carrying out BLAST 
searches against available genome sequences from thermophiles.  Using this 
method several previously uncharacterised RTs, from IEP within Group II 
Introns, were discovered.  These included IEPs from B. caldovelox and B. 
caldotenax, which were identical in gene sequence, one from a New Zealand 
strain of B. stearothermophilus, one from T. carboxydivorans and three almost 
identical IEPs from P.  mobilis.   
 
The cloning of these genes followed by their protein expression was 
successfully carried out and a manipulation of the B. caldovelox IEP was made 
with the fusion of a Sac7d domain on the C-terminal of the protein.  Purification 
of these proteins proved to be very difficult as the enzyme co-purified with many 
protein contaminants or the removal of nucleic acids causing protein insolubility.  
Despite using an extensive range of methods to purify the IEP from T. 
carboxydivorans and one of the IEPs from P. mobilis, a pure protein sample was 
never obtained.  However, both partially purified enzymes were shown to exhibit 
RT activity using MS2 RNA as a template. 
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The IEP from B. caldovelox and the IEP-Sac7d fusion protein were successfully 
purified and characterisation studies were carried out.  Both enzymes were 
shown to have an optimum reaction temperature at 54ºC.  This optimum 
temperature was 12ºC higher than the recommended optimum reaction 
temperature of MMLV-RT.  The RTs could also synthesise cDNA at 
temperatures higher than their optimum with greater efficiency than MMLV-RT, 
with activity still being seen at 76ºC.  This higher reaction temperature is 
potentially very useful in situations where mesophilic RTs have struggled to 
synthesise cDNA from targets with a high degree of secondary structure.   
 
Retroviral RTs also display DNA-dependent DNA polymerase and RNase H 
activity, which are required as part of their retroviral lifecycle.  The lack of an 
RNase H domain on the IEPs suggests that no RNA degradation would occur 
within an RNA:DNA hybrid.  This is an advantage that would prevent cleavage 
of the RNA template and therefore reduce truncated products in the final cDNA 
yield.  The DNA-dependent DNA polymerase assay revealed a complete 
absence of this activity within the IEPs, reflecting the difference in their lifecycle 
compared to the retroviral RTs. 
 
The wild-type B. caldovelox IEP was compared to IEP-Sac7d to see if there was 
any enhancement in the processivity of the enzyme with the addition of the 
Sac7d domain.  However, the sensitive assay used to detect DNA-dependent 
DNA polymerase activity was unsuccessful when using RNA, with several 
different approaches failing to detect an extension product.  A more basic 
processivity assay showed that the Sac7d domain appeared to have no 
enhancement on the speed of the enzyme.  As a further disadvantage, this 
additional domain also appeared to lower the thermostability of the enzyme with 
a slight reduction in activity seen on qPCR data with increasing reaction 
temperatures. 
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Although the B. caldovelox IEP has potential as a thermophilic RT enzyme a 
major problem was seen when challenging the enzymes with low-copy targets 
and complex templates in the form of human placental RNA.  The IEPs were 
incapable of producing correct cDNA under several different conditions where 
MMLV-RT was successful.  
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6.2 – DISCUSSION AND FUTURE ASPECTS 
 
Optimum Reaction Temperature 
The studied IEP of B. caldovelox had a higher optimum reaction temperature 
than wild-type retroviral RTs.  However, at 54ºC this optimum reaction 
temperature was at least 16ºC lower than expected.  The growth temperature of 
the bacterium is 70ºC, and as a general rule enzymes are usually adapted to be 
functioning optimally in a range close to or slightly above that of the growth 
conditions of the source organism (Hough and Danson, 1999).  The IEPs from 
B. caldovelox, B. caldotenax and G. kaustophilus were all identical and it is 
possible that, due to the mobile nature of Group II Introns, these IEPs were 
originally from a bacterium that grew at lower temperatures.  These thermophilic 
bacteria could have acquired the Group II Intron, containing the IEP, from this 
mesophilic bacterium.  Even if the IEP was not functional at their growth 
temperatures, the Group II Intron would not prove deleterious to the host 
providing that the intron was still capable of auto-splicing from RNA transcripts.  
With no known advantage to the host, there would be no pressure on the IEP to 
adapt to the higher temperature and it therefore would not necessarily be a 
thermostable enzyme. 
 
Improving B. caldovelox IEP Performance 
The IEP from B. caldovelox looks disappointing in terms of its potential for 
commercial use as an RT.  Chapter 5 highlighted the fact that this IEP has 
difficulties using complex RNA templates.  More research needs to be carried 
out on the IEP to detect the reason for the poor performance on these 
templates.  Several factors could be influencing the IEP during these 
experiments, including: 
• The IEP may not be sensitive enough to detect low-copy RNAs or these 
low-copy RNAs are destroyed during the higher reaction temperature 
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• There is a possibility that a low level of E. coli RNA is still present in the 
sample.  This low level of RNA could be providing a non-specific target 
during cDNA synthesis, which is why a standard template dilution series 
cannot be detected.  Running a no-template control with the enzyme and 
using E. coli specific primers could indicate if this was the case. 
• Although 1ng of enzyme is required for the basic MS2 RNA template, a 
much larger quantity might be optimum for a more difficult and complex 
target.  Altering reaction component concentrations may see an 
improvement in the performance of this enzyme. 
 
Fidelity 
Unlike retroviruses, the Group II Introns do not need to evade the immune 
system of a eukaryotic host and therefore do not have this pressure to 
constantly mutate and evolve.  It was expected that the Group II Intron would 
require a high-fidelity RT to reduce the likelihood of a mutation occurring that 
could prevent the auto-splicing of the intron from an RNA transcript.  If the intron 
permanently interrupted an essential host gene then this could prove deleterious 
or possibly lethal to the host.  It was a surprise to find that the error rate of the B. 
caldovelox IEPs were in fact lower than that seen for both AMV-RT and MMLV-
RT (chapter 5).  This lower fidelity would be problematic where an exact copy of 
the mRNA transcript is required for research such as sequencing or molecular 
cloning, and therefore poses a huge disadvantage to the use of these RTs in the 
place of current retroviral RTs. 
 
 
Characterisation of Alternative IEP 
More promising thermophilic RTs could still be found in the IEPs of T. 
carboxydivorans and P. mobilis.  Although these partially purified proteins were 
shown to exhibit RT activity, they were not analysed in terms of their optimum 
reaction temperature or thermostability due to the impurity of the sample.  It is 
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possible that these enzymes could have a higher optimum reaction temperature 
than the IEPs studied so far, and therefore the complete purification of these 
proteins is essential to continue the research on these types of RTs. 
 
Alternative Purification Methods 
A major limitation in the purification of some of the IEPs appears to be related to 
their tight association with nucleic acids.  An experiment carried out during the 
purification process showed that the T. carboxydivorans protein was associating 
specifically with RNA and not DNA (Chapter 4).  This can be expected as with 
an absence of DNA-dependent DNA polymerase activity the protein has no 
requirement for binding DNA.  A method to efficiently remove this RNA 
contamination is required, possibly by using RNase immobilised on a column.  
However, it would be essential that the column was in no way ‘leaky’ 
contaminating the protein sample with RNases that would inhibit subsequent 
reactions by cleaving the RNA template.  
 
Completely removing nucleic acids from the sample might prove impossible.  It 
could be that nucleic acids are essential for the stability of these enzymes.  As 
seen in Chapter 5, the absence of RNA during a 60ºC incubation step resulted 
in a marked decrease in enzymatic activity compared to the same experiment in 
the presence of RNA.  The RNA is clearly having an effect on the enzyme, 
causing it to be more stable at higher temperatures, and could be required for 
the other IEPs that were attempted to be purified to ensure they remain soluble.  
In chapter 4 it was found that in partially pure samples of T. carboxydivorans 
IEP, in the absence of nucleic acids, insoluble material formed and RT activity 
could no longer be detected.  This would be a great limitation to the purification 
of these enzymes as it is essential that background nucleic acids are removed 
to avoid contamination of downstream applications. 
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Processivity Studies 
Processivity was also explored during this report.  Having a more processive 
enzyme could reduce reaction times at the high temperatures, therefore 
minimising metal ion catalysed hydrolysis of the mRNA template (Das et al. 
2001).  Furthermore, a tighter association with the template by means of 
attaching a tethering protein to the template could reduce complete dissociation 
of the enzyme, so reducing the level of truncated products in the final yield. 
Sso7d is a DNA-binding protein that has been shown to improve processivity of 
DNA-dependent DNA polymerases, presumably by tethering the protein to the 
DNA strand and reducing the occurrence of dissociation events (Wang et al. 
2004).  Preliminary results on the Sac7d domain fused to the IEP showed no 
apparent enhancement of the enzyme in terms of its processivity.  In Nature the 
Sac7d domain would bind dsDNA and is possibly not able to have the same 
tethering affect, seen with DNA polymerases, due to the RNA template and the 
RNA:DNA hybrid constructs.   
 
It is possible that a less specific molecule would be needed to improve the 
processivity of these types of polymerases.  Thioredoxin, for example is an 
alternative protein that is thought to act as a clamp once it has bound the 
polymerase (Bedford et al. 1997).  This protein has no natural affinity for DNA 
and this lack of specificity could allow the method to be extended to RTs, 
enabling the enzyme to produce longer length cDNA during a single enzymatic 
event.  
 
Another alternative enhancement factor for RTs might be found in the form of 
bacterial ssDNA-binding proteins (SSB) instead of the dsDNA-binding protein, 
Sac7d, which has been studied in this report.    Their role in Nature is thought to 
be to protect DNA where the double-stranded structure has been disrupted 
(Perales et al. 2003).  The Thermus thermophilus SSB (TthSSB) was studied by 
Perales et al. (2003) as a possible method to enhance PCR.  This group found 
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that the TthSSB protein not only halved elongation time for Tth and Pfu DNA 
polymerases, but that it also had an additional effect of increasing the fidelity of 
Tth DNA polymerase.  Their results then went on to show that the TthSSB 
protein could also interact with RNA and greatly enhanced the RT activity of the 
Tth DNA polymerase allowing the production of cDNA, detected by PCR, up to 
3285 bases in length, which could not be achieved in the absence of TthSSB.  
SSBs therefore have a potential role in improving processivity of RT-PCR when 
added during the cDNA synthesis step.  The affect of enhanced fidelity on RT 
activity is yet to be studied. 
 
Effect of Template Related RT Pausing 
The IEP from B. caldovelox has yet to be tested for dissociation at sites of 
secondary structure, partly due to the failure of the processivity assay.  Once 
this assay is functional it could be adapted to use a FAM-labelled primer and an 
RNA template with known secondary structure to detect whether dissociation 
events are common at this site.  Frequently occurring dissociation events at a 
specific site will result in the accumulation of known sized products that can be 
detected and recorded as a major peak using the ABI3100 Gene Scanner 
programme and Peak Scanner Software.  Comparisons can be made with 
retroviral RTs and with increasing reaction temperatures to see if a thermostable 
enzyme will allow the reduction or elimination of these dissociation events.  
 
 
Alternative Characterisation 
Currently there is limited information as to the exact structural nature of the IEP 
from a Group II Intron.  Blocker et al. (2005) compared a theoretical secondary 
structure of the LtrA protein encoded by the Lactobacillus lactis LI.LtrB Group II 
Intron and predicated the protein to form a homodimer.  However, even among 
related RTs such as those from retroviruses the structures can differ, with 
MMLV-RT forming a monomer and AMV-RT forming a heterodimer.  
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Techniques such as gel filtration will allow an estimation of the Mr value of the 
protein and therefore elucidation of the basic protein conformation by means of 
its oligomeric state while X-ray crystallographic studies could provide more 
detail into the protein structure as well as protein-template interactions and 
possibly structural roles of the additional protein domains found at the C-
terminus of the protein. 
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APPENDIX 
 
 
I – Primers  
 
16s Primers 
27F:    5’ aga gtt tga tcm tgg ctc ag 3’ 
1429R:   5’ tac ggy tac ctt gtt acg act t 3’ 
 
CODEHOP primers 
RTF1:   5’ cac aaa act gag gaa ggn can ccn car gg 3’ 
RTF2:   5’ cac aaa act gag gaa ggn gtn ccn car gg 3’ 
RTR1:   5’ gac ggt gat tac gaa rtc rtc cgc rat 3’ 
 
Screening primers 
pCR®2.1 and pUC screening primers 
M13 forward:  5’ AGC GGA TAA CAA TTT CAC ACA GGA 3’ 
M13 Reverse: 5’ GCG GTC CCA AAA GGG TCA GTG CTG 3’ 
 
pET vector screening primers 
T7 Promoter:  5’ AAA TTA ATA CGA CTC ACT ATA GGG 3’ 
T7 Terminator: 5’ GCT AGT TAT TGC TCA GCG G 3’ 
 
pUC19 screening primers 
pUC19_F_Screen:  5’ atg ttg aat act cat act ctt cct 3’ 
pUC19_R_Screen:  5’ tta cag aca agc tgt gac cg 3’ 
 
Gene-Walking primers – B. caldovelox 
B.cv_GW1_NterR_nest: 5’ gtg gac tga gcg gcc c 3’ 
B.cv_GW1_NterR:  5’ cag gag aat gtt gga cag g 3’ 
B.cv_GW1_CterF:  5’ gag ctg gac aaa gaa ttg g 3’ 
B.cv_GW1_CterF_Nest: 5’ aac gag ggc aca agt ttg 3’ 
 
 
Gene-Walking Primers – B. caldotenax 
B.ctnx_GW1_NterR_Nest: 5’ cag cag cgg tga gag tat G 3’ 
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B.ctnx_GW1_NterR: 5’ acc gtc aga gcg atg ttg 3’ 
B.ctnx_GW1_CterF: 5’ ccg tgt gaa atg gga tg 3’ 
B.ctnx_GW1_CterF_nest:  5’ atc gga cat ctc agc gg 3’ 
 
Gene-Walking Primers – New Zealand B. Stearothermophilus Strain 11 
NZ_GW1_NterR_Nest: 5’ agg ggg ctg agg gga ccg 3’ 
NZ_GW1_CterF_Nest: 5’ cgt gga ttg aaa ttc tgc cgc 3’ 
NZ_Gw1_CterF:  5’ tta gac aag gag ttg gag aag 3’ 
NZ_GW1_NterR:  5’ cga gaa gga tgt tcg cc 3’ 
 
NZ_GW2_CterF_nest: 5’ ctg aaa cag cgg att cga c 3’ 
NZ_GW2_CterR_nest: 5’ ttt cac ata gat gtt gca 3’ 
NZ_GW2_CterF:  5’ gga acg aaa agc gcg aat c 3’ 
NZ_GW2_CterR:  5’ ctt tgt ttc acc cgt tgc c 3’ 
 
7.6_GW3_Cterf_Nest: 5’ ata ccc gaa aag gag ctt ggc 3’ 
7.6_GW3_CterF:  5’ gga gac agc ggt gat gga gat c 3’ 
7.6_GW3_CterR:  5’ tca cga att ctg gtt ctg acc c 3’ 
7.6_GW3_CterR_Nest: 5’ ttt cca ttg aag cca ttg aca gag 3’ 
 
Cloning primers – B. caldovelox  
Bcv_IEP_F1_Start: 5’ gct tag cat atg tgg atg aaa cag gta 
atg tca cga 3’ 
B.cv_IEP_R1_EcoRI: 5’ ttg tct gga att cgt ttc gct aat atc 
c3’  
B.cv_IEP_F2_EcoRI: 5’ gcg aaa cga att cca gac aaa atc 3’ 
B.cv_IEP_R2_Stop_SalI:  5’ aag ctt gga tcc gtc gac tta agt ctg 
acg cag aga ttc ata tcg 3’ 
 
Cloning Primers – Thermosinus carboxydivorans 
T.c_IEP_F_NdeI: 5’ cac gaa tta cat atg atg gca tcc cga 
ccg acc 3. 
T.c_IEP_R_XhoI: 5’ gaa tcc gtc gac ctc gag tta acc acc 
gga cgt gcg 3’ 
T.c_IEP_R_XhoI_His: 5’ gaa tcc gtc gac ctc gag cac cac cgg 
acg tgc g 3’ 
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Cloning Primers – Petratoga mobilis 
P.m_IEP1/2_F_NdeI: 5’ gga ggt ttc gac ata tga aag atg cga 
agg 3’ 
P.m_IEP3_F_NdeI: 5’ gga ggt ttc gac ata tga aag atg cga 
aga 3’ 
P.m_IEP1_R_XhoI: 5’ ccg ttc ggt ata cct cga gtt aac aga 
att cat gc 3’ 
P.m_IEP2_R_XhoI: 5’ ccg ttc gga ata cct cga gtt aac aga 
att gat gt 3’ 
P.m_IEP3_R_XhoI: 5’ ccg ttc ggt ata cct cga gtt aac aga 
att gat gt 3’ 
 
New Zealand strain 11 B. stearothermophilus 
NZ11_F_NdeI: 5’ GAG GAA GAG CAT ATG GCT TTG TTG GAA 
CGC ATC 3’ 
NZ11_R_XhoI: 5’ GAG GCA TTC CTC GAG ATT AAC CTT GAC 
GGA GTT CGA AAT AT 3’ 
 
Site Directed Mutagenesis Primers 
Bcv_NdeI_SDM_F: 5’ gag tgc cca agc aga aag cct atg aat 
ggg gaa aca c 3’ 
Bcv_NdeI_SDM_R: 5’ gtg ttt ccc cat tca tag gct ttc tgc 
ttg ggc act c 3’ 
 
Overlap Extension Primers 
P1 - Sac7d _Nter_F_NdeI: 5’ ccg tcc ccg cat atg gtg aaa gtg aaa 
ttt aaa tac aaa ggt g 3’ 
P2 - Sac7d _Nter_R: 5’ ctc gtg aca tta cct gtt tca tcc aca 
taa cgg tac cac ctt ttt tct cgc gtt ccg 
3’ 
P3 - B.cv_Cter_F: 5’ cgt gcg gaa cgc gag aaa aaa ggt ggt 
acc gtt atg tgg atg aaa cag gta atg tca 
cga g 
P4 - Bcv_IEP_Cter_R_XhoI: 5’ ccg ccg ctc gag att aag tct gac 
gca gag att cat atc g 3’ 
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P5 - Bcv_IEP_Nter_F_NdeI: 5’ ccg tcc ccg cat atg tgg atg aaa 
cag gta atg tca c 3’ 
P6:  B.cv_Nter_R: 5’ acc ttt gta ttt aaa ttt cac ttt cac 
cat aac ggt acc agt ctg acg ca gaga ttc 
ata tcg tt 3’ 
P7:  Sac7d _Cter_F: 5’ tat caa cga tat gaa tct ctg cgt cag 
act ggt acc gtt atg gtg aaa gtg aaa ttt 
aaa tac aaa ggt 3’ 
P8:  Sac7d _Cter_R_XhoI: 5’ ccg ccg ctc gag att aac ctt ttt tct 
cgc gtt ccg 3’ 
 
Overlap Extension Primers  - To remove GTV linker 
Sac7_Nter_L_No linker:   5’ ctc gtg aca tta cct gtt tca tcc aca 
tac ctt ttt tct cgc gtt ccg cac g 3’ 
Sac7_Nter_U_No linker:   5’ cgt gcg gaa cgc gag aaa aaa ggt atg 
tgg atg aaa cag gta atg tca cga g 3’ 
 
Reverse Transcription primers 
MS2:3014_F:    5’ agg tat gtc aga tcc acg cct cta t 3’ 
MS2:2475_F:    5’ tcg atc aac cag cgt ctg gct cag c 3’ 
MS2:3231_F:    5’ ttc agc gaa aag cac gac agt ggt c 3’ 
MS2:13_F:     5’ ttt cgg ggt cct gct caa ctt cct g 3’ 
MS2:1868_F:    5’ tcc gca cag tga cga ctt tac agc a 3’ 
MS2:3529_R:    5’ aat ccc ggg tcc tct ctt tag ggg g 3’ 
MS2:3193_R:    5’ cga gcg ata cga gca aga cgg aaa c 3’ 
MS2:3127_R:    5’ ttg gtg tat acc gag act gcc gta g 3’ 
MS2:3395_R:    5’ tta cgg ggg tcc ctc ggt cag cta c 3’ 
 
RT-qPCR primers 
MS2:3231_F:    5’ ttc agc gaa aag cac gac agt ggt c 3’ 
MS2:3395_R:    5’ tta cgg ggg tcc ctc ggt cag cta c 3’ 
 
28S_F:   5’ aac gag att ccc act gtc cct a 3’ 
28S_R:   5’ ggt ctt ctt tcc ccg ctg att 3’ 
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Mitochondrial_ATP_Synthase_F: 5’ cag tga tta tag gct ttc 
gct cta a 3’ 
Mitochondrial_ATP_Synthase_R: 5’ cag ggc tat tgg ttc aat 
gag ta 3’ 
 
GAPDH_F:   5’ gac agt cag ccg cat ctt ctt 3’ 
GAPDH_R:   5’ tcc gtt gac tcc gac ctt ca 3’ 
 
β-2-microglobulin_F: 5’ aag gac tgg tct ttc tat ctc ttg ta 
3’ 
β-2-microglobulin_R: 5’ act taa cta tct tgg gct gtc aca 3’ 
 
Fidelity Assay 
LacIq_F_SacII: 5’ gaa ttc cat atc ccg cgg ata atg agg 
ttc tgt acc cga cac 3’ 
LacIq_R_SacII: 5’ gaa ttc cat atg ccg cgg ctg acg tga 
ggt tct tgc 3’ 
LacIq_U_seq: 5’ cgt ggt ggt gtc gat ggt ag 3’ 
LacIq_F_seq: 5’ gtt gca gca agc ggt cca cg 3’ 
SacB_F_AatII: 5’ tta cca gac gtc cat atg cct gcc gtt 
cac t 3’ 
SacB_R_AatII: 5’ gaa ttc gac gtc gga tcc cgg cat ttt 
ctt3’ 
 
DNA-Dependent DNA Polymerase Activity 
-40M13LFF: 5’ Fam-gtt ttc cca gtc acg acg ttg taa 
aac gac ggc c 3’ 
 
RNA-Dependent DNA Polymerase Activity 
FAM_MS2:3193R: 5’ Fam-cga gcg ata cga gca aga cgg aaa 
c3’ 
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II – Genotype of E. coli Strains 
 
TOP10F’ 
F´{lacIq, Tn10(TetR)} mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74 
recA1 araD139 ∆(ara leu) 7697 galU galK rpsL (StrR) endA1 nupG 
 
TOP10 
F– mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(ara 
leu) 7697 galU galK rpsL (StrR) endA1 nupG 
 
KRX 
[F2, traD36, ⊗ompP, proA+B+, lacIq, ⊗(lacZ)M15] ⊗ompT, endA1, recA1, 
gyrA96 (Nalr), thi-1, hsdR17 (rk–, mk+), e14– (McrA–), relA1, supE44, ⊗(lac-
proAB), ⊗(rhaBAD)::T7 RNA polymerase 
 
ArcticExpress™ 
E. coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal λ(DE3) endA Hte [cpn10 
cpn60 Gentr] [argU ileY leuW Strr] 
 
 
 
III – DNA and Protein Sequences 
 
Geobacillus kaustophilus recombinase of Bh.Int-like element DNAsequence 
 
        1 atgtggatga aacaggtaat gtcacgagag aatctcctgc gagcactcaa 
       51 acaagtggaa aagaataaag ggtcccatgg aaccgatgga atgtccgtca 
      101 aagacctgcg aagacacctc gtggaacatt gggacgcgat acggcacgct 
      151 ttagaagaag ggacctacga accttgcccg gtccgacggg tcgaaatccc 
      201 gaaaccgaac ggaggagtca ggttactagg aatcccgacc gtgacagacc 
      251 ggttcatcca acaggccatc gcccaagtgc tcacgccgat ctttgaccca 
      301 tccttttcgg aacacagcta cgggtttcgt cccggtcgaa gaggacacga 
      351 cgcggtgaaa aaggcgaagc agtatattca ggaaggatat acatgggtgg 
      401 tagatatcga cttggaaaag ttctttgatc gagtcaacca tgacaaactg 
      451 atggggatat tagcgaaacg aattccagac aaaatcctcc taaagttgat 
      501 acggaagtat ctacaggcag gggtcatgat caacggggtg gtcatggaaa 
      551 cacaagaggg gactccacaa ggagggccgc tcagtccact cctgtccaac 
      601 attctcctgg atgagctgga caaagaattg gaaaaacgag ggcacaagtt 
      651 tgtacggtat gcggatgact gcaatatcta cgtaaggacg aagaaggccg 
      701 gggaacgggt gatgaaatcg atcacggcat tcatcgaaaa gaaactccgg 
      751 ctgaaagtca acgaaaccaa atcggcagtg gatcgtccgt ggaggagaaa 
      801 attcctcggt tttagcttca ccccaagtaa ggagccaaaa atccgaattg 
      851 caaaggaaag cattcggcgc atgaagcaaa ggatacgcac catgacgagc 
      901 cgatcgaaac cgattcccat gcccgaacga atcgaacagc tcaatcaata 
      951 cattctggga tggtgtggat acttttcgct agcagagacc ccaagtgtgt 
     1001 tcaaagaact agatggatgg attcgacgaa ggctgcgcat gtgccaatgg 
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     1051 aaagagtgga aacttccgag aaccagagtc cgaaaactgc aaagtttagg 
     1101 agtgcccaag cagaaagcat atgaatgggg aaacactcgg aagaaatatt 
     1151 ggagagtggc cgccagtccc atcctgcata aagcccttgg caactcctat 
     1201 tgggagagcc aagggctgaa gagtctttat caacgatatg aatctctgcg 
     1251 tcagacttaa     
 
The highlighted region represents the sequence that was identified during gene 
walking of B. caldovelox. 
 
 
Geobacillus kaustophilus recombinase of Bh.Int-like element protein sequence 
 
        1 MWMKQVMSRE NLLRALKQVE KNKGSHGTDG MSVKDLRRHL VEHWDAIRHA 
       51 LEEGTYEPCP VRRVEIPKPN GGVRLLGIPT VTDRFIQQAI AQVLTPIFDP 
      101 SFSEHSYGFR PGRRGHDAVK KAKQYIQEGY TWVVDIDLEK FFDRVNHDKL 
      151 MGILAKRIPD KILLKLIRKY LQAGVMINGV VMETQEGTPQ GGPLSPLLSN 
      201 ILLDELDKEL EKRGHKFVRY ADDCNIYVRT KKAGERVMKS ITAFIEKKLR 
      251 LKVNETKSAV DRPWRRKFLG FSFTPSKEPK IRIAKESIRR MKQRIRTMTS 
      301 RSKPIPMPER IEQLNQYILG WCGYFSLAET PSVFKELDGW IRRRLRMCQW 
      351 KEWKLPRTRV RKLQSLGVPK QKAYEWGNTR KKYWRVAASP ILHKALGNSY 
      401 WESQGLKSLY QRYESLRQT   
  
Length in amino acids: 419 
Molecular weight in kD: 49.09 
Iso-electric point (IP): 10.14 
 
 
Sac7d E. coli codon optimized DNA sequence 
 
        1 atggtgaaag tgaaatttaa atacaaaggt gaagagaaag aagttgacac 
       51 ttctaaaatt aaaaaagtgt ggcgtgtggg taaaatggtt tctttcacct 
      101 atgatgataa cggcaaaacc ggtcgcggtg cggtgtctga gaaagacgcg 
      151 ccgaaagaac tgctggatat gctggcgcgt gcggaacgcg agaaaaaagg 
      201 ttaa    
 
 
Sac7d E. coli codon optimized protein sequence 
 
        1 MVKVKFKYKG EEKEVDTSKI KKVWRVGKMV SFTYDDNGKT GRGAVSEKDA 
       51 PKELLDMLAR AEREKKG    
 
 
Sac7d-B.cv IEP fusion gene sequence 
 
        1 atggtgaaag tgaaatttaa atacaaaggt gaagagaaag aagttgacac 
       51 ttctaaaatt aaaaaagtgt ggcgtgtggg taaaatggtt tctttcacct 
      101 atgatgataa cggcaaaacc ggtcgcggtg cggtgtctga gaaagacgcg 
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      151 ccgaaagaac tgctggatat gctggcgcgt gcggaacgcg agaaaaaagg 
      201 tggtaccgtt atgtggatga aacaggtaat gtcacgagag aatctcctgc 
      251 gagcactcaa acaagtggaa aagaataaag ggtcccatgg aaccgatgga 
      301 atgtccgtca aagacctgcg aagacacctc gtggaacatt gggacgcgat 
      351 acggcacgct ttagaagaag ggacctacga accttgcccg gtccgacggg 
      401 tcgaaatccc gaaaccgaac ggaggagtca ggttactagg aatcccgacc 
      451 gtgacagacc ggttcatcca acaggccatc gcccaagtgc tcacgccgat 
      501 ctttgaccca tccttttcgg aacacagcta cgggtttcgt cccggtcgaa 
      551 gaggacacga cgcggtgaaa aaggcgaagc agtatattca ggaaggatat 
      601 acatgggtgg tagatatcga cttggaaaag ttctttgatc gagtcaacca 
      651 tgacaaactg atggggatat tagcgaaacg aattccagac aaaatcctcc 
      701 taaagttgat acggaagtat ctacaggcag gggtcatgat caacggggtg 
      751 gtcatggaaa cacaagaggg gactccacaa ggagggccgc tcagtccact 
      801 cctgtccaac attctcctgg atgagctgga caaagaattg gaaaaacgag 
      851 ggcacaagtt tgtacggtat gcggatgact gcaatatcta cgtaaggacg 
      901 aagaaggccg gggaacgggt gatgaaatcg atcacggcat tcatcgaaaa 
      951 gaaactccgg ctgaaagtca acgaaaccaa atcggcagtg gatcgtccgt 
     1001 ggaggagaaa attcctcggt tttagcttca ccccaagtaa ggagccaaaa 
     1051 atccgaattg caaaggaaag cattcggcgc atgaagcaaa ggatacgcac 
     1101 catgacgagc cgatcgaaac cgattcccat gcccgaacga atcgaacagc 
     1151 tcaatcaata cattctggga tggtgtggat acttttcgct agcagagacc 
     1201 ccaagtgtgt tcaaagaact agatggatgg attcgacgaa ggctgcgcat 
     1251 gtgccaatgg aaagagtgga aacttccgag aaccagagtc cgaaaactgc 
     1301 aaagtttagg agtgcccaag cagaaagcct atgaatgggg aaacactcgg 
     1351 aagaaatatt ggagagtggc cgccagtccc atcctgcata aagcccttgg 
     1401 caactcctat tgggagagcc aagggctgaa gagtctttat caacgatatg 
     1451 aatctctgcg tcagacttaa    
 
 
Sac7d-B.cv IEP fusion protein sequence 
 
        1 MVKVKFKYKG EEKEVDTSKI KKVWRVGKMV SFTYDDNGKT GRGAVSEKDA 
       51 PKELLDMLAR AEREKKGGTV MWMKQVMSRE NLLRALKQVE KNKGSHGTDG 
      101 MSVKDLRRHL VEHWDAIRHA LEEGTYEPCP VRRVEIPKPN GGVRLLGIPT 
      151 VTDRFIQQAI AQVLTPIFDP SFSEHSYGFR PGRRGHDAVK KAKQYIQEGY 
      201 TWVVDIDLEK FFDRVNHDKL MGILAKRIPD KILLKLIRKY LQAGVMINGV 
      251 VMETQEGTPQ GGPLSPLLSN ILLDELDKEL EKRGHKFVRY ADDCNIYVRT 
      301 KKAGERVMKS ITAFIEKKLR LKVNETKSAV DRPWRRKFLG FSFTPSKEPK 
      351 IRIAKESIRR MKQRIRTMTS RSKPIPMPER IEQLNQYILG WCGYFSLAET 
      401 PSVFKELDGW IRRRLRMCQW KEWKLPRTRV RKLQSLGVPK QKAYEWGNTR 
      451 KKYWRVAASP ILHKALGNSY WESQGLKSLY QRYESLRQT 
 
Length in amino acids: 489 
Molecular weight in kD: 57.00 
Iso-electric point (IP): 10.06 
 
 
B.cv IEP-Sac7d fusion gene sequence 
 
        1 atgtggatga aacaggtaat gtcacgagag aatctcctgc gagcactcaa 
       51 acaagtggaa aagaataaag ggtcccatgg aaccgatgga atgtccgtca 
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      101 aagacctgcg aagacacctc gtggaacatt gggacgcgat acggcacgct 
      151 ttagaagaag ggacctacga accttgcccg gtccgacggg tcgaaatccc 
      201 gaaaccgaac ggaggagtca ggttactagg aatcccgacc gtgacagacc 
      251 ggttcatcca acaggccatc gcccaagtgc tcacgccgat ctttgaccca 
      301 tccttttcgg aacacagcta cgggtttcgt cccggtcgaa gaggacatga 
      351 cgcggtgaaa aaggcgaagc agtatattca ggaaggatat acatgggtgg 
      401 tagatatcga cttggaaaag ttctttgatc gagtcaacca tgacaaactg 
      451 atggggatat tagcgaaacg aattccagac aaaatcctcc taaagttgat 
      501 acggaagtat ctacaggcag gggtcatgat caacggggtg gtcatggaaa 
      551 cacaagaggg gactccacaa ggagggccgc tcagtccact cctgtccaac 
      601 attctcctgg atgagctgga caaagaattg gaaaaacgag ggcacaagtt 
      651 tgtacggtat gcggatgact gcaatatcta cgtaaggacg aagaaggccg 
      701 gggaacgggt gatgaaatcg atcacggcat tcatcgaaaa gaaactccgg 
      751 ctgaaagtca acgaaaccaa atcggcagtg gatcgtccgt ggaggagaaa 
      801 attcctcggt tttagcttca ccccaagtaa ggagccaaaa atccgaattg 
      851 caaaggaaag cattcggcgc atgaagcaaa ggatacgcac catgacgagc 
      901 cgatcgaaac cgattcccat gcccgaacga atcgaacagc tcaatcaata 
      951 cattctggga tggtgtggat acttttcgct agcagagacc ccaagtgtgt 
     1001 tcaaagaact agatggatgg attcgacgaa ggctgcgcat gtgccaatgg 
     1051 aaagagtgga aacttccgag aaccagagtc cgaaaactgc aaagtttagg 
     1101 agtgcccaag cagaaagcct atgaatgggg aaacactcgg aagaaatatt 
     1151 ggagagtggc cgccagtccc atcctgcata aagcccttgg caactcctat 
     1201 tgggagagcc aagggctgaa gagtctttat caacgatatg aatctctgcg 
     1251 tcagactggt accgttatgg tgaaagtgaa atttaaatac aaaggtgaag 
     1301 agaaagaagt tgacacttct aaaattaaaa aagtgtggcg tgtgggtaaa 
     1351 atggtttctt tcacctatga tgataacggc aaaaccggtc gcggtgcggt 
     1401 gtctgagaaa gacgcgccga aagaactgct ggatatgctg gcgcgtgcgg 
     1451 aacgcgagaa aaaaggttaa  
   
 
B.cv IEP-Sac7d fusion protein sequence 
 
 
        1 MWMKQVMSRE NLLRALKQVE KNKGSHGTDG MSVKDLRRHL VEHWDAIRHA 
       51 LEEGTYEPCP VRRVEIPKPN GGVRLLGIPT VTDRFIQQAI AQVLTPIFDP 
      101 SFSEHSYGFR PGRRGHDAVK KAKQYIQEGY TWVVDIDLEK FFDRVNHDKL 
      151 MGILAKRIPD KILLKLIRKY LQAGVMINGV VMETQEGTPQ GGPLSPLLSN 
      201 ILLDELDKEL EKRGHKFVRY ADDCNIYVRT KKAGERVMKS ITAFIEKKLR 
      251 LKVNETKSAV DRPWRRKFLG FSFTPSKEPK IRIAKESIRR MKQRIRTMTS 
      301 RSKPIPMPER IEQLNQYILG WCGYFSLAET PSVFKELDGW IRRRLRMCQW 
      351 KEWKLPRTRV RKLQSLGVPK QKAYEWGNTR KKYWRVAASP ILHKALGNSY 
      401 WESQGLKSLY QRYESLRQTG TVMVKVKFKY KGEEKEVDTS KIKKVWRVGK 
      451 MVSFTYDDNG KTGRGAVSEK DAPKELLDML ARAEREKKG     
 
 
Length in amino acids: 489 
Molecular weight in kD: 57.00 
Iso-electric point (IP): 10.06 
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Thermosinus carboxydivorans IEP gene sequence 
 
        1 ttgatggcat cccgaccgac cggcttcggg accaaatacg cgccgaatgg 
       51 ccgcgcatcc gggaagaact gctcgcgggt acctacaaac cgatgcccgt 
      101 gcgccgggtc gaaatcccga aagtgcggag gaggtacacg gatgctgggg 
      151 atacccaccg tgatggaccg cctgatccag caggcccttc tgcaggtact 
      201 gacgcatatc tttgacccgc acttttccga agccagctac gggttccgtc 
      251 ctggcaagaa agcacatgat gcggtaagga aggcgcgcca atacgtggaa 
      301 gaaggctatg aatgggctgt ggacatggac cttgagaaat tcttcgacag 
      351 ggtaaaccat gatatactca tggcccgagt ggcccgaaaa gtaacagaca 
      401 aaagagtgtt aaaactcatc cgccgctatc tccaggcagg catcatggtc 
      451 aatggtgtgg tcatggacag ggaagaagga acaccgcaaa gcggaccatt 
      501 aagcccactc ctggccaaca tcctactgga tgacctggat aaggaactgg 
      551 agaaacgtgg ccacaagttc atgcgttatg ccgatgactg caatatctac 
      601 gtaaagacta ggcgcgcggg tgaaagaata ttgactagtg tccgcaacta 
      651 cttgcaggag cggttaaaac tcaaactgaa cgaagagaaa agcatggtag 
      701 accgaccgtg gaaactgaaa tttctgggct ttagcatgta taaagccaaa 
      751 ggtgggaaaa tcctcatccg cctggcgtca caaacaatcg accgggtgaa 
      801 acagaaaatc cgggaagcga ctgctcgtag tgctccacaa tcaatggcgg 
      851 agcggataga acgcctgaac acctatttgg gaggatggat aggatacttc 
      901 gccttggcgg atactcccag cgtctttaag aacatagacg gctggatacg 
      951 gagaagatta cgcatgtgcc tgtggaagca gtggaagcga gtgaggacca 
     1001 gatacagtga gttaagggct ttgggactac cggaatgggt agtgcatgaa 
     1051 ttcgccaata cccgcaaagg accatggcga atggcccacg ggccaatgaa 
     1101 tagagccctg ggcaatgcct actggcgagc ccagggcctg atgagtttaa 
     1151 ccgaacgtta ccaaaagctt cgccaagctt ggcgaaccgc cggatgcgga 
     1201 cccgcacgtc cggtggtgtg a   
 
 
Thermosinus carboxydivorans IEP sequence 
 
        1 LMASRPTGFG TKYAPNGRAS GKNCSRVPTN RCPCAGSKSR KCGGGTRMLG 
       51 IPTVMDRLIQ QALLQVLTHI FDPHFSEASY GFRPGKKAHD AVRKARQYVE 
      101 EGYEWAVDMD LEKFFDRVNH DILMARVARK VTDKRVLKLI RRYLQAGIMV 
      151 NGVVMDREEG TPQSGPLSPL LANILLDDLD KELEKRGHKF MRYADDCNIY 
      201 VKTRRAGERI LTSVRNYLQE RLKLKLNEEK SMVDRPWKLK FLGFSMYKAK 
      251 GGKILIRLAS QTIDRVKQKI REATARSAPQ SMAERIERLN TYLGGWIGYF 
      301 ALADTPSVFK NIDGWIRRRL RMCLWKQWKR VRTRYSELRA LGLPEWVVHE 
      351 FANTRKGPWR MAHGPMNRAL GNAYWRAQGL MSLTERYQKL RQAWRTAGCG 
      401 PARPVV     
 
Length in amino acids: 406 
Molecular weight in kD: 46.74 
Iso-electric point (IP): 10.35 
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Petrotoga mobilis SJ95 IEP1 Gene Sequence 
 
        1 ttgaaagatg cgaagggaca cggaaaaagc atacaacttc gattagaagg 
       51 tttcctacat gaagataagg gagagcctga aaataatgta gaagcgccta 
      101 gtataacttc tacgtctgaa agaggaagaa acgatgataa gggatgcagt 
      151 gaagggatgc ttgaaaagat attatccaag gataatatga ataaagcata 
      201 caagaaggta aaggccaaca aaggagcccc tgggatagac gggatgaaag 
      251 tagaagaact ctttggatat ctcagacaac acggagaaga attaaggcaa 
      301 gagctccttg aaggaaggta caccccgaag tcggtaagga ggaaagaaat 
      351 accgaaaccg gatggaggga aaagactact aggcatacca acatcaattg 
      401 acagagtaat ccagcaatcc atagcccagg tgttgacacc tatttacgaa 
      451 aagaaatttg tagataacag ttatggattc aggccattac gggatgcaaa 
      501 acaagccata cgaaaaagca aagaatacct aaacaaaggg catacatggg 
      551 tagtggacat agacttagaa cgctactttg acacagtcaa ccatgacaaa 
      601 ctgatgagga taatatcaaa agacgtaaaa gatggcagag tgatatccct 
      651 gataaggaaa tacctcaaga gtggggtaat ggtaaatggg gtagtaatag 
      701 aaactgaaga agggactcca caagggggac cgctatcccc attactaagc 
      751 aacataatgc tccacgaact tgacgtagaa ctaacgaaaa ggggacacaa 
      801 gttttgcagg tatgcagacg attgcaacat atacgtgaaa agcgagaaat 
      851 ccgcatatag ggtgatggaa agtataacaa aatacataga gaagaaatta 
      901 aagctaaaag tgaatagcaa gaaaagcaaa gtagtcagac cttgggacct 
      951 caaatactta gggttctcct tctacgtgaa agaagagaag tacgaaatta 
     1001 gagtccatgg aaaatccatt aaagaattca aaaagaagtt aaaaggagaa 
     1051 acgaagagaa gcagtggaag aagcatggca tacaggctgt caaggataaa 
     1101 acaaataata acaggatgga caaactacta tggaatagca aacatgaaat 
     1151 cgatagcggg aagtcttgat ggatggctta gaaggagaat taggatgtgt 
     1201 atctggaagg aatggaagaa aatcaaaaca aggtataaaa acttagtcaa 
     1251 attagggtta aacatctaca aagcatggga atatgcaaat acaaggaaag 
     1301 gctattggag aatctccaac agccccatac tttcaagaac actaactaat 
     1351 aaacacctta agaaaatggg gttaacttcg atcctggaaa cgtataacct 
     1401 aaagcatgaa ttctgttga    
 
 
Petrotoga mobilis SJ95 IEP1 Sequence 
 
 
        1 lkdakghgks iqlrlegflh edkgepennv eapsitstse rgrnddkgcs 
       51 egmlekilsk dnmnkaykkv kankgapgid gmkveelfgy lrqhgeelrq 
      101 ellegrytpk svrrkeipkp dggkrllgip tsidrviqqs iaqvltpiye 
      151 kkfvdnsygf rplrdakqai rkskeylnkg htwvvdidle ryfdtvnhdk 
      201 lmriiskdvk dgrvislirk ylksgvmvng vvieteegtp qggplsplls 
      251 nimlheldve ltkrghkfcr yaddcniyvk seksayrvme sitkyiekkl 
      301 klkvnskksk vvrpwdlkyl gfsfyvkeek yeirvhgksi kefkkklkge 
      351 tkrssgrsma yrlsrikqii tgwtnyygia nmksiagsld gwlrrrirmc 
      401 iwkewkkikt ryknlvklgl niykaweyan trkgywrisn spilsrtltn 
      451 khlkkmglts iletynlkhe fc   
 
Length in amino acids: 472 
Molecular weight in kD: 54.74 
Iso-electric point (IP): 9.86 
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Petrotoga mobilis SJ95 IEP2 Gene Sequence 
        1 ttgaaagatg cgaagggaca cggaaaaagc atacaacttc gattagaagg 
       51 tttcctacat gaagataagg gagagcctga aaataatgta gaagcgccta 
      101 gtataacttc tacgtctgaa agaggaagaa acgatgataa gggatgcagt 
      151 gaagggatgc ttgaaaagat attatccaag gataatatga ataaagcata 
      201 caagaaggta aaggccaaca aaggagcccc tgggatagac gggatgaaag 
      251 tagaagaact ctttggatat ctcagacaac acggagaaga attaaggcaa 
      301 gagctccttg aaggaaggta caccccgaag tcggtaagga ggaaagaaat 
      351 accgaaaccg gatggaggga aaagactact aggcatacca acatcaattg 
      401 acagagtaat ccagcaatcc atagcccagg tgttgacacc tatttacgaa 
      451 aagaaatttg tagataacag ttatggattc aggccattac gggatgcaaa 
      501 acaagccata cgaaaaagca aagaatacct aaacaaaggg catacatggg 
      551 tagtggacat agacttagaa cgctactttg acacagtcaa ccatgacaaa 
      601 ctgatgagga taatatcaaa agacgtaaaa gatggcagag tgatatccct 
      651 gataaggaaa tacctcaaga gtggggtaat ggtaaatggg gtagtaatag 
      701 aaactgaaga agggactcca caagggggac cgctatcccc attactaagc 
      751 aacataatgc tccacgaact tgacgtagaa ctaacgaaaa ggggacacaa 
      801 gttttgcagg tatgcagacg attgcaacat atacgtgaaa agcgagaaat 
      851 ccgcatatag ggtgatggaa agtataacaa aatacataga gaagaaatta 
      901 aagctaaaag tgaatagcaa gaaaagcaaa gtagtcagac cttgggacct 
      951 caaatactta gggttctcct tctacgtgaa agaagagaag tacgaaatta 
     1001 gagtccatgg aaaatccatt aaagaattca aaaagaagtt aaaaggagaa 
     1051 acgaagagaa gcagtggaag aagcatggca tacaggctgt caaggataaa 
     1101 acaaataata acaggatgga caaactacta tggaatagca aacatgaaat 
     1151 cggtagcggg aagtcttgat ggatggctca gaaggagaat taggatgtgt 
     1201 atctggaagg aatggaagaa aatcaaaaca aaacatgaaa acttagtcaa 
     1251 attaggacta aacacctaca aagcatggga atatgcaaac acaagaaaag 
     1301 gctattggag gatctccaac agcccgatac tttcaatgac actaactaat 
     1351 aaacgcctta aggaaatggg gttaacttcg atcctggaaa cgtataacct 
     1401 aaaacatcaa ttctgttga    
 
Petrotoga mobilis SJ95 IEP2 Sequence 
 
        1 lkdakghgks iqlrlegflh edkgepennv eapsitstse rgrnddkgcs 
       51 egmlekilsk dnmnkaykkv kankgapgid gmkveelfgy lrqhgeelrq 
      101 ellegrytpk svrrkeipkp dggkrllgip tsidrviqqs iaqvltpiye 
      151 kkfvdnsygf rplrdakqai rkskeylnkg htwvvdidle ryfdtvnhdk 
      201 lmriiskdvk dgrvislirk ylksgvmvng vvieteegtp qggplsplls 
      251 nimlheldve ltkrghkfcr yaddcniyvk seksayrvme sitkyiekkl 
      301 klkvnskksk vvrpwdlkyl gfsfyvkeek yeirvhgksi kefkkklkge 
      351 tkrssgrsma yrlsrikqii tgwtnyygia nmksvagsld gwlrrrirmc 
      401 iwkewkkikt khenlvklgl ntykaweyan trkgywrisn spilsmtltn 
      451 krlkemglts iletynlkhq fc   
 
Length in amino acids: 472 
Molecular weight in kD: 54.66 
Iso-electric point (IP): 9.82 
 
 
 
290 
Petrotoga mobilis SJ95 IEP3 Gene Sequence 
 
        1 ttgaaagatg cgaagagaca cggaaaaagc atacaacttc gattagaagg 
       51 tttcctacat gaagataagg gagagcctga aaataatgta gaagcgccta 
      101 gtgtaacttc tacgtctgaa agaggaagaa acgatgataa aggatacagt 
      151 gaagggatgc ttgaaaagat attatccaag gataatatga ataaagcata 
      201 taagaaggta aaggccaaca aaggagcccc tggaatagac gggatggaag 
      251 tagaagaact ctttgaatat ctcaaacaac atggagaaga attaaggcaa 
      301 gagctccttg aaggaaggta caccccgaac ccggtaagga ggaaagagat 
      351 accgaaaccg gatggaggga aaagactact aggcatacca acagcaatag 
      401 acagagtaat ccaacaatcc atagcccagg aactgatacc gatttatgaa 
      451 aagaaatttg tagataacag ctatggattt aggccattac gagatgcaaa 
      501 acaagccata cggaaaagca aagaatacct aaacgaagga cacacgtggg 
      551 tagtggacat agatttagaa cgatactttg acacagtcaa ccatgacaaa 
      601 ctgatgagga taatatcaaa agacgtaaaa gatggcagag tgatatccct 
      651 gataaggaaa tacctcaaga gtggggtaat ggtaaatggg gtagtaatag 
      701 aaacagaaga agggactccg caagggggac cgctatcccc attactaagc 
      751 aacataatgc tccacgaact tgacgtagaa ctaacgaaaa ggggacacaa 
      801 gttttgcagg tatgcagacg attgcaacat atacgtgaaa agcgagaaat 
      851 ccgcatatag ggtgatggaa agtataacaa aatacataga gaagaaatta 
      901 aagttaaaag tgaacaggaa gaaaagcaaa gtagtcaagc ctttggacct 
      951 caaatactta gggttctcct tctacgggaa agaagagcaa tacgaaatca 
     1001 gagtgcatga gaaatccatc aaagaattta aaaagaagtt aaaagaagaa 
     1051 acgaaaagaa gcagtggaag gagcatgaca tacaggctgt caaagataaa 
     1101 acaaataata acaggatgga taaactacta tggaatagca aacatgaaat 
     1151 cggcagcgga aagtcttgat ggatggctta gaaggagaat taggatgtgt 
     1201 atctggaagg aatggaagaa aatcaaaaca aggtataaaa acttagtcaa 
     1251 attaggacta aacacataca aagcatggga atatgcaaac acaagaaaag 
     1301 gccattggag gatctccaac agcccgatac tttcaagaac actaactaat 
     1351 aagcacctta aggaaattgg attaacttcg atcctggaaa catataacct 
     1401 aaaacatcaa ttctgttga    
 
 
Petrotoga mobilis SJ95 IEP3 Sequence 
        1 lkdakrhgks iqlrlegflh edkgepennv eapsvtstse rgrnddkgys 
       51 egmlekilsk dnmnkaykkv kankgapgid gmeveelfey lkqhgeelrq 
      101 ellegrytpn pvrrkeipkp dggkrllgip taidrviqqs iaqelipiye 
      151 kkfvdnsygf rplrdakqai rkskeylneg htwvvdidle ryfdtvnhdk 
      201 lmriiskdvk dgrvislirk ylksgvmvng vvieteegtp qggplsplls 
      251 nimlheldve ltkrghkfcr yaddcniyvk seksayrvme sitkyiekkl 
      301 klkvnrkksk vvkpldlkyl gfsfygkeeq yeirvheksi kefkkklkee 
      351 tkrssgrsmt yrlskikqii tgwinyygia nmksaaesld gwlrrrirmc 
      401 iwkewkkikt ryknlvklgl ntykaweyan trkghwrisn spilsrtltn 
      451 khlkeiglts iletynlkhq fc   
 
 
Length in amino acids: 472 
Molecular weight in kD: 54.66 
Iso-electric point (IP): 9.82 
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Bacillus stearothermophilis trt DNA Sequence 
 
        1 atggctttgt tggaacgcat cttagcgaga gacaacctca tcacggcgct 
       51 caaacgggtc gaagccaacc aaggagcacc gggaatcgac ggagtatcaa 
      101 ccgatcaact ccgtgattac atccgcgctc actggagcac gatccgcgcc 
      151 caactcttgg cgggaaccta ccggccggcg cctgtccgca gggtcgaaat 
      201 cccgaaaccg ggcggcggca cacggcagct aggcattccc accgtggtgg 
      251 accggctgat ccaacaagcc attcttcaag aactcacacc cattttcgat 
      301 ccagacttct ccccttccag cttcggattc cgtccgggcc gcaacgccca 
      351 cgatgccgtg cggcaagcgc aaggctacat ccaggaagga tatcggtacg 
      401 tggtcgacat ggacctggaa aagttctttg atcgggtcaa ccatgacatc 
      451 ttgatgagtc gggtggcccg aaaagtcaag gataaacgcg tgctgaaact 
      501 gatccgtgcc tacctgcaag ccggcgttat gatcgaaggg gtgaaggtgc 
      551 agacggagga agggacgccg caaggcggcc ccctcagccc cctgctggcg 
      601 aacatccttc tcgacgattt agacaaggaa ttggagaagc gaggattgaa 
      651 attctgccgt tacgcagatg actgcaacat ctatgtgaaa agtctgcggg 
      701 caggacaacg ggtgaaacaa agcatccaac ggttcttgga gaaaacgctc 
      751 aaactcaaag taaacgagga gaaaagtgcg gtggaccgcc cgtggaaacg 
      801 ggcctttctg gggtttagct tcacaccgga acgaaaagcg cgaatccggc 
      851 tcgccccaag gtcgattcaa cgtctgaaac agcggattcg acagctgacc 
      901 aacccaaact ggagcatatc gatgccagaa cgaattcatc gcgtcaatca 
      951 atacgtcatg ggatggatcg ggtattttcg gctcgtcgaa accccgtctg 
     1001 tccttcagac catcgaagga tggattcgga ggaggcttcg actctgtcaa 
     1051 tggcttcaat ggaaacgggt cagaaccaga atccgtgagt taagagcgct 
     1101 ggggctgaaa gagacagcgg tgatggagat cgccaatacc cgaaaaggag 
     1151 cttggcgaac aacgaaaacg ccgcaactcc accaggccct gggcaagacc 
     1201 tactggaccg ctcaagggct caagagtttg acgcaacgat atttcgaact 
     1251 ccgtcaaggt tga    
 
 
Bacillus stearothermophilis trt Protein Sequence 
 
        1 MALLERILAR DNLITALKRV EANQGAPGID GVSTDQLRDY IRAHWSTIRA 
       51 QLLAGTYRPA PVRRVEIPKP GGGTRQLGIP TVVDRLIQQA ILQELTPIFD 
      101 PDFSPSSFGF RPGRNAHDAV RQAQGYIQEG YRYVVDMDLE KFFDRVNHDI 
      151 LMSRVARKVK DKRVLKLIRA YLQAGVMIEG VKVQTEEGTP QGGPLSPLLA 
      201 NILLDDLDKE LEKRGLKFCR YADDCNIYVK SLRAGQRVKQ SIQRFLEKTL 
      251 KLKVNEEKSA VDRPWKRAFL GFSFTPERKA RIRLAPRSIQ RLKQRIRQLT 
      301 NPNWSISMPE RIHRVNQYVM GWIGYFRLVE TPSVLQTIEG WIRRRLRLCQ 
      351 WLQWKRVRTR IRELRALGLK ETAVMEIANT RKGAWRTTKT PQLHQALGKT 
      401 YWTAQGLKSL TQRYFELRQG    
 
Length in amino acids: 420 
Molecular weight in kD: 48.65 
Iso-electric point (IP): 10.54 
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New Zealand Bacillus stearothermophilus Strain 11 IEP Gene Sequence 
 
 
        1 atggctttgt tggaacgcat cttagcgaga gacaacctca ccacggcgct 
       51 caaacgggtc gaagcgaacc aaggagcacc gggaatcgac ggagtatcaa 
      101 ccgatcaact ccgtgattcc atccgcgctc actggggcac gatccgcgcc 
      151 caactcttgg cgggaaccta ccggccggcg cctgtccgca gggtcgaaat 
      201 cccgaaaccc agcggcggca cacggcagct aggcattccc accgtggtgg 
      251 accggctgat ccaacaagcc attcttcaag aactcacccc cattttcgat 
      301 ccagacttct ccccgtccag cttcggattc cgtccgggcc gcaacgctca 
      351 cgatgccgtg cggcaagcgc aaggctacat ccaggagggg tatcggtacg 
      401 tggtcgacat ggacctggaa aagttctttg atcgggtcaa ccatgacatc 
      451 ctgatgagtc gggtggcccg aaaagtcaag gataaacgcg tgctgaaact 
      501 gatccgtgcc tacctgcaag ccggcgttat gatcgaaggg gtgaaggtgc 
      551 agacggagga agggacgccg caaggcggtc ccctcagccc cctgctggcg 
      601 aacatccttc tcgacgattt agacaaggag ttggagaagc gcggattgaa 
      651 attctgccgc tacgcagatg acggcaacat ctatgtgaaa agtctgcggg 
      701 cagggcaacg ggtgaaacaa agcatccaac ggttcttgga gaaaacgctc 
      751 aaactcaaag taaacgagga gaaaagtgcg gtggaccgcc cgtggaaacg 
      801 ggcctttcta gggtttagct tcacaccgga acgaaaagcg cgaatccggc 
      851 ttgccccaag gtcgattcaa cgtctgaaac agcggattcg acagctgacg 
      901 aacccaaact ggagcctatc gatgccagaa cgaattcatc gtgtccatca 
      951 atacgtcatg ggatggatcg ggtattttcg gctcgtcgaa accccgtctg 
     1001 tccttcagac catcgaagga tggattcgga ggaggcttcg actctgtcaa 
     1051 tggcttcaat ggaaacgggt cagaaccaga attcgtgagt taagggcgct 
     1101 ggggttgaag gagacagcgg tgatggagat cgccaatacc cgaaaaggag 
     1151 cttggcgaac aacgaaaacg ccacaactcc accaagccat gggcaaggac 
     1201 tattggactg tccaaggact caagagtttg acgcaacgat atttcgaact 
     1251 ccgtcaaggt taa    
 
 
New Zealand Bacillus stearothermophilus Strain 11 IEP Sequence 
 
        1 mallerilar dnlttalkrv eanqgapgid gvstdqlrds irahwgtira 
       51 qllagtyrpa pvrrveipkp sggtrqlgip tvvdrliqqa ilqeltpifd 
      101 pdfspssfgf rpgrnahdav rqaqgyiqeg yryvvdmdle kffdrvnhdi 
      151 lmsrvarkvk dkrvlklira ylqagvmieg vkvqteegtp qggplsplla 
      201 nillddldke lekrglkfcr yaddgniyvk slragqrvkq siqrflektl 
      251 klkvneeksa vdrpwkrafl gfsftperka rirlaprsiq rlkqrirqlt 
      301 npnwslsmpe rihrvhqyvm gwigyfrlve tpsvlqtieg wirrrlrlcq 
      351 wlqwkrvrtr irelralglk etavmeiant rkgawrttkt pqlhqamgkd 
      401 ywtvqglksl tqryfelrqg    
 
 
 
Length in amino acids: 420 
Molecular weight in kD: 48.60 
Iso-electric point (IP): 10.58 
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IV – Sequence Alighnments 
 
New Zealand strain B. stearothermophilus IEP compared to the B. 
stearothermophilus Trt protein 
 
NZ              MALLERILARDNLTTALKRVEANQGAPGIDGVSTDQLRDSIRAHWGTIRAQLLAGTYRPA 
B.st            MALLERILARDNLITALKRVEANQGAPGIDGVSTDQLRDYIRAHWSTIHAQLLAGTYRPA 
                ************* ************************* *****.**:*********** 
 
NZ              PVRRVEIPKPSGGTRQLGIPTVVDRLIQQAILQELTPIFDPDFSPSSFGFRPGRNAHDAV 
B.st            PVRRVEIPKPGGGTRQLGIPTVVDRLIQQAILQELTPIFDPDFSSSSFGFRPGRNAHDAV 
                **********.*********************************.*************** 
 
NZ              RQAQGYIQEGYRYVVDMDLEKFFDRVNHDILMSRVARKVKDKRVLKLIRAYLQAGVMIEG 
B.st            RQAQGYIQEGYRYVVDMDLEKFFDRVNHDILMSRVARKVKDKRVLKLIRAYLQAGVMIEG 
                ************************************************************ 
 
NZ              VKVQTEEGTPQGGPLSPLLANILLDDLDKELEKRGLKFCRYADDGNIYVKSLRAGQRVKQ 
B.st            VKVQTEEGTPQGGPLSPLLANILLDDLDKELEKRGLKFCRYADDCNIYVKSLRAGQRVKQ 
                ******************************************** *************** 
 
NZ              SIQRFLEKTLKLKVNEEKSAVDRPWKRAFLGFSFTPERKARIRLAPRSIQRLKQRIRQLT 
B.st            SIQRFLEKTLKLKVNEEKSAVDRPWKRAFLGFSFTPERKARIRLAPRSIQRLKQRIRQLT 
                ************************************************************ 
 
NZ              NPNWSLSMPERIHRVHQYVMGWIGYFRLVETPSVLQTIEGWIRRRLRLCQWLQWKRVRTR 
B.st            NPNWSISMPERIHRVNQYVMGWIGYFRLVETPSVLQTIEGWIRRRLRLCQWLQWKRVRTR 
                *****:*********:******************************************** 
 
NZ              IRELRALGLKETAVMEIANTRKGAWRTTKTPQLHQAMGKDYWTVQGLKSLTQRYFELRQG 
B.st            IRELRALGLKETAVMEIANTRKGAWRTTKTPQLHQALGKTYWTAQGLKSLTQRYFELRQG 
                ************************************:** ***.**************** 
NZ              ATGGCTTTGTTGGAACGCATCTTAGCGAGAGACAACCTCACCACGGCGCTCAAACGGGTC 
B.st            ATGGCTTTGTTGGAACGCATCTTAGCGAGAGACAACCTCATCACGGCGCTCAAACGGGTC 
                **************************************** ******************* 
 
NZ              GAAGCGAACCAAGGAGCACCGGGAATCGACGGAGTATCAACCGATCAACTCCGTGATTCC 
B.st            GAAGCCAACCAAGGAGCACCGGGAATCGACGGAGTATCAACCGATCAACTCCGTGATTAC 
                ***** **************************************************** * 
 
NZ              ATCCGCGCTCACTGGGGCACGATCCGCGCCCAACTCTTGGCGGGAACCTACCGGCCGGCG 
B.st            ATCCGCGCTCACTGGAGCACGATCCACGCCCAACTCTTGGCGGGAACCTACCGGCCGGCG 
                *************** ********* ********************************** 
 
NZ              CCTGTCCGCAGGGTCGAAATCCCGAAACCCAGCGGCGGCACACGGCAGCTAGGCATTCCC 
B.st            CCTGTCCGCAGGGTCGAAATCCCGAAACCGGGCGGCGGCACACGGCAGCTAGGCATTCCC 
                *****************************  ***************************** 
 
NZ              ACCGTGGTGGACCGGCTGATCCAACAAGCCATTCTTCAAGAACTCACCCCCATTTTCGAT 
B.st            ACCGTGGTGGACCGGCTGATCCAACAAGCCATTCTTCAAGAACTCACACCCATTTTCGAT 
                *********************************************** ************ 
 
NZ              CCAGACTTCTCCCCGTCCAGCTTCGGATTCCGTCCGGGCCGCAACGCTCACGATGCCGTG 
B.st            CCAGACTTCTCCTCTTCCAGCTTCGGATTCCGTCCGGGCCGCAACGCCCACGATGCCGTG 
                ************ * ******************************** ************ 
 
NZ              CGGCAAGCGCAAGGCTACATCCAGGAGGGGTATCGGTACGTGGTCGACATGGACCTGGAA 
B.st            CGGCAAGCGCAAGGCTACATCCAGGAAGGGTATCGGTACGTGGTCGACATGGACCTGGAA 
                ************************** ********************************* 
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NZ              AAGTTCTTTGATCGGGTCAACCATGACATCCTGATGAGTCGGGTGGCCCGAAAAGTCAAG 
B.st            AAGTTCTTTGATCGGGTCAACCATGACATCTTGATGAGTCGGGTGGCCCGAAAAGTCAAG 
                ****************************** ***************************** 
 
NZ              GATAAACGCGTGCTGAAACTGATCCGTGCCTACCTGCAAGCCGGCGTTATGATCGAAGGG 
B.st            GATAAACGCGTGCTGAAACTGATCCGTGCCTACCTGCAAGCCGGCGTTATGATCGAAGGG 
                ************************************************************ 
 
NZ              GTGAAGGTGCAGACGGAGGAAGGGACGCCGCAAGGCGGTCCCCTCAGCCCCCTGCTGGCG 
B.st            GTGAAGGTGCAGACGGAGGAAGGGACGCCGCAAGGCGGCCCCCTCAGCCCCCTGCTGGCG 
                ************************************** ********************* 
 
NZ              AACATCCTTCTCGACGATTTAGACAAGGAGTTGGAGAAGCGCGGATTGAAATTCTGCCGC 
B.st            AACATCCTTCTCGACGATTTAGACAAGGAATTGGAGAAGCGAGGATTGAAATTCTGCCGT 
                ***************************** *********** *****************  
 
NZ              TACGCAGATGACGGCAACATCTATGTGAAAAGTCTGCGGGCAGGGCAACGGGTGAAACAA 
B.st            TACGCAGATGACTGCAACATCTATGTGAAAAGTCTGCGGGCAGGACAACGGGTGAAACAA 
                ************ ******************************* *************** 
 
NZ              AGCATCCAACGGTTCTTGGAGAAAACGCTCAAACTCAAAGTAAACGAGGAGAAAAGTGCG 
B.st            AGCATCCAACGGTTCTTGGAGAAAACGCTCAAACTCAAAGTAAACGAGGAGAAAAGTGCG 
                ************************************************************ 
 
NZ              GTGGACCGCCCGTGGAAACGGGCCTTTCTAGGGTTTAGCTTCACACCGGAACGAAAAGCG 
B.st            GTGGACCGCCCGTGGAAACGGGCCTTTCTGGGGTTTAGCTTCACACCGGAACGAAAAGCG 
                ***************************** ****************************** 
 
NZ              CGAATCCGGCTTGCCCCAAGGTCGATTCAACGTCTGAAACAGCGGATTCGACAGCTGACG 
B.st            CGAATCCGGCTCGCCCCAAGGTCGATTCAACGTCTGAAACAGCGGATTCGACAGCTGACC 
                *********** ***********************************************  
 
 
NZ              AACCCAAACTGGAGCCTATCGATGCCAGAACGAATTCATCGTGTCCATCAATACGTCATG 
B.st            AACCCAAACTGGAGCATATCGATGCCAGAACGAATTCATCGCGTCAATCAATACGTCATG 
                *************** ************************* *** ************** 
 
NZ              GGATGGATCGGGTATTTTCGGCTCGTCGAAACCCCGTCTGTCCTTCAGACCATCGAAGGA 
B.st            GGATGGATCGGGTATTTTCGGCTCGTCGAAACCCCGTCTGTCCTTCAGACCATCGAAGGA 
                ************************************************************ 
 
NZ              TGGATTCGGAGGAGGCTTCGACTCTGTCAATGGCTTCAATGGAAACGGGTCAGAACCAGA 
B.st            TGGATTCGGAGGAGGCTTCGACTCTGTCAATGGCTTCAATGGAAACGGGTCAGAACCAGA 
                ************************************************************ 
 
NZ              ATTCGTGAGTTAAGGGCGCTGGGGTTGAAGGAGACAGCGGTGATGGAGATCGCCAATACC 
B.st            ATCCGTGAGTTAAGAGCGCTGGGGCTGAAAGAGACAGCGGTGATGGAGATCGCCAATACC 
                ** *********** ********* **** ****************************** 
 
NZ              CGAAAAGGAGCTTGGCGAACAACGAAAACGCCACAACTCCACCAAGCCATGGGCAAGGAC 
B.st            CGAAAAGGAGCTTGGCGAACAACGAAAACGCCGCAACTCCACCAGGCCCTGGGCAAGACC 
                ******************************** *********** *** ********  * 
 
NZ              TATTGGACTGTCCAAGGACTCAAGAGTTTGACGCAACGATATTTCGAACTCCGTCAAGGT 
B.st            TACTGGACCGCTCAAGGGCTCAAGAGTTTGACGCAACGATATTTCGAACTCCGTCAAGGT 
                ** ***** *  ***** ****************************************** 
 
NZ              TAA 
B.st            TGA 
                * * 
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PMIEP1_DNA      TTGAAAGATGCGAAGGGACACGGAAAAAGCATACAACTTCGATTAGAAGGTTTCCTACAT 
PMIEP2_DNA      TTGAAAGATGCGAAGGGACACGGAAAAAGCATACAACTTCGATTAGAAGGTTTCCTACAT 
PMIEP3_DNA      TTGAAAGATGCGAAGAGACACGGAAAAAGCATACAACTTCGATTAGAAGGTTTCCTACAT 
                *************** ******************************************** 
 
PMIEP1_DNA      GAAGATAAGGGAGAGCCTGAAAATAATGTAGAAGCGCCTAGTATAACTTCTACGTCTGAA 
PMIEP2_DNA      GAAGATAAGGGAGAGCCTGAAAATAATGTAGAAGCGCCTAGTATAACTTCTACGTCTGAA 
PMIEP3_DNA      GAAGATAAGGGAGAGCCTGAAAATAATGTAGAAGCGCCTAGTGTAACTTCTACGTCTGAA 
                ****************************************** ***************** 
 
PMIEP1_DNA      AGAGGAAGAAACGATGATAAGGGATGCAGTGAAGGGATGCTTGAAAAGATATTATCCAAG 
PMIEP2_DNA      AGAGGAAGAAACGATGATAAGGGATGCAGTGAAGGGATGCTTGAAAAGATATTATCCAAG 
PMIEP3_DNA      AGAGGAAGAAACGATGATAAAGGATACAGTGAAGGGATGCTTGAAAAGATATTATCCAAG 
                ******************** **** ********************************** 
 
PMIEP1_DNA      GATAATATGAATAAAGCATACAAGAAGGTAAAGGCCAACAAAGGAGCCCCTGGGATAGAC 
PMIEP2_DNA      GATAATATGAATAAAGCATACAAGAAGGTAAAGGCCAACAAAGGAGCCCCTGGGATAGAC 
PMIEP3_DNA      GATAATATGAATAAAGCATATAAGAAGGTAAAGGCCAACAAAGGAGCCCCTGGAATAGAC 
                ******************** ******************************** ****** 
 
PMIEP1_DNA      GGGATGAAAGTAGAAGAACTCTTTGGATATCTCAGACAACACGGAGAAGAATTAAGGCAA 
PMIEP2_DNA      GGGATGAAAGTAGAAGAACTCTTTGGATATCTCAGACAACACGGAGAAGAATTAAGGCAA 
PMIEP3_DNA      GGGATGGAAGTAGAAGAACTCTTTGAATATCTCAAACAACATGGAGAAGAATTAAGGCAA 
                ****** ****************** ******** ****** ****************** 
 
PMIEP1_DNA      GAGCTCCTTGAAGGAAGGTACACCCCGAAGTCGGTAAGGAGGAAAGAAATACCGAAACCG 
PMIEP2_DNA      GAGCTCCTTGAAGGAAGGTACACCCCGAAGTCGGTAAGGAGGAAAGAAATACCGAAACCG 
PMIEP3_DNA      GAGCTCCTTGAAGGAAGGTACACCCCGAACCCGGTAAGGAGGAAAGAGATACCGAAACCG 
                *****************************  **************** ************ 
 
PMIEP1_DNA      GATGGAGGGAAAAGACTACTAGGCATACCAACATCAATTGACAGAGTAATCCAGCAATCC 
PMIEP2_DNA      GATGGAGGGAAAAGACTACTAGGCATACCAACATCAATTGACAGAGTAATCCAGCAATCC 
PMIEP3_DNA      GATGGAGGGAAAAGACTACTAGGCATACCAACAGCAATAGACAGAGTAATCCAACAATCC 
                ********************************* **** ************** ****** 
 
PMIEP1_DNA      ATAGCCCAGGTGTTGACACCTATTTACGAAAAGAAATTTGTAGATAACAGTTATGGATTC 
PMIEP2_DNA      ATAGCCCAGGTGTTGACACCTATTTACGAAAAGAAATTTGTAGATAACAGTTATGGATTC 
PMIEP3_DNA      ATAGCCCAGGAACTGATACCGATTTATGAAAAGAAATTTGTAGATAACAGCTATGGATTT 
                **********   *** *** ***** *********************** ********  
 
PMIEP1_DNA      AGGCCATTACGGGATGCAAAACAAGCCATACGAAAAAGCAAAGAATACCTAAACAAAGGG 
PMIEP2_DNA      AGGCCATTACGGGATGCAAAACAAGCCATACGAAAAAGCAAAGAATACCTAAACAAAGGG 
PMIEP3_DNA      AGGCCATTACGAGATGCAAAACAAGCCATACGGAAAAGCAAAGAATACCTAAACGAAGGA 
                *********** ******************** ********************* ****  
 
PMIEP1_DNA      CATACATGGGTAGTGGACATAGACTTAGAACGCTACTTTGACACAGTCAACCATGACAAA 
PMIEP2_DNA      CATACATGGGTAGTGGACATAGACTTAGAACGCTACTTTGACACAGTCAACCATGACAAA 
PMIEP3_DNA      CACACGTGGGTAGTGGACATAGATTTAGAACGATACTTTGACACAGTCAACCATGACAAA 
                ** ** ***************** ******** *************************** 
 
PMIEP1_DNA      CTGATGAGGATAATATCAAAAGACGTAAAAGATGGCAGAGTGATATCCCTGATAAGGAAA 
PMIEP2_DNA      CTGATGAGGATAATATCAAAAGACGTAAAAGATGGCAGAGTGATATCCCTGATAAGGAAA 
PMIEP3_DNA      CTGATGAGGATAATATCAAAAGACGTAAAAGATGGCAGAGTGATATCCCTGATAAGGAAA 
                ************************************************************ 
 
PMIEP1_DNA      TACCTCAAGAGTGGGGTAATGGTAAATGGGGTAGTAATAGAAACTGAAGAAGGGACTCCA 
PMIEP2_DNA      TACCTCAAGAGTGGGGTAATGGTAAATGGGGTAGTAATAGAAACTGAAGAAGGGACTCCA 
PMIEP3_DNA      TACCTCAAGAGTGGGGTAATGGTAAATGGGGTAGTAATAGAAACAGAAGAAGGGACTCCG 
                ******************************************** **************  
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PMIEP1_DNA      CAAGGGGGACCGCTATCCCCATTACTAAGCAACATAATGCTCCACGAACTTGACGTAGAA 
PMIEP2_DNA      CAAGGGGGACCGCTATCCCCATTACTAAGCAACATAATGCTCCACGAACTTGACGTAGAA 
PMIEP3_DNA      CAAGGGGGACCGCTATCCCCATTACTAAGCAACATAATGCTCCACGAACTTGACGTAGAA 
                ************************************************************ 
 
PMIEP1_DNA      CTAACGAAAAGGGGACACAAGTTTTGCAGGTATGCAGACGATTGCAACATATACGTGAAA 
PMIEP2_DNA      CTAACGAAAAGGGGACACAAGTTTTGCAGGTATGCAGACGATTGCAACATATACGTGAAA 
PMIEP3_DNA      CTAACGAAAAGGGGACACAAGTTTTGCAGGTATGCAGACGATTGCAACATATACGTGAAA 
                ************************************************************ 
 
PMIEP1_DNA      AGCGAGAAATCCGCATATAGGGTGATGGAAAGTATAACAAAATACATAGAGAAGAAATTA 
PMIEP2_DNA      AGCGAGAAATCCGCATATAGGGTGATGGAAAGTATAACAAAATACATAGAGAAGAAATTA 
PMIEP3_DNA      AGCGAGAAATCCGCATATAGGGTGATGGAAAGTATAACAAAATACATAGAGAAGAAATTA 
                ************************************************************ 
 
PMIEP1_DNA      AAGCTAAAAGTGAATAGCAAGAAAAGCAAAGTAGTCAGACCTTGGGACCTCAAATACTTA 
PMIEP2_DNA      AAGCTAAAAGTGAATAGCAAGAAAAGCAAAGTAGTCAGACCTTGGGACCTCAAATACTTA 
PMIEP3_DNA      AAGTTAAAAGTGAACAGGAAGAAAAGCAAAGTAGTCAAGCCTTTGGACCTCAAATACTTA 
                *** ********** ** *******************  **** **************** 
 
PMIEP1_DNA      GGGTTCTCCTTCTACGTGAAAGAAGAGAAGTACGAAATTAGAGTCCATGGAAAATCCATT 
PMIEP2_DNA      GGGTTCTCCTTCTACGTGAAAGAAGAGAAGTACGAAATTAGAGTCCATGGAAAATCCATT 
PMIEP3_DNA      GGGTTCTCCTTCTACGGGAAAGAAGAGCAATACGAAATCAGAGTGCATGAGAAATCCATC 
                **************** ********** * ******** ***** ****  ********  
 
PMIEP1_DNA      AAAGAATTCAAAAAGAAGTTAAAAGGAGAAACGAAGAGAAGCAGTGGAAGAAGCATGGCA 
PMIEP2_DNA      AAAGAATTCAAAAAGAAGTTAAAAGGAGAAACGAAGAGAAGCAGTGGAAGAAGCATGGCA 
PMIEP3_DNA      AAAGAATTTAAAAAGAAGTTAAAAGAAGAAACGAAAAGAAGCAGTGGAAGGAGCATGACA 
                ******** **************** ********* ************** ****** ** 
 
PMIEP1_DNA      TACAGGCTGTCAAGGATAAAACAAATAATAACAGGATGGACAAACTACTATGGAATAGCA 
PMIEP2_DNA      TACAGGCTGTCAAGGATAAAACAAATAATAACAGGATGGACAAACTACTATGGAATAGCA 
PMIEP3_DNA      TACAGGCTGTCAAAGATAAAACAAATAATAACAGGATGGATAAACTACTATGGAATAGCA 
                ************* ************************** ******************* 
 
PMIEP1_DNA      AACATGAAATCGATAGCGGGAAGTCTTGATGGATGGCTTAGAAGGAGAATTAGGATGTGT 
PMIEP2_DNA      AACATGAAATCGGTAGCGGGAAGTCTTGATGGATGGCTCAGAAGGAGAATTAGGATGTGT 
PMIEP3_DNA      AACATGAAATCGGCAGCGGAAAGTCTTGATGGATGGCTTAGAAGGAGAATTAGGATGTGT 
                ************  ***** ****************** ********************* 
 
PMIEP1_DNA      ATCTGGAAGGAATGGAAGAAAATCAAAACAAGGTATAAAAACTTAGTCAAATTAGGGTTA 
PMIEP2_DNA      ATCTGGAAGGAATGGAAGAAAATCAAAACAAAACATGAAAACTTAGTCAAATTAGGACTA 
PMIEP3_DNA      ATCTGGAAGGAATGGAAGAAAATCAAAACAAGGTATAAAAACTTAGTCAAATTAGGACTA 
                *******************************   ** *******************  ** 
 
PMIEP1_DNA      AACATCTACAAAGCATGGGAATATGCAAATACAAGGAAAGGCTATTGGAGAATCTCCAAC 
PMIEP2_DNA      AACACCTACAAAGCATGGGAATATGCAAACACAAGAAAAGGCTATTGGAGGATCTCCAAC 
PMIEP3_DNA      AACACATACAAAGCATGGGAATATGCAAACACAAGAAAAGGCCATTGGAGGATCTCCAAC 
                ****  *********************** ***** ****** ******* ********* 
 
PMIEP1_DNA      AGCCCCATACTTTCAAGAACACTAACTAATAAACACCTTAAGAAAATGGGGTTAACTTCG 
PMIEP2_DNA      AGCCCGATACTTTCAATGACACTAACTAATAAACGCCTTAAGGAAATGGGGTTAACTTCG 
PMIEP3_DNA      AGCCCGATACTTTCAAGAACACTAACTAATAAGCACCTTAAGGAAATTGGATTAACTTCG 
                ***** **********  ************** * ******* **** ** ********* 
 
PMIEP1_DNA      ATCCTGGAAACGTATAACCTAAAGCATGAATTCTGTTGA 
PMIEP2_DNA      ATCCTGGAAACGTATAACCTAAAACATCAATTCTGTTGA 
PMIEP3_DNA      ATCCTGGAAACATATAACCTAAAACATCAATTCTGTTGA 
                *********** *********** *** *********** 
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PMIEP1_PROTEIN      LKDAKGHGKSIQLRLEGFLHEDKGEPENNVEAPSITSTSERGRNDDKGCSEGMLEKILSK 
PMIEP2_PROTEIN      LKDAKGHGKSIQLRLEGFLHEDKGEPENNVEAPSITSTSERGRNDDKGCSEGMLEKILSK 
PMIEP3_PROTEIN      LKDAKRHGKSIQLRLEGFLHEDKGEPENNVEAPSVTSTSERGRNDDKGYSEGMLEKILSK 
                    ***** ****************************:************* *********** 
 
PMIEP1_PROTEIN      DNMNKAYKKVKANKGAPGIDGMKVEELFGYLRQHGEELRQELLEGRYTPKSVRRKEIPKP 
PMIEP2_PROTEIN      DNMNKAYKKVKANKGAPGIDGMKVEELFGYLRQHGEELRQELLEGRYTPKSVRRKEIPKP 
PMIEP3_PROTEIN      DNMNKAYKKVKANKGAPGIDGMEVEELFEYLKQHGEELRQELLEGRYTPNPVRRKEIPKP 
                    **********************:***** **:*****************:.********* 
 
PMIEP1_PROTEIN      DGGKRLLGIPTSIDRVIQQSIAQVLTPIYEKKFVDNSYGFRPLRDAKQAIRKSKEYLNKG 
PMIEP2_PROTEIN      DGGKRLLGIPTSIDRVIQQSIAQVLTPIYEKKFVDNSYGFRPLRDAKQAIRKSKEYLNKG 
PMIEP3_PROTEIN      DGGKRLLGIPTAIDRVIQQSIAQELIPIYEKKFVDNSYGFRPLRDAKQAIRKSKEYLNEG 
                    ***********:*********** * ********************************:* 
 
PMIEP1_PROTEIN      HTWVVDIDLERYFDTVNHDKLMRIISKDVKDGRVISLIRKYLKSGVMVNGVVIETEEGTP 
PMIEP2_PROTEIN      HTWVVDIDLERYFDTVNHDKLMRIISKDVKDGRVISLIRKYLKSGVMVNGVVIETEEGTP 
PMIEP3_PROTEIN      HTWVVDIDLERYFDTVNHDKLMRIISKDVKDGRVISLIRKYLKSGVMVNGVVIETEEGTP 
                    ************************************************************ 
 
PMIEP1_PROTEIN      QGGPLSPLLSNIMLHELDVELTKRGHKFCRYADDCNIYVKSEKSAYRVMESITKYIEKKL 
PMIEP2_PROTEIN      QGGPLSPLLSNIMLHELDVELTKRGHKFCRYADDCNIYVKSEKSAYRVMESITKYIEKKL 
PMIEP3_PROTEIN      QGGPLSPLLSNIMLHELDVELTKRGHKFCRYADDCNIYVKSEKSAYRVMESITKYIEKKL 
                    ************************************************************ 
 
PMIEP1_PROTEIN      KLKVNSKKSKVVRPWDLKYLGFSFYVKEEKYEIRVHGKSIKEFKKKLKGETKRSSGRSMA 
PMIEP2_PROTEIN      KLKVNSKKSKVVRPWDLKYLGFSFYVKEEKYEIRVHGKSIKEFKKKLKGETKRSSGRSMA 
PMIEP3_PROTEIN      KLKVNRKKSKVVKPLDLKYLGFSFYGKEEQYEIRVHEKSIKEFKKKLKEETKRSSGRSMT 
                    ***** ******:* ********** ***:****** *********** **********: 
 
PMIEP1_PROTEIN      YRLSRIKQIITGWTNYYGIANMKSIAGSLDGWLRRRIRMCIWKEWKKIKTRYKNLVKLGL 
PMIEP2_PROTEIN      YRLSRIKQIITGWTNYYGIANMKSVAGSLDGWLRRRIRMCIWKEWKKIKTKHENLVKLGL 
PMIEP3_PROTEIN      YRLSKIKQIITGWINYYGIANMKSAAESLDGWLRRRIRMCIWKEWKKIKTRYKNLVKLGL 
                    ****:******** ********** * ***********************:::******* 
 
PMIEP1_PROTEIN      NIYKAWEYANTRKGYWRISNSPILSRTLTNKHLKKMGLTSILETYNLKHEFC 
PMIEP2_PROTEIN      NTYKAWEYANTRKGYWRISNSPILSMTLTNKRLKEMGLTSILETYNLKHQFC 
PMIEP3_PROTEIN      NTYKAWEYANTRKGHWRISNSPILSRTLTNKHLKEIGLTSILETYNLKHQFC 
                    * ************:********** *****:**::*************:** 
 
 
